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Many human populations spend approximately 90 % of their time indoors, yet 
relatively little is known about the microbial communities associated with indoor 
environments. This is despite knowledge that these microorganisms can contribute to 
adverse health effects, including the acquisition of healthcare-associated infections, 
which cause significant morbidity and mortality. The concept of the ‘indoor 
microbiome’ is relatively new and to date, few studies have been field-based, 
systematic and long-term. Hospitals in particular, are unique environments which 
have been shown to drive microbial evolutionary processes as they contain a 
different sub-set of the human population. The study of the hospital microbiome 
could have important implications for healthcare and infection control.   
This thesis explores a range of methods for investigating microorganisms in different 
indoor environments, including a classroom and outpatient’s waiting areas and wards 
in a hospital. Results show that the classroom is much more heavily contaminated in 
terms of total viable counts (TVCs) of bacteria recovered than the hospital 
environment. This was thought to be attributed to the absence of a strict cleaning 
regime in the classroom. High-touch items were less contaminated than other 
objects, likely due to them being obvious cleaning targets. Potential pathogens, 
including a number of Enterobacteriaceae were cultured from the classroom, 
outpatient’s waiting area and ward. Virus nucleic acid was recovered from an 
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outpatient’s area, including norovirus and rotavirus RNA. Adenovirus DNA was 
frequently isolated throughout a 3 month screening protocol and there appeared to be 
evidence to suggest that a viral marker may be more appropriate than TVCs for 
identifying viral contamination. Human-associated bacteria were found to be 
dominant on a hospital ward over a 12 month longitudinal screening study and the 
presence of numerous bacterial taxa, which may be of concern in the context of 
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Microorganisms such as bacteria and viruses have evolved with primates over 
millions of years and as humans have moved into indoor environments, so too have 
various forms of microbial life. People have long been aware of microorganisms in 
their surroundings and it is thought that exposure to some species may even aid the 
development of the immune system and provide protection from conditions such as 
asthma (1), (2). Despite a large proportion of human populations spending 
approximately 90 % of their time indoors (3), relatively little is known about the 
microbial composition of these indoor environments. Whilst research has been 
conducted in specific indoor locations for specific microorganisms, information 
regarding total microbial populations in human environments is lacking (4). This is 
particularly true of viruses and airborne microorganisms as they can be difficult to 
isolate and quantify (5). The Earth plays host to more than 10
30
 microbial cells (6) 
but despite this abundance, knowledge and understanding of the microbial ecology 




The buildings in which people live, work and socialise and their microbial 
inhabitants are known to have an impact on health. Sick building syndrome (7), 
exposure to moulds from flooding and damp (8), the role of ventilation (9), (10) and 
the role of the environment in the spread of nosocomial infection (11), (12), (13) are 
well documented. In spite of this knowledge, these health issues are still of concern 
and adverse effects linked to indoor spaces continue to be reported.  
The concept of the ‘indoor microbiome’, the ecological community of 
microorganisms within a given space, is relatively new and despite the availability of 
published articles, few studies which analyse the microbial diversity within indoor 
environments have been field-based, systematic and long-term. Currently, there is 
also a lack of standardisation of sampling and analysis methods, meaning that data 
are hard to compare across research groups (14). Therefore, there are a number of 
stand-alone studies that cannot provide practical applications for the research. Few 
studies combine air and surface sampling and little is known about whether 
environmental microbial quantity and composition relates to risk of infection. 
Methodologies to investigate the indoor microbiome have been traditionally centred 
on culture-based techniques but these have a tendency to underestimate the 
complexity of microbial diversity, as it is widely recognised that only  0.1 – 10 % of 
bacteria are cultivable (15), (16), (17). Research that isolates viruses from indoor 
locations is beginning to appear in the literature  (18–21) but the methods are not 
fully developed, so findings tend to be general or inconclusive.  Problems arise due 
20 
 
to the fact that sampling can damage virions (22), the isolation of live virus is 
laborious and costly and some species have no in vitro growth model.  
Nucleic-acid based methods are routinely used in clinical diagnostics, with a number 
of assays available for the simultaneous detection of multiple pathogens but these 
have yet to be validated for use with environmental samples. With the increase in use 
and popularity of non-culture based analysis methods for determining microbial 
diversity, the concept of the indoor environmental microbiome is being introduced.  
Investigating the indoor environment and its associated microorganisms could allow 
a greater understanding of the means of transmission of some pathogens. It could 
also provide information as to the effectiveness of measures designed to reduce 
infection such as cleaning, ventilation, building design, or choice of furnishings. 
Without long-term, in-depth studies to quantify and identify microbial diversity, 
systematic, informed measures to reduce risk cannot be taken. Effective surveillance 
of environmental microorganisms can have a significant benefit to health. For 
example, cases of hospital-acquired pneumonia in Germany due to air-associated 
Legionella pneumophila were reduced from 16.6 % to 0.1 % over the course of a 6 
year sampling and monitoring programme (23).  
There is a need for investigations that are concerned with understanding what is 
present, where, how this changes with regards to temporal factors and importantly, 
why a space may have a particular microbial profile and what that means in terms of 
21 
 
human health. Factors such as increasing drug resistance for example, can mean that 
certain species of bacteria which were once not considered to be of great concern, 
become a health-risk (24). In particular environments, species that are non-
pathogenic to the majority of the population can become a risk, for example to the 
long-term hospitalised (25) or the immunocompromised (26). It is therefore 
important not just to investigate the presence of specific pathogenic taxa. The 
community context of these bacteria must also be understood because the abundance 
of a given pathogen is likely to be a function of the other taxa it interacts with within 
its ecological niche.  
Understanding the causes and consequences of the microbial inhabitants of indoor 
spaces is not only important and interesting from an ecological point of view but is 
vital to reduce or prevent the spread of disease. 
1.2 The indoor microbiome: current research 
The concept of ‘indoor ecology’ as a collaborative effort to understand the microbial 
composition of our environments is relatively new. As previously mentioned, 
culture-based techniques vastly underestimate the diversity of microorganisms 
present but with the advent of molecular techniques, this limitation in our ability to 
discover novel species and gain a better insight into microbial ecosystems has been 
lifted. This has become even more apparent with the recent development and use of 
next-generation sequencing (NGS) which allows the sequencing of vast numbers of 
microorganisms from the same sample, at the same time in a much shorter time 
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period than traditional sequencing.  This technology (discussed further in Chapter 6) 
has led to the initiation of various microbiome projects with a view to understanding 
the microbial communities within us and around us. The Human Microbiome Project 
(HMP), based at the National Institutes of Health, has conducted extensive research 
into the microbial ecology of humans (27). The project has produced microbial maps 
of the human body and aims to discover how changes in the microbiome are 
associated with health and disease. Over 190 scientific articles have been published 
to date by its collaborators since the project’s launch in 2008. Major findings so far 
include the discovery of a link between oral and gut microbiota and atherosclerosis 
and cardiovascular disease (28).   
More recently, the Earth Microbiome Project (EMP) has begun with the aim:  
“...to attempt to characterize the global microbial taxonomic and functional diversity 
for the benefit of the planet and mankind” (29).  
The EMP is aimed at examining global microbial communities using metagenomics: 
the study of genetic material directly extracted from environmental samples, 
metatranscriptomics: the study of transcribed genetic regions directly from 
environmental samples and sequencing to produce a ‘Global Gene Atlas’- a vast 
database of microbial communities. It is proposed that this database will enable 
advances in our understanding of the ecology and evolution of previously unknown 
species. The EMP is predominantly concerned with natural samples such as soil, 
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water and outdoor air and does not currently place a great emphasis on indoor 
environments. However, the Hospital Microbiome Project, as part of the EMP aims 
to conduct large-scale environmental screening of a hospital in the United States 
(US) with a view to investigate microbial communities. The availability of scientific 
literature spanning the last few decades regarding the indoor microbiota indicates 
that this is an area of interest to the scientific community. However, research 
focussed on the analysis of indoor microbial communities has, to date, been 
conducted seemingly haphazardly with no defined standard methodologies or data 
analysis protocols.  
Much of the prior research conducted has been entirely culture-based and has had a 
tendency to focus on the isolation of specific pathogens (30), (31), (32), (33). The 
Microbiology of the Built Environment network (www.microBE.net) is one of the 
only groups attempting to bring together research conducted in this area and 
encouraging collaborative work. In the United Kingdom (UK), research in this field 
is currently very limited with only a few laboratories being involved and none (at the 
time of writing) involved in using NGS technologies to characterise building 
microbiology.   
Table 1.1 shows a very small selection of work reporting bacterial counts and basic 
taxonomic analysis from air and surface samples collected from indoor sources, not 
using NGS.…………….... …………………………………………………………. 
  
Table 1.1: A selection of work reporting bacteria counts and basic taxonomic analysis from air and surface samples 
collected from indoor sources prior to the availability of next-generation sequencing 
Author Location Method 
Culture 
Medium 

































890  / m
3
 (lobby) 





Bartlett (36) School  
Andersen air 
sampler 
TSA 325 / m
3








150 - 1380 /  m
3
 Gram positive cocci 



















Ferroni (40) Cystic fibrosis ward Omega air sampler TSA 583.4 / m
3




Author Location Method 
Culture 
Medium 
Average CFU Predominant genera or groups 
Al-Shahwani (41) Hospital Not reported Not reported 478.6 Not reported 
Okten (42) Paediatric Unit Settle plates 
BHI
d
 with 5% 
blood 
43-234 / plate 
Staphylococcus, Bacillus, 
Corynebacterium  






1 – 85 / m3 
> 3000 / swab 
Bacillus, Micrococcus, 
Staphylococcus, Acinetobacter 
Wojgani (44) Hospital door handles Contact plates TSA > 300 / plate Not reported 
Gaudart (45) ITU Contact plates TSA 350 / plate Staphylococcus 
a) Tryptic soy agar, b) Intensive care unit, c) Coagulase-negative staphylococci, d) Brain-heart infusion
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It can be seen from Table 1.1 that the techniques used are wide ranging, making 
comparison between studies difficult. Variable conditions and differences in the type 
of information gained from sampling mean that, as yet, there is no single method 
used for all applications (46). There is a need for standardisation of sampling 
techniques that can be used to assess the microbial community in an area and 
possibly predict risk to human health. Once risk has been assessed, then action can 
be taken to prevent disease. Quantitative assessment of air and surface 
microorganisms is important in indoor areas where people gather, as high 
concentrations of pathogens may accumulate and outbreaks may occur, such as 
schools, hospitals and prisons. 
1.3 Indoor microbial source and distribution  
Despite not knowing the overall composition of microbial communities in indoor 
spaces, the origins of bacteria which may be present is largely understood. Although 
it may appear obvious, it has only been recently shown that outdoor air and human 
occupancy are among the major contributing factors to the presence of 
microorganisms indoors (47). 
1.3.1 Human microbial sources  
The human body is host to many varied microbial populations which are mostly non-
pathogenic and in some cases as in the gut, for example, can be beneficial. However, 
the body can also carry microorganisms which have the potential to be pathogenic if 
27 
 
the right conditions arise. A number of these potential pathogens can be transmitted 
to other people and into the environment through coughing, sneezing, talking and 
movement. The main source of microbial particles in an indoor environment is 
known to be the presence of humans (10), (35), (48–52). It is estimated that the 
human body sheds approximately 10
7
 skin particles per day (51), which are released 
into the environment and may carry microorganisms. Particles from the respiratory 
tract can attach to the skin or clothing via coughing, sneezing or talking and become 
aerosolised or involved in contact transmission from surfaces (50). Microorganisms 
normally associated with the skin or gastrointestinal tract may also spread to the 
environment through contact by hands (53) or vomiting (54), for example. 
A sampling study conducted in Eastern Europe showed that indoor levels of bacteria 
were higher than in outdoor samples when large numbers of people were present 
(55).  Ambroise et al. concluded the same; that exposure to viable airborne bacteria 
is much higher in the indoor environment and increases with human occupancy. In 
contrast, fungal spores do not often originate from humans and were found in the 
same study to be at much higher concentration outdoors than indoors (52). 
Along with microorganisms which are part of the normal human microbiota, the 
body can  serve as a source of transient microbiota, carrying those species that are 
not normally resident (53). Hands are often the main source of these transient species 
and can carry them from one location to another.  
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The normal human microbiota contains a number of bacteria which have the 
potential for pathogenicity (Table 1.2). Bacterial pneumonia, for example, is most 
commonly caused by Streptococcus pneumoniae and currently accounts for the 
majority of respiratory infection-related deaths and illness in England (56).              
S. pneumoniae is carried in the nasopharynx of approximately 60 % of healthy pre-
school children (57) and rates of colonisation have been shown to be important in the 
spread of the organism in day-care centres (58). Concentrations of viable bacteria 
can be high in indoor settings and this can be further increased depending on the type 
of building, ventilation rates and other environmental factors.  
Table 1.2: Examples of bacteria and their approximate rates of 













100 % 100 % 100 % 25 % 100 % 100 % 
Staphylococcus 
aureus 
25 % 20 % 25 % 100 % <5 % 25 % 
Streptococcus 
mitis 
  25 % 100 % <5 % 25 % 25 % 
Streptococcus 
salivarius 
  100 % 100 %       
Streptococcus 
mutans 
  25 % 100 %       
Enterococcus 
faecalis 






25 %     <5 % 
Streptococcus 
pyogenes 




28-100 %  
children 















Neisseria sp.   
25 % - 
100% 











Escherichia coli <5 % 5-25 % 25 % 100 % 25 % 25 % 
Proteus sp. <5 % 25 % 25 % 25 % 25 % 25 % 
Kingella kingae   
18 % 
children 
        
Pseudomonas 
aeruginosa 
  <5 % <5 % 25 % <5 %   
Haemophilus 
influenzae 
<5 % 75 % 25 %       
Haemophilus 
parainfluenzae 
  77-100 %         
Bacteroides sp.       100 % 25 % <5 % 
Lactobacillus 
sp. 
  25 % 100 % 100 %   100 % 
Clostridium sp.     <5 % 100 %     
Clostriduim 
tetani 
      <5 %     
Corynebacteria 100 % 25 %-100 % 25 % 25 % 25 % 25 % 
Mycobacteria 25 % <5 % <5 % 25 % 25 %   
Actinomycetes   25 % 25 %       
Spirochetes   25 % 100 % 100 %     
Mycoplasmas   25 % 25 % 25 % <5 % 25 % 
Adapted from Todar (59). GI: Gastrointestinal 
 
1.3.2 Other sources of microorganisms 
Whilst the predominant source of microorganisms in an indoor environment is its 
human occupants, other factors can contribute to microbial content. For example, 
30 
 
microorganisms from the outdoor environment will be introduced via outdoor 
clothing, shoes and open windows. Outdoor microorganism composition is 
influenced by the generation of aerosols during agricultural practices, waste water 
treatment, composting, animal husbandry and from landfill sites, soil and water 
bodies (60), (61). As such, it could be expected that a proportion of the indoor 
microbial community is also derived from these sources. The absence of curtains and 
regular floor cleaning have been shown to increase levels of outdoor bacteria in 
hospitals (50) and household environments (62). In a recent project screening 
residential properties, Dunn et al. have shown that the presence of pet dogs 
significantly contributes to the indoor microbiota. They demonstrated that 
differences in bacterial diversity between homes was mainly attributed to the 
presence or absence of a dog (63). This may also apply to other types of pet but this 
has yet to be reported. 
Building work, contaminated furnishings, ventilation systems and overall building 
design can also influence the type of microorganisms found in indoor environments 
and alter the microbial profile (4), (10). Bacterial diversity has been shown to be 
lower in mechanically-ventilated rooms than in those that use open windows (4). 
Sink drain biofilms have also been shown to contribute to air contamination on 
hospital wards. Gilbert et al. found Stentrophomonas maltophilia, Enterobacter 
cloacae and Sphingomonas paucimobilis present in both air samples and in sink 
drain biofilm swab samples taken from the same ward (64). Building design and 
engineering has begun to be recognised as an important factor driving the microbial 
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ecology within a space (4), (65). The correct use of engineering control systems such 
as ventilation and waste disposal is also paramount in reducing the risk of infection. 
When systems such as these are misused or poorly maintained, problems related to 
outbreaks and health can occur. For example, multi-drug resistant P. aeruginosa 
caused a hospital-wide, long-term outbreak between 2005 and 2011 at a London 
teaching hospital when drains became blocked due to inappropriate disposal of waste 
and the sluice room and macerator were misused (66). 
1.3.3 Spatial distribution 
The spatial distribution of microorganisms within an environment appears to be 
largely dependent on the type of materials present, the presence or absence of 
moisture and the touch frequency of surfaces, however, once again, there is 
inconsistency in reports found in scientific literature (67). The majority of research 
into spatial distribution of microorganisms has been conducted in hospitals or health-
care facilities. This is likely due to the fact that there can be some kind of control and 
replication applied to the studies due to the relatively regulated nature of these 
spaces. Particular species have been associated with particular spatial distribution, 
for example Burkholderia cepacia is often found on nebulisers and dental equipment 
and S. maltophilia on wet surfaces and sinks (68).  Acinetobacter baumanii has been 
isolated from hospital bed rails, keyboards, mattresses and curtains (11) and the type 
of material bed rails are made from has been shown to have an impact on the 
survival and transmission of methicillin-resistant Staphylococcus aureus (MRSA) 
(69).   
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Recently, a number of projects have been carried out in the US to determine the 
spatial distribution of bacteria found in indoor environments. In a series of 
publications, it has been demonstrated that different areas within public restrooms, 
residential kitchens and other areas of the home have distinct bacterial communities 
(63), (70), (71). These differences are attributed to the use of the particular area, 
source of the bacteria and the localised surface conditions. It is clear that indoor 
microbiomes are complex and can vary greatly within one room. Studies that provide 
a microbial map of indoor areas are of great importance as they can provide 
knowledge of sources of microorganisms and could possibly be used to track the 
spread of pathogens. 
1.4 Factors influencing the indoor microbiome 
1.4.1 Physical parameters  
Physical parameters such as temperature, relative humidity (RH), ultraviolet light 
(UV), air pressure and ventilation type have been shown to have an effect on the 
survival of microorganisms in the environment (10), (72) and overall microbial 
community structure (4). As these parameters can fluctuate frequently, it could be 
expected that the microbial population may change accordingly. However, 
understanding of how these factors influence microorganism populations and their 
compositions is limited and can be conflicting. Some studies show no correlation 
between microorganism presence and physical parameters. Augustowska et al., for 
example, found no correlation between microorganism numbers and temperature, 
RH or atmospheric pressure in a year-long monitoring study of hospital air (38). 
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Others suggest a correlation does exist; Obbard & Fang found that numbers of 
airborne bacteria were positively correlated to RH but not to temperature on a 
hospital ward (35), whereas Tham & Zurami found that under experimental 
conditions, viable airborne bacterial concentrations were higher at 20 
O
C than at     
26 
O
C (51). Petti et al. agreed that humidity correlates positively with MRSA 
survival time on surfaces (73). A recent study by Kembel et al. showed a significant 
relationship between RH and temperature and the community structure of bacteria in 
indoor air. They demonstrated a difference in the number of taxa present and relative 
abundance in rooms with warm dry air versus those with cool moist air. They also 
found no correlation between ventilation method and pathogen load when testing 
naturally and mechanically ventilated rooms; however, they found that increased 
airflow by either ventilation type did reduce load (4). This has also been 
demonstrated by other studies (74), (75).  
1.4.2 Temporal factors 
Temporal variation in microbial communities has previously been linked to 
meteorological events (76) and season (60), (77). In the indoor environment, where 
the effects of season or weather may be less pronounced, certain activities or 
occurrences may contribute to peaks in microbial recovery, for example increased 
occupancy (52), bed making (78), or vomiting episodes (79). Also, outbreak 
conditions within indoor environments are transient and could influence the 
microbial community composition. The presence of certain taxa within a room may 
be influenced by the microorganisms carried by previous visitors to that room. This 
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is something highlighted by studies that have found if previous occupants of a room 
were colonised or infected with microorganisms, subsequent patients are at greatly 
increased risk of becoming colonised or infected with that same microorganism (80), 
(81), (82), (83). It is important to have knowledge of the ‘baseline’ profile of an 
environment in order to be able to interpret data gathered over a temporal survey. 
The temporal nature of microbial communities in air especially, is acknowledged in 
the literature (84), (85), which highlights the need for more long-term studies in 
order to be able to understand the indoor environment more thoroughly.   
1.4.3 Bacterial survival on surfaces 
Fomites are defined as any object capable of carrying an infectious microorganism 
and include items such as clinical equipment, keyboards and toys, for example. 
Fomites and surfaces are known to contribute to the spread of infection in indoor 
environments (12), (73), (80), (86). The role of inanimate objects in microbial 
transmission was previously controversial and debated but the presence of 
microorganisms on environmental surfaces and objects is now widely recognised, 
though it is often difficult to understand the significance of this. Microorganisms 
involved in infection including Norovirus, Clostridium difficile, Escherichia coli, 
MRSA and Pseudomonas aeruginosa have been shown to survive on inanimate 









Influenza  Aerosolisation after sweeping, 
fomites, coughing and sneezing 
24-48 hours (67) 
Parainfluenza Clothing and surfaces 10 hours on surfaces, 6 hours 
on clothing (87) 
Norovirus Persistent outbreaks, extensive 
contamination, aerosolisation 
RNA survival 7 days, 
surrogate virus 40 days (11) 
SARS-associated 
coronavirus 
Positive cultures from the 
environment 
24-96 hours on fomites (67) 
Candida spp Fomites 3-14 days (88) 
C. difficile Extensive and air Spores: 5 months ,vegetative: 
15 min- 6 hours (81) 
P. aeruginosa Sink drains, biofilms on dry 
surfaces 
33 days on plastic (89) 48 
hours on dry surfaces (90) 
MRSA Extensive and air 4 months (73) 
Enterococcus spp Extensive 48 days on surfaces (91) 
 
1.5 Environmental sampling methods 
1.5.1 Air Sampling 
Air sampling can be passive, whereby particles are allowed to settle by gravity onto 
nutrient agar plates, or active, consisting of drawing air into a sampling device at a 
specified flow rate. Passive air sampling may provide an initial indication of levels 
of microbial contamination but is not quantitative or of use in assessing bacterial 
diversity and will therefore not be discussed further. Methods of active air sampling 
include sampling onto filters from which microorganisms are mechanically removed 
(92), impaction onto solid agar or liquid impingement (93).  
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Choice of sampler depends on study type, required sampling time, portability and 
level of noise generated by the sampler. When quantifying viable microorganisms 
from the air, the ability of a sampler to retain viability (bioefficiency) is important 
(94). However, relying on bioefficiency alone may result in underestimation of 
microorganisms present. A low proportion of total bacteria will actually be 
culturable (95), (96) and particularly high viability losses are reported when dealing 
with Gram negative bacteria (97), (98). When assessing the total diversity of 
microorganisms in the air, molecular downstream processing techniques may be 
more useful, therefore maintaining viability is not always a priority.   
1.5.1.1 Impingers: collection into liquid. 
Impingers are collection vessels which operate under a pump that draws air into a 
collection liquid. Some models claim to have a collection efficiency of almost 100 % 
and collection into liquid may allow for greater flexibility of sample analysis than 
onto agar (99). However, evaporation can occur at long sample durations and pumps 
can only be operated at a low flow rate of 12.5 l / min, the average human breathing 
rate, therefore restricting the number of microorganisms collected.  
1.5.1.2 Impactors: collection on to a surface 
Impactors can be single stage or multi-stage and collect particles onto nutrient agar 
plates. The 6-stage Andersen sampler (Figure 1.1) is designed to collect bioaerosols 
of varying sizes, separating them into 6 fractions as a model of the human respiratory 
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system (51). Collection efficiency has been previously validated in many studies 
(51), (97), (100) and despite the possibility of agar drying out at extended sampling 
times, the sampler is still commonly used. 
The volume of air sampled is limited when using agar-based sampling equipment. 
Sampling larger volumes of air might be expected to produce more accurate results 
but should the total number of  colony-forming units (CFU) collected on agar plates 
exceed 200, it becomes difficult to count individual colonies due to overlapping (49). 
This means that these samplers can only be used for short periods of time. 
 
Figure 1.1: Andersen 6-stage cascade impactor sampler. 
1.5.1.3 Filter samplers 
A range of filter types have been previously used for the capture of airborne 
microorganisms. These include polycarbonate (PC), polytetrafluoroethylene (PTFE), 
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mixed cellulose ester and gelatine. A review by Peccia et al.  found that PC filters 
were the most commonly used for air sampling (101). Comparison studies suggest 
that PC filters are more efficient than PTFE at collecting small viral phages during 
experimental aerosolisation (102). Filters have been shown to have a collection 
efficiency of close to 100 %  for bacteria and viruses but despite this, sample loss 
may occur during removal of microorganisms from the filter prior to processing  
(103). Gelatine filters avoid these losses as they can be completely dissolved in a 
buffer meaning total collection of all material (104). They have also been shown to 
collect viable virus from the air (102).  
The AirPort MD8
®
 (Sartorius Stedim Biotech, Germany) is a portable air sampler 
that can be used with gelatine filters in order to collect airborne microorganisms 
(Figure 1.2). It allows the collection of large volumes of air at flow rates consistent 
with not being damaging to microorganisms. The sampler has been used successfully 




Figure 1.2: Sartorius Stedim AirPort MD8
®
 air sampler with gelatine 
filter. 
 
1.5.2 Surface sampling 
Environmental surface sampling can involve the use of swabs or agar contact plates 
to recover microorganisms (45),  (105), (106).  
1.5.2.1 Swabs 
Overall microbial recovery using swabs tends to be low (< 25 %) as microorganisms 
become trapped within the swab and this means the technique is never truly 
quantitative (107). There are a variety of types of swabs and methods proposed for 
increasing recovery, for example, flocked nylon swabs and the type of wetting 
solution may increase microorganism release (105), (108). There is a lack of 
standardisation of swab type and method across the literature. It is difficult to 
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standardise pressure and pattern of swabbing and this is a recognised limitation of 
the technique. Swabbing is however widely used and can provide useful information 
regarding surface contamination and is suitable for molecular and culture-based 
downstream processing methods.  
1.5.2.2. Swabbing and enrichment culture 
Swabbing followed by enrichment culture is often used when carrying out 
environmental sampling for specific pathogens such as MRSA (109) and 
glycopeptide-resistant enterococci (GRE) (110) and also when isolating pathogens 
from patient samples (111–113). These enrichment steps reduce the time taken to 
obtain positive results and can allow the detection of low concentrations of 
pathogens. Brain-heart infusion medium (BHI) is suitable for the culture of 
fastidious microorganisms from a range of materials and is often used when 
conducting enrichment from swabs  (43), (114).  
1.5.2.3 Contact Plates 
Contact plates are small petri dishes filled with nutrient agar, typically trypticase soy 
agar (TSA) and are generally considered to provide a better measure of viable 
surface microorganisms than swabs when low numbers are expected to be present 
(105). The agar is poured to sit with a slight protrusion from the rim so when pressed 
down onto a surface, it makes contact and bacteria adhere. Again, there are 
limitations to this method and it is only quantitative in as far as it can remove 
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microorganisms from a surface. Also, some bacteria may grow better on a particular 
type of agar than others, so the method is not useful for total diversity studies. 
Contact plates may however, avoid the losses that occur with some swabs as there is 
no intermediate step between surface and growth medium.  
 
1.5.3 Post-sampling processing: culture methods 
To determine total viable counts of microorganisms, culture-based methods can be 
used. Liquid from impinger samples can be plated out onto selective agar when 
assessing bacteria or in vitro cell cultures carried out if investigating viruses. Filters 
can be directly placed onto agar or microbes can be disassociated into fluid which 
can be plated out, or added to cell monolayers.   
Identification of bacteria from cultures can be carried out in a number of ways. Pure 
cultures must initially be obtained, which involves picking colonies from a mixed 
population and sub-culturing until all colonies appear uniform. Morphological 
classification can be achieved by the use of the Gram stain (54), however, this 
technique only allows the visualisation of shape and staining characteristics. To 
identify bacteria further, methods relying on biochemical properties such as the API 
system (Biomerieux, France) can be employed. This system provides identification 
based on the ability of bacteria to produce enzymes, such as catalase, or to 
metabolise certain compounds. While useful for identifying clinical isolates, the API 
system may not be as relevant for environmental strains as reference databases 
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available are not as comprehensive for these types of bacteria. Identification of virus 
from culture is a far more complex procedure and different viruses require different 
cell types to propagate. Therefore, identification of viruses from environmental 
samples using cell culture would involve only attempting to isolate one or a small 
number of selected virus types. This technique is not suitable for the quantification 
or identification of all viruses present in an indoor environment.   
1.5.3.1 Limitations of culture methods 
It is recognised that some bacteria, particularly Gram negatives and viruses can be 
damaged by sampling methods, becoming unculturable (115), (116). This can lead to 
an underestimation of quantity and if a particular genus is more susceptible than 
others to damage, misrepresentation of diversity within a sample.  
Culture-based methods of isolating bacteria from the environment often use a single 
non-selective medium such as TSA [27], which allows detection of a wide range of 
bacteria. Some species, particularly some Gram positives, grow rapidly and may out-
compete others on this type of agar, while other species may require complex 
nutrients and fail to grow on non-specific media. Many types of agar are available 
for the detection of different bacteria, such as mannitol salt agar for Gram positive 
bacteria and blood agar for haemolytic streptococci. In order to attempt to reliably 
isolate all types of bacteria from an area, multiple agar types can be used, as 
highlighted by a year-long study of a composting facility (117) but this can be time-
consuming and expensive. Culture-based methods do not account for the large 
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proportion of bacteria which are unculturable. By definition this group will contain 
unknown and under-defined taxa and may lead to problems when trying to assess 
richness. 
Aside from some taxa not being able to be cultured under any circumstances, a 
proportion of a bacterial population will be in a viable but not culturable state 
(VBNC) (15), (118), (119). This is thought to be induced in response to adverse 
environmental conditions such as low temperature in the case of Salmonella spp. or 
Vibrio spp., for example (15). This might be the case for bacteria in indoor 
environments, particularly pathogens as they will not be in their ‘natural habitat’. 
The presence of VBNC bacteria may again lead to an underestimation of numbers if 
relying on colony counts on agar media.  These bacteria may still pose a risk in an 
indoor environment and therefore must be considered when choosing a sampling 
strategy to assess the indoor microbiota.  
Technical difficulties such as the overlapping of colonies on culture plates can also 
lead to the underestimation or poor interpretation of bacterial counts (115) (Figure 
1.3). Despite these difficulties, a large proportion of investigations carried out that 
are concerned with microbial quantification and identification still rely on culturing 
to some extent. Culture can be a rapid way to identify areas that might be 
problematic in terms of cleanliness and risk in particular indoor environments, or to 
determine the presence of known culturable species. However, culture cannot solely 




Figure 1.3: Tryptic soy agar contact plates showing overlapping and 
merged bacterial colonies leading to difficulty in counting.  
 
1.5.4 Post-sampling processing: molecular methods 
Knowledge and understanding of microbial communities has been greatly 
accelerated by the advent of nucleic acid analysis methods such as the polymerase 
chain reaction (PCR) and the development of deoxyribonucleic acid (DNA) 
sequencing in the 1970s (120). Currently, the most common approach for 
determining the phylogenetic and taxonomic structure of a bacterial community is to 
extract and purify DNA from samples, amplify a universal gene region; commonly 
within the 16S ribosomal ribonucleic acid (16S rRNA) gene, sequence the resulting 
amplicons and analyse the sequence data (121). This method has provided great 
insights into microbial communities from all environments and current rapid 
technological advances mean this knowledge is continuing to increase. Viral 
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identification is also possible without the need for culture and multiple virus types 
can be identified simultaneously from a single sample. 
Nucleic acid amplification techniques provide advantages over culture techniques in 
that they are more sensitive, specific and rapid, allowing more data to be obtained 
quickly. They do not rely on the ability of the organisms to grow and can therefore 
detect viruses, unculturable bacterial species and those in a VBNC state.  
The analysis of nucleic acids for microbial community studies involves extracting 
genetic material, amplifying a specific region of it to detectable or workable 
quantities and often, sequencing the fragments to identify the organism. The choice 
of method is fundamentally driven by the sample type but there are a number of 
issues to be considered that are universal to all sample types and investigations.  Bias 
can be introduced at all stages when assessing microbial communities, from 
sampling through to data analysis and can have an impact on estimations of 
composition and abundance. Whilst some bias is currently unavoidable, steps can be 
taken to reduce it. 
1.5.4.1 Nucleic acid extraction 
A variety of protocols and kits are available for nucleic acid extraction and again, the 
method of choice is determined by sample type and to some extent, the post-
extraction methods to be used. Very little, if any, comparative work investigating the 
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best methods for DNA extraction from indoor swabs and air samples has been 
carried out. Most comparative studies come from investigating human samples (121) 
or environmental samples such as soil and sediment (122).  
DNA extraction involves disruption of the cell, known as cell lysis, followed by 
removal of cell membrane lipids and cellular proteins and purification of nucleic 
acids. Extraction techniques can introduce bias into diversity studies if cell lysis is 
incomplete, if compounds which inhibit downstream processing are co-extracted, or 
by loss or degradation of the nucleic acids. Silica column-based extraction methods 
or the addition of certain reagents such as bovine serum albumin (BSA), formamide 
or polyethylene glycol (PEG) are known to reduce the amount of inhibitors that are 
co-extracted (122), (123). 
Disruption of microorganism cell walls and membranes can be achieved by physical, 
chemical or enzymatic lysis. It is recognised that Gram negative bacteria and viruses 
are more susceptible to lysis than Gram positive bacteria and spores. This can lead to 
overestimation of the number of Gram negative taxa in a sample, should the method 
not be sufficient to lyse all Gram positives. If the lysis step is too harsh, it could lead 
to the underestimation of Gram negative species due to damage to exposed nucleic 
acids. Viruses are also susceptible to damage by shearing and as such, methods may 
need to be adjusted if considering their recovery. The addition of a physical lysis 
step such as ‘bead-beating’ with glass or zirconia beads to extraction protocols is 
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often used to ensure efficient lysis of Gram positive bacteria and spores (101), (124), 
(125).  
Physical lysis methods such as bead-beating often take place in the presence of a 
lysis buffer containing surfactants or detergents to simultaneously disrupt cell 
membrane lipids. Following cell lysis, a centrifugation step ensures separation and 
removal of cell debris. Nucleic acids are associated with proteins inside a cell and 
these must be removed to provide a pure solution. This is most often achieved by 
incubation with an enzyme such as protease or proteinase K. The nucleic acid is then 
purified to remove salts, detergents or other reagents used in the extraction process, 
as they may inhibit further analysis. This can be achieved by precipitating the DNA 
with ethanol, or by binding it to a column and washing a number of times. 
1.5.4.2 End-point polymerase chain reaction 
PCR is widely used to amplify a chosen region of DNA from target microorganisms 
and consists of three stages; 1) denaturation: double-stranded DNA (dsDNA) is split 
into two single strands, 2) annealing: small oligonucleotides that are complimentary 
to a chosen DNA region (primers) bind to the single-stranded template, 3) 
elongation: the chosen region of DNA is amplified. The reaction occurs in the 
presence of enzymes and components that are required for synthesis of new DNA 
strands. This results in the doubling of one dsDNA molecule to become two identical 
molecules. The process is repeated for a number of cycles and results in an 
exponential increase in the amount of DNA present. This large increase in 
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concentration of the target region allows it to be detected, usually by visualising on 
an agarose gel.   
The ability of PCR to specifically detect microbial and viral DNA without the 
concern of culture makes it a powerful tool for the analysis of the indoor 
microbiome. The method can be targeted for the detection of specific 
microorganisms or for broad-range assays such as for the 16S rRNA gene, common 
to all known bacteria and Archaea and can be used alongside further processing to 
allow the detection of multiple bacterial taxa.  
1.5.4.3 Nucleic acid-based analysis- quantitative real-time PCR 
Quantitative real-time PCR (qPCR) allows the detection of PCR products as they are 
being generated, enabling quantification and avoiding the need for gel 
electrophoresis. Fluorescent dyes are included in the reaction mix, either in the form 
of SYBR
®
 green, which binds to all dsDNA, or as probes, designed to be specific to 
the target region. As DNA concentration increases, so does fluorescence and the 
cycle number at which the fluorescence curve crosses a threshold value, the Ct, is 
used to quantify the amount of DNA in the starting sample compared to a standard 
curve. 
qPCR is more sensitive than end-point PCR and can theoretically detect one gene 
copy in a sample. Probe-based assays are highly-specific and can identify small 
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target regions. Primers are used in the same way as for end-point PCR but another 
small oligonucleotide, which is complementary to a region inside the target DNA, is 
also included. The probe is synthesized with a fluorescent dye, known as a 
fluorophore, attached to one end and a compound which prevents it from fluorescing, 
a quencher, attached to the other end (Figure 1.4). The probe binds to the target 
region of nucleic acid and as the strand is copied by the PCR reaction, the 
fluorophore is cleaved from the probe. Fluorescence is detected by the qPCR 
instrument and is translated into DNA copy number.    
 
Figure 1.4: Diagram of primer and probe binding and fluorescence in 
qPCR. 
qPCR can be used to identify and quantify specific microorganisms in samples from 
indoor environments and is a useful tool for this purpose (126), (127), (128). The 
routine use of specific molecular-based detection methods has the potential to have a 
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significant impact on public health. The rapid molecular detection of viruses such as 
the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) or avian 
influenza from the air in prisons, schools and nursing homes, for example, could 
allow for physical barriers to infection to be implemented, preventing large 
outbreaks. This could also be true for bacteria such as Mycobacterium tuberculosis 
(Mtb) which is difficult to grow with samples taking weeks to show positivity. The 
detection of Mtb in the air with a rapid, specific test could allow the prevention of 
spread of infection as demonstrated by Vadrot et al.  in a hospital environment (129). 
The use of broad-range 16S rRNA gene qPCR to quantify total bacteria in indoor 
environments has so far not been widely investigated. The only information a broad-
range qPCR assay such as this can give is an estimation of gene copy number present 
in a sample and whether it increases or decreases in relation to a parameter (130), 
(131). As such, it is usually carried out only as part of a larger investigation but may 
be useful as a quick indication of microbial contamination or ‘bioburden’.  
1.5.4.4 Limitations of PCR 
End-point PCR as described, has practical detection limits between 8.0 × 10
4
 and 4.3 
× 10
6
 gene copies and varies greatly depending on the DNA extraction method used 
and other factors (132). In order to detect a positive result, more than 4.3 x 10
6
 gene 
copies must be present in the in the initial sample as DNA extraction is unlikely to 
ever be 100 % efficient. qPCR can overcome some of this limitation in that lower 
copy numbers are required for successful amplification. Inhibition of a PCR, be it 
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end-point or qPCR, results when a substance present in the sample prevents nucleic 
acid amplification and a false negative result is obtained. Environmental samples 
pose particular problems due to the presence of phenolic compounds, dust, pollen 
and humic acids which are known PCR inhibitors (129), (133). The appropriate 
DNA extraction method can clean up starting material and reduce or remove 
inhibitors. The PowerSoil
®
 DNA extraction kit (MoBio, USA), for example, has 
Inhibitor Removal Technology
®
 which claims to remove 100 % of environmental 
inhibitors but may not be suitable for all sample types. The addition of BSA, dilution 
and filtration have also been shown to remove inhibitors from environmental 
samples (123), (129). Care must be taken with samples of low microbial load, as the 
addition of BSA or other neutralising solutions may itself have an inhibitory effect 
and dilution of the sample to reduce this may result in the removal of target 
microbial sequences. 
1.5.5 16S ribosomal RNA 
Ribosomes are found in all living cells and are responsible for protein synthesis. 
They have 2 subunits and the genes that encode these subunits have been targeted for 
bacterial community analysis. The first molecular investigations attempting to 
characterise microbial biodiversity in environmental samples began in the early 
1980’s and utilised a component of the large ribosomal subunit; 5S rRNA (134).  
Ribosomal RNA (rRNA) was extracted, separated by polyacrylamide gel 
electrophoresis and analysed to provide phylogenetic information. However, this 
method proved only to be of value when analysing simple communities as, being 
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relatively short at 120 nucleotides long, the 5S rRNA could only provide limited 
taxonomic information.  
The 16S rRNA gene was sequenced from E. coli in 1978 and the system of 
nomenclature referring to the nucleotide positions along the gene is still currently in 
use (135).  The gene is approximately 1500 base pairs (bp) long and is present in all 
known species of bacteria and Archaea (136). The number of 16S rRNA gene 
operons varies between species and even between individuals within a species, 
ranging from  1 – 14 copies (137). 16S rRNA is a structural component of the small 
subunit of the ribosome and due to its ubiquity and key cellular function, the gene 
contains regions of highly conserved sequences. These sequences are interspersed 
with 9 hypervariable regions: V1 – V9, each of which show significant sequence 
diversity between bacterial taxa (138). The presence of highly conserved sequences 
allows the generation of universal PCR primers; designed to be complimentary to 
part of the conserved regions. These primers are designed to capture and amplify a 
portion of the 16S rRNA gene that contains at least one hypervariable region (Figure 





Figure 1.5: Schematic of the 16S rRNA gene showing approximate 
locations of hypervariable regions V1 – V9 and examples of primer 
pair locations. Matching colours indicate complementarity. Adapted 
from Amann et al. (15). 
1.5.5.1 16S rRNA gene microbial community analysis 
Microbial community analysis using the 16S rRNA gene began in the mid-1980’s 
and was shown to be a rapid method to gain a large amount of information (139). 
Methods have traditionally used PCR of 16S rDNA followed by the generation of a 
genetic ‘fingerprint’ of the target microbial community. After PCR, the fingerprint 
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can be generated by a number of methods including those that utilise the sequence 
variation present in the amplicons such as; Denaturing Gradient Gel Electrophoresis 
(DGGE), Temperature Gradient Gel Electrophoresis (TGGE) and Terminal 
Restriction Fragment Length Polymorphism analysis (T-RFLP) or those that use the 
differences in length of generated amplicons such as; Ribosomal Intergenic Spacer 
Analysis (RISA) or length-heterogeneity PCR (LH-PCR). All of these methods 
allow a picture to be produced, either from an agarose gel or a chromatogram of 
fluorescent peaks, with each band or peak theoretically corresponding to one 
bacterial taxon. This allows the diversity of samples to be compared and intensity of 
bands or peaks theoretically corresponds to relative abundance within a sample. 
The above methods are useful for detecting changes in microbial communities over 
time or in response to changing factors, however they have a number of limitations. 
Primarily, they do not allow the direct identification of bacterial taxa from samples. 
Bands can be cut from gels and sequenced but the ‘gold standard’ for identification 
of bacteria within a mixed sample has traditionally been through the generation of 
clone libraries. This technique is still in use but has limitations due to the relatively 
small number of fragments that can be analysed. NGS techniques are gaining 
popularity as they allow the theoretical sequencing of all 16S rRNA genes within a 
sample without the need for a cloning step. A review of NGS technologies is given 
in Chapter 6. 
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The use of the 16S rRNA gene for bacterial identification through sequencing has 
been pivotal in clinical research and practice. In 1991, the use of the technique 
allowed the characterisation of a previously unknown, unculturable actinomycete; 
Tropheryma whippelii. This was identified as the causative agent of Whipple’s 
disease, a systemic infection commonly involving the duodenum and small intestine, 
resulting in fever, pain and diarrhoea (140). The use of 16S rRNA gene PCR for the 
detection of low copy number or unculturable bacteria in clinical samples was 
proposed in 2003 by Harris and Hartley and is currently in routine clinical use at 
GOSH and other NHS Trusts (141). 
Sequencing of the 16S rRNA gene has been widely used to identify community 
structures of bacteria from indoor environments (142), soil and aquatic samples, 
(143), (144), (145) as well as for clinical diagnosis (141) and analysis of bacterial 
community structure related to periodontitis (146). It has also been demonstrated that 
16S rDNA PCR-based methods are valid and useful when analysing the 
microbiological community within air (95), (101).  
There is currently no consensus on which hypervariable regions of the 16S rRNA 
gene should be targeted to provide the most accurate bacterial identification. 
Comparative work has been carried out using many primer sets to determine the 
optimum hypervariable region to amplify. Chakravorty et al. reported  that region V6 
(nucleotides 986 -1043), despite being the shortest of the hypervariable regions at 56 
bp, was the most heterogeneous, thus providing the best discriminating power (138). 
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They found that using the V6 hypervariable region, they could distinguish all but the 
most closely related of the Enterobacteriaceae; Escherichia sp., Shigella sp. and 
Salmonella sp. Wang et al. also found that the amplifying the V6 region could reduce 
the bias observed when amplifying other regions. Although, they reported only 91 % 
coverage when amplifying the V6 region, meaning that 9 % of bacteria in a sample 
were not identified (147). The V4 region currently appears to be the most popular 
choice for environmental studies, likely made so by the pioneering work of Caporaso 
et al. using Illumina MiSeq NGS technology (145). The V4 region is also used for 
NGS studies in the Earth Microbiome Project (29).   
1.5.5.2 Limitations of 16S rRNA gene PCR  
Copy number of the 16S rRNA gene varies among and within bacterial species and 
this can influence the sensitivity of a PCR reaction and can lead to over- or under-
estimation of members of a bacterial community (137). Sequencing of the 16S rRNA 
gene classifies bacteria well at the genus level; however, there can be limitations 
when species-level identification is required. Some closely-related bacterial species 
share a high homology in the 16S rRNA gene sequence. Neisseria species, for 
example, show up to 96 % homology between pathogenic and non-pathogenic 
strains, therefore they are difficult to distinguish using this method (148), (149), 
(150). Identification of bacteria is dependent on the scope of the available database 




If a PCR primer is chosen to amplify a broad range of microorganisms, it is likely 
that even with the utmost care, contamination will be a concern. Some studies have 
shown that contamination of PCR assays can be caused by the PCR reagents 
themselves, especially Taq polymerase, as it is of bacterial origin (152), (153). The 
use of ultra-clean PCR reagents, reduction in number of PCR cycles, cleaning of 
equipment with DNAase (Ambion, UK) and separation of nucleic acid extraction, 
PCR set-up and post-PCR manipulation steps can reduce the chance of 
contamination occurring (154). 
Bias can be introduced at all stages during molecular analysis of microbial 
communities, as previously discussed regarding cell lysis. The PCR step is 
recognised as one of the major factors contributing to biased results. Preferential 
amplification of certain templates over others is known to occur, along with the 
formation of chimeric sequences (15), (155). Chimeras are formed due to the 
elongation step of the PCR being terminated prematurely or by the annealing of 
highly conserved regions of 16S rDNA from different species (15) and can lead to 
incorrect identification in community analysis studies.  
16S rDNA end-point PCR alone cannot be used to quantify relative abundance of 
bacterial taxa in a sample due to the differing numbers of gene operons between 
species. This also makes qPCR only semi-quantitative as multiple fluorescent signals 
do not always correspond to multiple bacteria. 
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1.5.6 Alternatives to 16S rRNA gene PCR for culture-
independent bacterial identification 
Other gene targets can be used to identify bacteria from samples. These include 
genes encoding for bacterial proteins such as topoisomerases which contain 
conserved and variable regions similar to those encoding 16S rRNA. Bacterial DNA 
gyrase and topoisomerase IV each have 2 subunits and the gyrB and parE subunits 
have been used as alternatives to 16S rRNA gene analysis when attempting to 
identify bacteria (156). These techniques have also been shown to be good at 
discriminating very closely-related bacteria such as species of Pseudomonas, 
Bacillus, and Enterobacteriaceae (157) and may therefore be a useful tool in clinical 
diagnostics.  
Non-nucleic acid-based methods to identify bacteria have also been suggested in 
recent studies. Fox et al. suggest the use of modified matrix-assisted laser 
desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF MS) which 
uses peptides to differentiate bacteria based on peptide sequences (151).  Each 
protein has a unique signal and can provide species-level identification (158). 
However, in the Fox et al. study, air was sampled onto agar culture plates prior to 
colony isolation and analysis, meaning that only the culturable fraction was 
identified. This is common when performing MALDI-TOF MS analysis, meaning 
that it may be more suitable for use in analysing factors such as drug-resistance after 
a molecular survey has been carried out (159). 
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1.6 Hospitals, nosocomial infection and the role 
of the environmental microbiome.  
The study of the indoor microbiota is of importance in places where people are 
present and may be at risk of infection. Hospitals are unique environments that have 
been shown to drive microbial evolutionary processes, for instance, the emergence of 
vancomycin-resistant enterococci (VRE), as they contain a different sub-set of the 
human population and antibiotic use is frequent (160), (161). Hospitals by their very 
nature are temporary homes to those with infections, immobilised people who are at 
risk of contracting infections due to proximity to others and those who are more 
susceptible to infection than the general populous. The indoor microbiome of a 
hospital is therefore likely to be largely influenced by the people present and may 
contain a disproportionate number of pathogens compared to other environments. 
Certainly, information available at present regarding bacteria within hospitals is 
largely focussed on pathogens and their spread throughout these environments. The 
hospital indoor microbiota may have different characteristics than that of other 
indoor environments due to the populations present, cleaning regimes, use of 
antibiotics and overall building design. It has recently been discovered by Vickery et 
al., when investigating microbial contamination of a hospital, that bacteria can form 
biofilms on dry surfaces (162). This changes survival characteristics for species 
within these biofilms, making them on average 100-250 times more resistant to 
chemical and physical removal and possibly even up to 1500 times more resistant 
(162).  The presence of biofilms must clearly now be born in mind when considering 
hospital environmental sampling. Other research has found that outbreak strains 
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within hospitals tend to be more resilient and resistant than sporadic strains (73). 
This research is beginning to aid our understanding of the hospital microbiome and 
may potentially lead to novel design and intervention strategies.  
Studies investigating the hospital microbiota could shed light on not only what is 
present in the environment but how effective cleaning strategies are, where different 
species accumulate and what role the environment plays in cross-transmission of 
disease. They could highlight problem areas and discover design and usage issues 
within particular facilities (66). Currently, much research into hospital cleanliness 
attempts to use total aerobic counts on surfaces to quantify risk of infection (163), 
(164). However, without knowing what species are present, this is impossible and 
NGS-based community studies could fill this gap in knowledge. 
1.6.1 Infection control and the hospital environment 
1.6.1.1 Healthcare-associated infections 
Healthcare-associated infections (HCAI) are defined by the Department of Health 
(DH) as;  
“Any infection by any infectious agent acquired as a consequence of a person’s 
treatment by the National Health Service (NHS) or which is acquired by a health 
care worker in the course of their NHS duties“ (165).  
HCAIs are an increasing threat to human health and are of particular concern in at-
risk groups such as the very young (166), (167), elderly (168), those with indwelling 
61 
 
devices such as catheters (33), (169), or the immunocompromised (170). HCAIs 
adversely affect the quality of the UK health service, as well as being a problem 
worldwide and are estimated to cost the NHS over £1 billion per year (171). The 
emergence of multi-drug resistant strains of bacteria such as Mtb and S. aureus and 
new strains of viruses such as influenza has also led to increasing concern for 
healthcare workers (172). It is therefore understandable that a large proportion of 
research into environmental contamination and transmission of infection has been 
carried out in hospitals, particularly on wards (38), in operating theatres (50) and in 
clean rooms (98). However, these studies have a tendency to look at specific 
pathogenic organisms such as Mtb (173), C. difficile (174), or A. baumanii (175), or 
at specific locations that are perceived as higher risk. Despite this research, the 
problem remains that the relationship between levels of environmental 
microorganisms and incidence of infection is still not clear (10). 
1.6.1.2 Hand hygiene 
Infection control policies are often focused on hand-hygiene practices to reduce the 
spread of HCAI (53). The hands of those who come into contact with patients, such 
as doctors, physiotherapists, parents and nurses have been shown to become 
contaminated and are therefore a potential vector for the spread of microorganisms 
within the hospital environment. Rate of acquisition of bacteria on the hands of 
hospital staff was shown by Pittet et al. to occur at a rate of 16 CFU per minute of 
patient care (53). 
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Despite the focus on hand hygiene to reduce transmission of infection, hand hygiene 
policies have been shown to be difficult to enforce and are not always adhered to 
(176). This may imply that when it comes to reducing frequency of HCAI, other 
targets may be more effective. A recent long-term study showed that despite a 
reduction in environmental contamination and in hand-carriage of MRSA through an 
enhanced cleaning regime, the incidence of patient acquisition of MRSA was not 
reduced (177). This could suggest that the air may play a role in cross-transmission 
of this and other pathogens and it certainly highlights that there is more to learn 
regarding the mechanisms of spread of nosocomial disease. Environmental sampling 
for the presence of clinically important viruses is still in its infancy, as sampling for 
viruses poses unique challenges, as discussed. This means that viral distribution and 
environmental transmission risks are even less understood than for bacteria.  
 More research into the communities of microorganisms present in hospitals is vital 
as these are locations where people who are particularly vulnerable to infection 
spend time. Many patients are more susceptible to acquiring infections or becoming 
colonised with potentially pathogenic bacteria than healthy individuals (178), (179) 
and some are staying long-term in an environment where antibiotic-resistant and 
nosocomial microorganisms may be endemic (167), (180). As such, levels of 
environmental contamination should be monitored closely and should perhaps be 




1.7 Clinically important pathogens 
Many bacteria have the capacity to become pathogenic under the right 
circumstances. The extent of pathogenicity relies predominantly on bacterial factors 
but also on host factors, such as susceptibility, reduced immune-competence or the 
presence of in-dwelling devices. Bacterial drug-resistance is widespread and makes 
it difficult to control infection. Presented below is a brief overview of selected 
microorganisms that are of clinical concern, particularly in healthcare environments.  
 
1.7.1 Enterobacteriaceae 
The Enterobacteriaceae is a large family of Gram negative, rod-shaped bacteria 
containing many genera that are part of the normal human microbiota, particularly of 
the gut. It also contains numerous taxa of clinical concern, mainly due to their ability 
to acquire and share drug-resistance genes. Clinically-relevant taxa include 
Klebsiella spp., Proteus spp., Enterobacter spp., Serratia spp., and E.coli.  
Gram negative Enterobacteriaceae, specifically those carrying drug-resistance genes, 
such as the extended spectrum beta-lactamase (ESBL)-producers, are the cause of a 
large proportion of HCAIs (181). Bacteraemia caused by resistant Gram negative 
bacteria has increased in the UK over recent years and is associated with increased 
mortality (182). Klebsiella pneumoniae, E. coli and E. cloacae cause a large 
proportion of nosocomial infection and are responsible for a wide range of clinical 
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presentations including urinary-tract infection (UTI), gastrointestinal infection, 
wound infection, bacteraemia and meningitis (181). ESBL-producing E. coli is also 
frequently isolated in community-acquired infections, particularly UTIs (183). 
1.7.2 Clostridium difficile 
C. difficile is Gram positive, anaerobic and spore-forming. It can be found in the 
normal gut flora of a low percentage of healthy adults (3 %), in a higher percentage 
of hospitalised adults (20-30 %) (184) and asymptomatic carriage in the guts of 
neonates is common (185). Clinical presentation of C. difficile infection is most 
commonly in the form of acute diarrhoea but infection can lead to severe colitis 
resulting in death (185), (186). Transmission predominantly occurs via the faecal-
oral route but episodes of diarrhoea can lead to heavy localised environmental 
contamination and evidence also suggests that spores can become airborne and 
deposit on surfaces further from the bed space (174). C. difficile colonisation usually 
occurs as a result of either cross-infection or the use of antibiotics which allow 
proliferation in the gut. Spores are highly resistant to environmental conditions and 
can persist for up to 5 months (87). 
1.7.3 Acinetobacter species 
Acinetobacter spp. are Gram negative bacilli, found in soil and on the human skin, 
oropharynx and perineum as part of the normal microbiota (186), (187). A. baumanii 
is the most frequently isolated species in cases of infection but other species such as 
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A. lwoffii, A. johnsonii and A. soli have also been associated with disease (187), 
(188).  
Pneumonia and lung infections are the most common presentations of Acinetobacter  
infection but a wide range of other infections can occur such as endocarditis, UTI, 
wound sepsis and bacteraemia (189). A. baumanii is one of the most common causes 
of neonatal bacteraemia and meningitis (190). Multidrug-resistant strains are 
commonly reported and are associated with poor clinical outcome and increased 
mortality (191), (192).  
Acinetobacter spp. are resistant to some disinfectants and irradiation, form biofilms 
and can utilise many substrates to provide energy, therefore are found to persist in 
the environment, particularly in healthcare settings (187), (192), (193). Transmission 
routes are not clear but the environment is known to play a key role in hospitals, in 
particular. Recently, A. baumanii was isolated from the air in rooms of infected 
patients, indicating an air-associated transmission mechanism which might account 
for the rapid spread of pneumonia in outbreak conditions (194). 
1.7.4 Pseudomonas aeruginosa 
P. aeruginosa is a Gram negative aerobic rod and is considered an opportunistic 
pathogen of clinical relevance (59). It is ubiquitous in soil and water but can infect 
almost any tissue in the body when host defences are weakened, particularly in the 
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case of burns, cancer, cystic fibrosis and acquired immunodeficiency syndrome 
(AIDS).  
Infection with P. aeruginosa can cause bacteraemia, cellulitis, pneumonia, UTI, 
endocarditis and neonatal diarrhoea (178). Nosocomial transmission has been shown 
to be linked to poor drainage and poor maintenance of water systems  (66), (170).   
P. aeruginosa readily forms biofilms and is of particular concern in a hospital 
environment as it is resistant to temperature fluctuations, salts, antiseptics, 
disinfectants and many antibiotics (59,66). Other Pseudomonas species have also 
been associated with infection, such as P. putida, causing neonatal bacteraemia 
(195), (196) or P. stutzeri, causing endocarditis (197) but these are less frequently 
reported. 
1.7.5 Staphylococcus aureus  
S. aureus is Gram positive, found in the nasal passages of approximately 20 % of the 
human population and causes a range of clinical symptoms from superficial skin 
problems to more serious infections such as bacteraemia and pneumonia (186), 
(198). S. aureus is also implicated in around 50 % of surgical site infections in the 
UK (171).  MRSA is resistant to a wide range of antibiotics and up to 50 % of S. 
aureus isolates in an area can be of this type (198).  Rates of MRSA infection in the 
UK have been in decline over recent years, likely as a result of changing antibiotic 
prescribing practices and increased screening and decolonisation practices (171) but 
still remains a significant cause for concern, both in healthcare and community 
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settings. MRSA is rapidly shed into the environment, where it can survive for 
extended periods of time and is easily transferred to the hands and clothing of 
healthcare workers (13). 
1.7.6 Drug-resistant enterococci 
Enterococcus is a genus of Gram positive cocci and contains species of clinical 
concern including E. faecalis and E. faecium, both of which are present as part of the 
normal human gut microbiota. E. faecium is more commonly-associated with 
outbreaks (199) and causes endocarditis, UTI, wound infection and bacteraemia with 
infection rates increasing due to increased drug-resistance (200). VRE are widely 
reported and have a high level of resistance to multiple antibiotic classes (198). 
Enterococci express a surface protein which allows the formation of biofilms and can 
colonise the skin and abiotic surfaces, changing rapidly between the two niches and 
demonstrate extended environmental survival (198). VRE rapidly contaminate 
surfaces and can survive for up to 2 months, causing prolonged and recurrent 
outbreaks (110). VRE transmission is thought to predominantly occur person-to-
person, likely through unwashed hands and via fomites (83). 
1.7.7 Viruses 





With the exception of Aspergillus spp. and some filamentous fungi of the order 
Mucorales, fungi do not tend to cause outbreak-scale infections. Yeast and fungal 
infections such as those caused by Candida spp., Pneumocystis spp. and 
Cryptococcus spp. can be of concern in immunocompromised patients. However, it 
was decided that, as the risk is relatively low and studies have been carried out into 
environmental contamination with some fungal species (201), (202), (203), (204), 
investigation into fungal contamination was outside the scope of this project. 
1.8 Infection and paediatric patients 
Pathogens of concern within healthcare environments currently include MRSA, 
VRE, C. difficile, drug-resistant and multi-drug resistant Enterobacteriaceae (MDE) 
such as ESBL-producing Klebsiella spp or E.coli, Norovirus (NV), Acinetobacter 
spp. and other antibiotic resistant bacteria (13), (161), (184), (182), (205). Within a 
paediatric environment, enteric and respiratory viruses such as NV, Adenovirus 
(AV), Rotavirus (RV) and respiratory syncytial virus (RSV), among others, represent 
additional challenges. Children tend to be more vulnerable to viral infections than 
older people due to the immaturity of their immune systems or the absence of 
vaccinations given at an older age (167), (206), (207). Children also have additional 
risk factors in the acquisition of disease; in addition to immunological naivety, they 
are often in close physical contact with their carers, visitors and other patients whilst 
in hospital, which may facilitate the spread of infection (167). Children may also 
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contribute to environmental contamination in different ways than adult populations. 
They can acquire disease early and may shed microorganisms, particularly viruses, 
for lengthened periods of time whilst remaining asymptomatic (167), (208), (209), 
(210), (211). Children are more likely to be admitted to hospital with infections that 
are related to community epidemics, such as respiratory and gastrointestinal viruses, 
and may therefore be a source of transmission within the setting of a vulnerable 
patient population.  
1.9 Aims of the project 
The aim of this project is to contribute towards the understanding of the microbiota 
of indoor environments.  It has been demonstrated that knowledge of bioburden and 
compositions of microbial communities in indoor environments and what this might 
mean to those who use those spaces is incomplete. At the time of writing, long-term 
environmental sampling studies investigating microbial diversity of different indoor 
environments have rarely been carried out. This is particularly true of hospitals but 
also of comparative studies of different indoor spaces and those that use a variety of 
techniques.  
The following thesis will be focussed on filling the identified gaps in the literature 
and the results gained from achievement of these aims will allow improved sampling 
of different indoor environments and increased knowledge of bacterial and viral 
communities within healthcare and educational settings. This study will allow an 
understanding of the microbial biodiversity within indoor environments and may 
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identify potential reservoirs of infection, providing practical applications for the 
knowledge obtained. This project introduces the concept of looking at an indoor 
environment as a distinct ecosystem. 
The project aims to identify: 
1) If levels of microbial contamination and taxonomic composition are different 
in healthcare and educational settings. 
2) If viruses can be isolated from the air and surfaces in a healthcare 
environment and what factors may influence this.  
3) If microbial numbers and community composition change over the course of 
a year on a new hospital ward and if the causes and consequences of any 
observed changes can be identified. 
The achievement of these aims is described through the following thesis, the 












The protocols detailed below use the best available and practicable techniques with a 
view to ensure that the highest possible quality of data was obtained. In order to 
determine the optimum environmental sampling and molecular methods to use for 
this study, validation experiments were carried out. These involved testing methods 
currently in use at Great Ormond Street Hospital (GOSH), the Eastman Dental 
Institute and from the literature to determine their suitability for the project. The 
results are presented in Chapter 3.  
2.1 Safety, sterility and quality control 
All laboratory techniques were carried out using good laboratory practice, aseptic 
technique where required and in accordance with local health and safety protocols, 
risk assessments and Control of Substances Hazardous to Health (COSHH) 
regulations. Where necessary, equipment, consumables and media were steam-
sterilised in an autoclave at 121 
O
C for 15 minutes or in a dry oven at 180 
O
C for up 
to 2 hours. Plastic-ware, filters, pipettes and reagents for molecular analysis were 
exposed to UV-light at 254 nm for 30 minutes to eliminate the presence of residual 
nucleic acids. 
2. Materials and Methods 
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2.2 Environmental sampling  
Environmental sampling was based on the GOSH Operational Policy for 
microbiological screening of environment and staff (Appendix 1). Changes were 
made to locations and number of sample sites and screening of personnel was not 
conducted.  
2.2.1 Contact plates 
5 cm diameter TSA contact plates (Oxoid, UK) (25 cm
2
) were used to gain a 
quantitative count of culturable bacteria present on surfaces. Plates were pressed 
onto surfaces with an even pressure for 10 seconds. They were then incubated at 37 
O
C for 48 hours prior to counting.   
Plates have a grid on the reverse side to facilitate counting. Counting was conducted 
in a systematic fashion from left to right, top to bottom one square at a time and 
recorded as CFU per plate. Colonies that fell on the right and bottom of a grid line 
were not counted to ensure they were only counted once.  The maximum colony 








2.2.2.1 Swabbing for molecular analysis 
Cotton swabs were used and swabbing was carried out to the immediate right of 
where the contact plate had been taken. The swab tip was wetted in sterile, UV-
irradiated AE buffer (10 mM Tris-Cl with 0.5 mM Ethylene-diaminetetraacetic acid 
(EDTA); pH 9.0) (Qiagen, UK) and run over the entire 10 cm
2
 swab site  
horizontally, vertically and diagonally before snapping into a sterile, UV-irradiated 
microcentrifuge tube with 1 ml AE buffer. Swabs were frozen at -80 
O
C for 
subsequent processing.  
2.2.2.2 Swabbing for enrichment  
Sterile charcoal transport swabs (MWE, UK) were removed from the plastic sheath 
in which they were supplied and wet in sterile, UV-irradiated water (Invitrogen, 
UK). The swab was taken as above (2.2.2.1) and returned to the sheath. In the 
laboratory, swabs were snapped off into bottles containing 3 ml BHI broth (Oxoid, 
UK) and shaken briefly (114) . The tubes were incubated at 37 
O
C overnight. A loop-
full (approximately 10 l) was then streaked out onto blood or chromogenic agar 
plates (Oxoid, UK) which were further incubated for 24 hours at 37 
O
C. The bacteria 




2.2.3 Air sampling  
The Sartorius MD8
® 
Airport portable air sampler was used (Sartorius Stedim, UK) 
(Figure 1.2). Prior to sampling, gelatine filters were placed inside sterile petri dishes 
and exposed to UV-light for 30 minutes on each side. They were loaded onto a 
support mesh on the sampler, using sterile forceps at the sampling location. The air 
sampler was used at a flow rate of 50 l / minute to collect a total of 1000 l of air (1 
m
3
) (49). Filters were removed from the sampler in an aseptic manner into a sterile 
petri dish which was sealed with parafilm and transported back to the laboratory.  
To ensure maximum recovery of airborne microorganisms from the filter and 
dissolution of the gelatine, filters were dissolved in 20 ml of pre-warmed, sterile, 
UV-irradiated phosphate buffered saline (PBS) (Invitrogen, UK). The dissolved filter 
was centrifuged at  40, 200 x g (15,000 rpm) for 20 minutes and the supernatant 
discarded (64). Any collected cells were then stored at -80 
O
C for subsequent 
processing.  This procedure was carried out rapidly to prevent growth of any gelatine 
metabolising bacteria present in the sample. 
2.2.4 Recording of environmental parameters 
Temperature and relative humidity readings were taken at minute-apart intervals for 
the duration of each sampling procedure with HOBO
®
 Data loggers (Tempcon 
Instrumentation Ltd., UK). 
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2.3 Culture methods 
2.3.1 Culture for preparation of known numbers of bacteria 
Cultures were prepared to provide known numbers of bacteria in suspension for 
DNA extraction to provide standards for molecular methods. Bacterial cultures were 
obtained from the American Type Culture Collection (ATCC). Strain numbers are 
given for each species in Table 2.1. Bacteria were sub-cultured onto blood agar 
(Oxoid, UK) and incubated overnight at 37 
O
C. The cultures were then processed 
using the Miles and Misra method described below (2.3.2). 
Table 2.1: Bacteria obtained from the American Type Culture 
Collection 
Bacteria ATCC Number 
Acinetobacter baumanii BAA747 
Elizabethkingia meningoseptica 13253 
Enterobacter cloacae 700323 
Klebsiella oxytoca 700334 
Klebsiella pneumoniae 700603 
Orchobactrum anthropi BAA749 
Proteus vulgaris 6380 
Pseudomonas aeruginosa BAA1744 
Pseudomonas aeruginosa 9721 
Shigella sonnei 25931 
Staphylococcus aureus 9144 






2.3.2 Miles and Misra method 
Quantification of CFU present in bacterial suspensions was determined by the Miles 
and Misra Method (212). Overnight cultures of bacteria were prepared and 10-fold 
serial dilutions made by adding 100 l of culture to 900 l of PBS. 5 x 20 l drops 
of bacterial suspension were pipetted onto agar plates from a height of 2.5 cm. 
Triplicate plates were prepared for each dilution. The plates were left to dry then 
incubated, inverted, for 24 hours at 37 
O
C. Plates of dilutions that showed discrete 
colonies of between 20-200 were counted (Figure 2.1). CFU per ml of original 
suspension was calculated by multiplying the average number of colonies across 3 
plates of the same dilution by 100 (to achieve CFU / ml of diluted suspension) then 
multiplying by the dilution factor: 




Figure 2.1: Miles & Misra preparation of bacterial suspension. a) Low 
dilution with merged colonies which are uncountable. b) Countable 
dilution. 
2.4 Post-culture analysis 
2.4.1 Gram staining  
The following method was employed for the discrimination of Gram positive from 
Gram negative bacteria. A small smear of bacterial culture was applied to a glass 
microscope slide and passed through the flame of a Bunsen burner to fix it to the 
slide. The slide was flooded with crystal violet (Sigma Aldrich, UK) and left for 1 
minute.  The slide was then rinsed briefly with a gentle flow of water, flooded with 
iodine and left for 1 minute. The slide was rinsed again very briefly in water and 
flooded with acetone / ethyl alcohol (50:50 v/v) for no longer than 10 seconds. 
Safranin counterstain was applied to the slide for 30 seconds and the slide was rinsed 
again and left to air dry. Once dry, the slide was observed on a light microscope, 
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under oil immersion (x 100 lens). Purple cells were recorded as Gram positive and 
pink as Gram negative (54). 
2.4.2 Biochemical identification 
Streptococci and staphylococci are both Gram positive cocci and can be difficult to 
differentiate by eye on a culture plate or by Gram stain. They can be differentiated 
by biochemical means. These tests were performed to confirm sequencing data, 
predominantly for the comparative study presented in Chapter 4.  
2.4.2.1 Catalase test 
A small amount of a bacterial colony was picked with a sterile toothpick. The colony 
was then dipped into a solution of hydrogen peroxide (H2O2). If bubbling occurred, 
this indicated the presence of the enzyme catalase which breaks down H2O2 to 
hydrogen and water and the colony was considered to be Staphylococcus (in 
conjunction with Gram stain results). An absence of bubbling was scored as catalase 
negative and if Gram stain showed chains of Gram positive cocci, was assumed to be 
Streptococcus. 
2.4.2.2 Latex agglutination 
In order to determine if the identified Staphylococcus was the S. aureus species, a 
Pastorex
®
 Staph Plus latex agglutination test was performed (Alere Ltd, UK). A 
small portion of a colony was picked with a plastic stick provided and smeared onto 
80 
 
a test card. A drop of test solution was added and the smear and solution blended 
with the stick. At the same time the colony was blended with a negative control 
solution on a different part of the test card. The card was rocked gently by hand for 
30 seconds and the results read by eye. Agglutination was taken to mean the 
bacterial culture was S. aureus (Figure 2.2). 
 
Figure 2.2: Pastorex latex agglutination of Staphylococcus aureus. The 
left sample is negative and the right positive.  
2.4.2.3 Freezing of bacteria 
Bacterial isolates, either pure or mixed, were frozen down by picking colonies from 
the agar plate on which they were grown, into a mixture of sterile nutrient broth and 







2.5 Nucleic acid extraction methods 
2.5.1 DNA extraction from pure bacterial cultures 
For the preparation of DNA from pure colonies, a boiling and bead-beating method 
was used.  A loop-full (10 l) of bacteria was taken from the agar plate and placed in 
a screw-cap 2 ml microcentrifuge tube (Sarstedt, Germany) containing 200 l of 0. 1 
mm diameter zirconia beads (BioSpec Products, USA) and 1 ml sterile, UV-
irradiated molecular grade water (AppliChem GmbH). The cultures were then heated 
to 95
 O
C and vortexed in a Disruptor Genie machine (Scientific Industries, Inc.) to 
disrupt cell walls and membranes. The tubes were then centrifuged at 16, 300 x g 
(13,300 rpm) for 2 minutes and the supernatant was removed to a clean tube. The 
resultant suspension was used as a DNA preparation for further analysis.  
2.5.2 DNA extraction from cotton swabs 
DNA extractions from swabs were carried out using a modified Qiagen DNA mini 
kit column-based protocol. Briefly, swabs were thawed and vortexed for 30 seconds. 
400 l fluid from the swab sample was added to a 1.5 ml screw capped tube 
containing 40 l proteinase K, 200 l 0.1 mm diameter silica beads, 400 l Qiagen 
buffer ATL and 20 l mouse cells to serve as an extraction / internal positive control 
(IPC) and qPCR inhibition control.  The tubes were then vortexed on a Disruptor 
Genie machine for 10 minutes to disrupt cell walls and membranes and placed on a 
shaking heat block at 56 
O
C for 1 hour at 900 rpm.  
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The tubes were centrifuged for 1 minute at 6,000 x g (8,000 rpm) and the supernatant 
removed to 2 fresh tubes per sample (approximately 400 l each). 400 l Qiagen 
buffer AL was added to each tube and the tubes vortexed for 15 seconds. They were 
then incubated at 70 
O
C for 10 minutes with shaking at 900 rpm. 200 ml ethanol was 
then added to each tube, followed by vortexing again for 15 seconds. The lysate was 
then applied to the Qiagen column supplied with the kit. Each sample had 2 tubes, so 
one tube of lysate was applied to the column which was centrifuged at 6,000 x g 
(8,000 rpm) for one minute then the remaining lysate was applied to the same 
column and centrifuged again to bind the DNA.  
The columns were then washed with 500 l Qiagen buffer AW1 and centrifuged as 
above, followed by a wash with 700 l Qiagen buffer AW2 and centrifuging again as 
before. The columns were finally washed with 700 l ethanol and centrifuged again 
before a final centrifugation at 16, 300 x g (13,300 rpm) for 3 minutes to dry the 
column. Columns were further dried by incubating at 56 
O
C with lids open for 3 
minutes to ensure no carry-over of ethanol.  Nucleic acid was eluted in 80 l buffer 
AE and stored at -80 
O
C until subsequent processing.  
Extraction controls were included for each extraction set carried out. This consisted 
of using sterile AE buffer instead of sample to check for any contamination of the 




2.5.3 DNA extraction from gelatine filters 
Gelatine filters were processed as described in Section 2.2.3. Frozen cell pellets were 
thawed and resuspended in 1 ml sterile AE buffer. 400 l of the resuspended pellet 
fluid was processed as above (Section 2.5.2). 
2.6 PCR methods 
2.6.1 16S rDNA end-point PCR 
A number of primer sets and conditions were used to amplify the 16S rRNA gene. 
All primers were from Eurofins MWG Operon, Germany, deoxyribonucleoside 
triphosphates (dNTPs), standard Taq, molecular grade water and PCR buffer all 
Bioline, UK. Moltaq, Molzyme water and buffer were from VH Bio, UK.  
5 l of sterile, UV-irradiated AE buffer was used as a negative, no-template control 
(NTC) in every reaction and positive controls consisted of 1l of genomic DNA 
from Escherichia coli. In order to determine if negative PCR reactions were truly 
negative, PCR inhibition controls were included as necessary.  A duplicate tube was 
prepared for PCR with 4 l template and 1 l positive control DNA (E. coli). If a 
negative result was obtained, the PCR was considered to be inhibited and was 
diluted 1:10 and re-run. Thermocycling was carried out in a G-Storm 482 
thermocycler (Labtech, UK). Conditions differed for different primer sets and are 
outlined below (Tables 2.2 – 2.4). 
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Volume (l) / 
reaction 
PCR H2O - - 34.25 
NH4 buffer 10 X 1 X 5 
dNTPs 10 mM 100 M 1 
MgCl2 50 nM 250 M 2.5 
27F 10 pmol / l 0.2 M 1 
1492R 10 pmol / l 0.2 M 1 
Taq polymerase 5U / l 1.25 U 0.25 
        
Primer Sequences     
27F AGA GTT TGA TCM TGG CTC AG 
1492R ACC TTG TTA CGA CTT 
        
Reference Weisburg (213)   
        
Mastermix added 45 l     
Template added 5 l     
Gene target 16S rDNA     
Amplicon size 1465 bp     
        
Cycling conditions     
Number 30     








Initial (x1) 95 5 minutes   
Denaturation 95 1 minute   
Annealing 54 1 minute   
Elongation 72 1 minute   











Volume (l) / 
reaction 
PCR H2O - - 36.4 
Molzyme buffer 10 X 1 X 5 
dNTPs 25 mM 200 M 0.4 
8A (16SFa) 20 pmol / l 0.4 M 1 
8B (16SFb) 20 pmol / l 0.4 M 1 
3R (16SR) 20 pmol / l 0.4 M 1 
MolTaq 5U / l 1.25 U 0.25 
        
Primer Sequences     
8A (16SFa) GCT CAG ATT GAA CGC TGG 
8B (16SFb) CTC AGG AYG AAC GCT GG 
3R (16SR) TAC TGC TGC CTC CCG TA 
        
Reference Harris & Hartley 
(141) 
  
    
Mastermix added 45 l     
Template added 5 l     
Gene target 16S rDNA V2     
Amplicon size 320 bp     
        
Cycling conditions     
Number 32     
        
Step Temperature (
O
C) Time   
Initial (x1) 94 3 minutes   
Denaturation 94 30 seconds   
Annealing 63 60 seconds   
Elongation 72 60 seconds   










Volume (l) / 
reaction 
PCR H2O - - 37.4 
Molzyme buffer 10 X 1 X 5 
dNTPs 25 mM 200 M 0.4 
785F 20 pmol / l 0.4 M 1 
1175R 20 pmol / l 0.4 M 1 
MolTaq 5U / ml 1.25 U 0.25 
        
Primer Sequences     
785F GGA TTA GAT ACC CBR GTA GTC 
1175R AGC TCR TCC CCD CCT TCC TC 
        
Reference Bonder, (214)   
    
Mastermix added 45 l     




    
Amplicon size 390 bp     
        
Cycling conditions     
Number 32     








Initial (x1) 94 3 minutes   
Denaturation 94 30 seconds   
Annealing 55 40 seconds   
Elongation 72 90 seconds   





2.6.1.1 Barcode 16S rDNA PCR for NGS 
In order for PCR amplicons to be sequenced using the Illumina MiSeq NGS platform 
chosen for this study, primers had to be modified. Adaptor sequences to enable the 
amplicons to bind to a flow cell were attached along with individual barcode 
sequences to allow each sequenced amplicon to be identified (discussed in Chapter 
6). Barcode sequences were obtained from http://www.earthmicrobiome.org/emp-
standard-protocols/16s/ and adapter and linker sequences were designed to be 
specific for the chosen primer set in-house by Ronan Doyle.  
The initial amount of template added was 2.5 l in a 25 µl reaction. However, 
variation occurred within the samples and if amplification did not occur, the amount 
was adjusted sequentially to 3 l, 5 l, and 8 l (reducing the water content 















Volume (l) / 
reaction 
PCR H2O - - 17.13 
Molzyme buffer 10 X 1 X 2.5 
dNTPs 25 mM 200 M 0.2 
785F + adaptor 10 pmol / l 0.4 M 1 
MolTaq 5U / l 1.25 U 0.165 
    
    
    
Primer Sequences   
785F + adaptor AATGATACGGCGACCACCGAGATCTACAC 
TACCGGGACT TA 
GGATTAGATACCCBRGTAGTC 
1175R  CAAGCAGAAGACGGCATACGAGAT BARCODE 
AACACGTTTT AA ACGTCRTCCCCDCCTTCCTC 
    
Mastermix added 21.5 l   
Template added 2.5 l   
Gene target 16S rDNA V5-
V7 
  
Amplicon size 520 bp (390 + 
130) 
  
    
Cycling conditions   
Number 30   








Initial (x1) 94 3 minutes  
Denaturation 94 30 seconds  
Annealing 56 40 seconds  
Elongation 72 90 seconds  





2.6.2 Quantitative real-time PCR  
qPCR was carried out for specific or broad-range targets when it was necessary to 
either attempt to quantify microorganisms or isolate a particular species with a 
technique more sensitive than end-point PCR.  
NTCs were included at least in duplicate by adding AE buffer in place of nucleic 
acid template. Accepted qPCR results had no amplification in NTCs and if a 
standard curve was included, reaction efficiency was within the range of 90 -110 % 
(215). If these criteria were not met, the assay was repeated.  
Primers and probes were from Eurofins MWG Operon. All qPCRs were performed 
on an Applied Biosystems (ABI) 7500 Real-Time PCR cycler (Life Technologies, 
UK) apart from the 16S rRNA gene qPCR assay, which was performed on an ABI 
7300 PCR System Cycler (Life Technologies, UK).  
2.6.2.1 Standard curves  
Standard curves were prepared, if appropriate, using the methods described in 
Sections 2.3.2 and 2.5.1 to quantify cell number and extracted DNA. A ten-fold 
dilution series of DNA was then prepared by diluting in AE buffer. Standard curves 
allow the quantification of DNA in test samples by comparing fluorescence 





A number of different commercially available master mixes were used, depending on 
the assay being carried out. An overview of each is given below.  
Qiagen QuantiTect Master Mix 
The QuantiTect Master Mix contains buffers to allow for efficient multiplexing of 
probe-based qPCR reactions, Uracil-N-glycosylase (UNG) to minimize carry-over 
contamination and HotStar Taq polymerase which requires activation at 95 
O
C prior 
to PCR. It also contains ROX passive reference dye which is required by ABI qPCR 
cyclers for fluorescence normalisation. Annealing and elongation steps are combined 
and fluorescence data are collected during this phase. 
TaqMan® Universal PCR Master Mix 
This master mix contains AmpliTaq Gold and provides an alternative to QuantiTect 
when multiplexing qPCR reactions. It has slightly different cycling conditions due to 
different components. It also contains ROX passive reference dye.  
Power SYBR® Green Master Mix 
Power SYBR
® 
Green Master Mix (Life Technologies, UK) was used for 16S rDNA 
qPCR. It contains the reagents necessary for qPCR and AmpliTaq Gold, a Hot Start 
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Taq polymerase which is ultra-purified to minimise non-specific amplification. 
Power SYBR
®
 Green Master Mix is reported by the manufacturer to be able to 
detect low copy numbers DNA from 1-10 copies per reaction.  
2.6.2.3 Quantitative PCR reaction conditions 



















Volume (l) / 
reaction 
PCR H2O - - 2.5 
Sa-3-F Primer 10 pmol /l 0.4 M 0.5 
Sa-3-R Primer 10 pmol /l 0.4 M 0.5 
CoA Probe 10 pmol /l 0.4 M 0.5 
QuantiTect 
Mastermix 
2 X 1 X 14 
        
Primer Sequences     
Sa-3-F GTA GAT TGG GCA ATT ACA TTT TGA AGG 
Sa-3-R CGC ATC TGC TTT GTT ATC CCA TGT A 
CoA Probe 
FAM- TAG GCG CAT TAG CAG TTG CAT C -
BHQ 1 
        
Master mix added 18 l     




    
Amplicon size 78 bp     
        
Cycling Conditions     
Number  45     








UNG activation (x1) 50 2 minutes   
Taq activation (x1) 95 10 minutes   
Denaturation 95 15 seconds   












Volume (l) / 
reaction 
PCR H2O - - 2.5 
ent-dnak-F 10 pmol / l 0.5 M 0.5 
ent-dnak-R 10 pmol / l 0.5 M 0.5 
dnaK Probe 10 pmol / l 0.5 M 0.5 
QuantiTect 
Mastermix 
2 X 1 X 14 
        
Primer Sequences     
ent-dnak-F ACC TGG GTA CWA CCA ACT CTT GTG T 
ent-dnak-R GTC ACT GCC TGA CGT TTA GC 
Probe FAM- AGG ATG GTG AAA CTC TGG TWG GTC 
AGC C –BHQ 3 
        
Master mix added 18 l     
Template added 10 l     
Gene target Chaperone 
protein dnaK 
    
Amplicon size 78 bp     
        
Cycling Conditions      
Number 45   








UNG activation (x1) 50 2 minutes   
Taq activation (x1) 95 10 minutes   
Denaturation 95 15 seconds   











Volume (l) / 
reaction  
PCR H2O - - 1 
Mus F 10 pmol / l 0.5 M 0.5 
Mus R 10 pmol / l 0.5 M 0.5 
Mus Probe 10 pmol / l 0.5 M 0.5 
TaqMan Master Mix 2 X 1 X 14 
    
Primer Sequences   
Mus F Unpublished – Not included at request of K. Harris 
Mus R Unpublished  
Mus Probe Unpublished  
    
Master mix added 18 ml   
Template added 10 ml   
Gene target Non-coding region   
Amplicon size 73bp   
    
Cycling Conditions   
Number  30   







Taq activation (x1) 95 10 min  
Denaturation 95 15 sec  













Volume (l) / 
reaction 
PCR H2O - - 9 
SYBR Mastermix 10 X 1 X 12.5 
785F 20 pmol / l 0.4 mM 0.5 
1175R 20 pmol / l 0.4 mM 0.5 
    
    
Primer Sequences   
785F GGA TTA GAT ACC CBR GTA GTC 
1175R AGC TCR TCC CCD CCT TCC TC 
    
    
Mastermix added 15 l   
Template added 10 l   
Gene target 16S rDNA   
    
    
Cycling conditions   
Number 40   







Initial (x1) 95 10 minutes  
Denaturation 95 30 seconds  
Annealing 55 40 seconds  
Elongation 72 90 seconds  
Dissociation (x1) 95 15 seconds  
 60 30 seconds  






2.7 Gel electrophoresis 
Different types of gel electrophoresis were carried out to visualise end-point PCR 
reaction products and are detailed below. E-gels
®
 (Invitrogen, UK) offered a time 
advantage over standard gels and often provided better images in gel documentation 
equipment.  
2.7.1 Standard agarose gels 
5 l of PCR product was mixed with 2 l Crystal 5 X DNA loading buffer Blue 
(Bioline Reagents Ltd, UK) and loaded into wells of a 2 % (w/v) agarose gel 
containing 1 l/100 ml Gel RedTM (Biotium, USA). Hyperladder I (Bioline Reagents 
Ltd, UK) was loaded into the first lane of each gel to assess the size of the PCR 
product. Gels were run in Tris/Borate/EDTA (TBE) buffer at 100 V for 
approximately 30 minutes. Gels were visualised under UV-light in a gel imager 300 
nm transilluminator (Protein Simple, USA) and images captured using computer 




 cassette was clipped into a Power BaseTM power pack (both 
Invitrogen, UK) and PCR product to a total volume of 20 l was loaded into each 
well. If 5 l PCR product was loaded, the remainder of the volume was made up by 
adding PCR-grade water. 5 l of Hyperladder I was mixed with 15 l PCR-grade 





 used contained SYBR Safe
®
 DNA stain within them and this allowed the DNA 
to be visualised in the same way as in Section 2.7.1. 
2.7.3 Size SelectTM 2 % E-gels® 
Size SelectTM E-gels
®
 (Invitrogen, UK) allow PCR product to be collected after it has 
run through an agarose gel. This allows targeted recovery of DNA bands of required 
molecular weight for further downstream processing and eliminates the need for 
cutting sections from gels and purifying with a column. This method offers a time 
advantage over traditional gel-purification methods and less potential loss of DNA 
which may occur with a column.  
Size SelectTM E-gels
®
 contain a proprietary fluorescent nucleic acid gel stain which 
allows the visualisation of anything above 1.5 ng of DNA per band to a maximum of 
500 ng and is compatible with the Invitrogen iBaseTM blue light transilluminator 
(excitation/emission at 490/522 nm). 
20 – 25 l PCR product was loaded into each well of a Size SelectTM 2 % E-gel® and 
10 l (250 ng) E-gel® 50 bp ladder (Invitrogen, UK) was loaded into the central well. 
The gel was run on a pre-set program (Number 2) for 15.5 minutes. During this time, 
the PCR product was watched as it migrated through the gel. When the DNA band of 
the correct size reached a reference line, the run was paused and 25 l of PCR-grade 
water was added to the empty collection wells. 
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The run was re-started and the bands of correct size were pipetted out of the well into 
a 1.5 ml low-bind Eppendorf tube (VWR, UK) as they migrated into the water. Size-
selected PCR products were stored at 4 
O
C until required.  
2.8 PCR purification 
In order to clean DNA after PCR to remove salts and unincorporated primers or 
other PCR reaction components, PCR product purification was carried out.  
 
2.8.1 Silica membrane column purification 
PCR products were purified with either a Promega Wizard SV Kit (Promega, UK) or 
a QIAquick PCR Purification Kit (Qiagen, UK). DNA was applied to a membrane 
and contaminants were washed through and discarded. Bound DNA was washed 
twice and eluted in TE buffer (1 mM EDTA with 10 mM Tris) (Invitrogen, UK).  
2.8.2 SephadexTM column purification 
GE illustra MicroSpin G-25 columns (Figure 2.3) hold SephadexTM resin which 
contains pores that allow molecules of differing sizes to pass through at different 




Columns were vortexed briefly to resuspend the SephadexTM. The cap was loosened 
by a quarter of a turn and the base of the column snapped off. The column was 
placed in a collection tube and centrifuged at 735 x g for 1 minute. The column was 
then placed into a fresh 1.5 ml tube and 50 ml PCR product was applied to the top. 
The column was centrifuged at 735 x g for 2 minutes and the eluate was stored at     
4 
O
C until further use.  
 
Figure 2.3: SephadexTM column and collection tube for clean-up of PCR 
reactions 
2.9 DNA concentration 
The purity and concentration of DNA was checked prior to sequencing. This was 
carried out using 2 methods, initially for the comparative study presented in Chapter 
4, the NanoDrop method was used. For the remainder of the work, the Qubit
® 
method was used. This method is reportedly more sensitive than the NanoDrop and 
is recommended by Illumina for DNA quantification prior to NGS. 
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2.9.1 NanoDrop spectrophotometer  
DNA concentration and purity were checked by measuring absorbance at 260 nm 
with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, UK). 1 l AE 
buffer was added to the pedestal fibre optic cable to set a background reading.  This 
was wiped away and 1.2 l of DNA solution was applied to the machine. The 
concentration was recorded in ng / l and purity assessed by recording the ratio of 
sample absorbance at 260 and 280 nm.  
2.9.2 Qubit® 2.0 Fluorometer  
The Qubit
®
 Fluorometer (Invitrogen, UK) uses fluorescent dyes which bind only to 
the molecule of interest; in this case dsDNA. This makes it a more accurate measure 
of concentration, as single-stranded nucleic acids, proteins and other contaminating 
materials do not interfere with readings. DNA samples were prepared using the 
Qubit
®
 dsDNA HS Assay (Invitrogen, UK), as described below. 
2.9.2.1 Qubit® dsDNA HS Assay 
For each DNA sample or standard, a total volume of 200 l was prepared by diluting 
the sample or provided standard in Qubit
®
 working solution. A range of DNA 
sample amounts were used from 1 l to 20 l depending on the amount of DNA 
solution available but final volume for the assay was always 200 l. Working 
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solution was made by diluting the Qubit
®
 dsDNA HS reagent 1:200 in Qubit
®
 
dsDNA HS buffer solution in a clean plastic tube.  
For example, if 8 samples were to be measured, working solution for 8 samples and 
2 standards was prepared:  10 tubes with 200 µl per tube yields 2 ml of working 
solution (10 µl of Qubit
®
 reagent plus 1,990 µl of Qubit
®
 buffer). 
Standards were prepared for each new batch of working solution made. Standards 
were prepared by adding 10 l Standard 1 to 190 µL of working solution and 10 l 
Standard 2 to 190 µL of working solution and vortexing each for 2-3 seconds. DNA 
sample was added to the appropriate amount of working solution. For example, if 
using 1 l this was added to 199 l working solution. If using 10 l, this was added 
to 190 l working solution. Tubes were incubated at room temperature for 2 minutes 
the loaded onto the Qubit
® 
Fluorometer and an absorbance reading was given. DNA 
concentration in the original suspension was calculated by the machine using the 
calculation below and recorded in ng / l. 
Sample concentration      alue  ( 
   
 
 ) 
QF value = the value given by the Qubit
®
 2.0 Fluorometer 
x = the number of l added to the assay tube 
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2.9.3 Agilent Bioanalyzer 
In order to check final size and concentration of DNA libraries for NGS, the Agilent 
2100 Bioanalyzer (Agilent Technologies, UK) was used. The DNA 1000 kit was 
used and prepared as follows, according to manufacturer’s instructions. Gel dye mix 
was prepared by equilibrating DNA dye and DNA gel matrix to room temperature 
for 30 minutes, vortexing for 10 seconds and pulse centrifuging.  25 l of dye was 
added to DNA gel matrix and vortexed for 10 seconds. The mixture was applied to a 
spin filter and centrifuged at 2240 x g for 15 minutes, after which the filter was 
discarded. 
9 l gel dye mix was then applied to a well of a DNA chip on the Chip Priming 
Station and pressure was applied by means of a syringe to distribute the gel around 
the chip. 5 l of DNA marker was added to each sample well and 1 l DNA ladder 
to the ladder well. The chip was vortexed for 60 seconds at 2400 rpm, loaded onto 
the Bioanalyzer and the analysis run started.  
2.10 DNA Sequencing 
2.10.1 Cycle (Sanger) Sequencing 
PCR was performed, followed by gel electrophoresis of 5 l PCR product (Section 
2.7.1 or 2.7.2).  If a band was visible on a gel, the remainder of the PCR product was 
purified and quantified using the methods given in Sections 2.8 and 2.9. 
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Concentrations of approximately 15 ng / l were considered appropriate for Sanger 
sequencing of 16S rDNA PCR products.  
For the comparative study (Chapter 4), 96 well plates containing 20 l DNA per well 
at a concentration of approximately 15 ng / l were prepared and sent to LGC 
Genomics (Germany) for sequencing. For the remainder of the study, samples were 
prepared and sequenced as follows.  
2.10.1.1 BigDye® Terminator v3.1 Cycle Sequencing Kit 
The BigDye
®
 Terminator v3.1 Cycle Sequencing Kit (ABI, UK) was used to prepare 
PCR products for sequencing. Forward and reverse sequencing was always 
performed to give better quality data. Primers used depended on the primers used for 
PCR. 
Sequencing primers were diluted to 2 pmol / l in PCR-grade water. For 1 reaction, 
1.5 ml PCR-grade water, 2.5 l sequencing primer (2 pmol / l), 1 ml BigDye® 
Sequencing Buffer and 2 l Ready Reaction Premix were combined. A master mix 
of these components was made according to the number of sequencing reactions to 
be carried out. 7 l of master mix was added to 0.2 ml PCR tubes (ABGene 
Thermoscientific, UK) and 3 l of PCR product was added and mixed by pipetting. 
If a weak band was observed on the agarose gel performed after PCR, 4.5 l of 
product was added and water omitted.  
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Tubes were loaded into a thermocycler and the following cycling conditions were 




C for 1 minute followed by 25 








C for 5 seconds, 




C for 4 minutes, RTR to 4 
O
C and hold until ready to proceed.  
2.10.1.2 Purification of extension products 
Unincorporated dye terminators from the previous reaction were removed prior to 
sequencing. Samples were loaded onto a 96 well sequencing plate (ABI, UK), 5 l 
125 mM EDTA and 60 l 96 % (v/v) ethanol (both Sigma, UK) was added to each 
well, the solution was mixed by pipetting and incubated at room temperature for 15 
minutes.  
The plate was centrifuged at 2,240 x g (4,680 rpm) for 30 minutes, then inverted on a 
paper towel and tapped, followed by a pulse centrifuge inverted on a paper towel to 
remove excess fluid.  
60 l 70 % (v/v) ethanol was added to each well and the plate centrifuged at 2240 x 
g for 5 minutes. The plate was inverted onto a paper towel and pulse centrifuged as 
before. Samples were then resuspended in 5 l Hi-Di formamide and sequenced on 




2.10.2 Illumina MiSeq Sequencing 
2.10.2.1 Sample pooling  
Prior to PCR for NGS library preparation, swab DNA extracts obtained for Chapter 
6 were pooled into bed-space, non-bed space, and floor, sink and air samples. Bed 
space samples comprised objects near to the bed; chair arm, over-bed light, drawers 
(middle and bottom level), entertainment monitor, patient table, bed rail, extendable 
light, drug cabinet and trolley. Non-bed space items were found in the general ward 
area; window ledges (high, middle and bottom), bin, and alcohol or soap dispenser. 
Each time point therefore had a total of 8 samples; one pooled sample for each of 
bed spaces A – D, one non-bed space sample, one floor sample consisting of all floor 
samples taken, one sink sample and one air sample.  
2.10.2.2 Standard MiSeq library preparation 
Purified barcode PCR products were quantified by the Qubit
®
 method (Section 
2.9.2.1) and the concentration in nM of each sample was calculated using the 
following equation:  
Concentration  nM    
           concentration ng   l 




This equation assumes the molecular weight of a single base pair of dsDNA is 649 g 
/ mole. The size of the product was 520 bp (amplicon plus barcoded primers). 
Each sample was then diluted to an equivalent nM concentration and 5 µl of each 
sample was pooled together to form the DNA library. The library was then 
quantified by the Qubit
® 
method (Section 2.9.6.1) using 20 µl sample to 180 µl 
working solution. The pooled library was adjusted to a concentration of 2 nM and re-
quantified using the Qubit
®
.  
2.10.2.3 Denaturation of library 
A fresh solution of 0.2 N sodium hydroxide (NaOH) was made by mixing 20 µl of 1 
N stock (Sigma, UK) with 80 µl molecular grade water (VH Bio, UK). 10 µl of 0.2 
N NaOH was added to 10 µl DNA library, vortexed and incubated at room 
temperature for 5 minutes. 980 µl HT1 buffer from the MiSeq Reagent Kit v2 
(Illumina, UK) was added to dilute the DNA library to a concentration of 20 pM. 
The library was then further diluted to a loading concentration of 8 pM by adding 
240 l DNA library to 360 l HT1 buffer.                                                                                                                                                                                                                                                                                                                         
2.10.2.4 Phi X control 
Phi X control DNA (Illumina, UK) was diluted to 4 nM by adding 2 l of a 10 nM 
stock solution to 3 l H2O. The Phi X library was denatured by adding 5 µl of 0.2 N 
NaOH to 5 µl Phi X, vortexing and incubating at room temperature for 5 minutes. 
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This was then diluted to a concentration of 20 pM by adding 980 µl HT1 buffer and 
diluted again to the same loading concentration as the DNA library. 100 µl Phi X 
was added to 900 µl DNA library to provide a final library with 10 % Phi X.  
2.10.2.5 Preparation of MiSeq cartridge 
The MiSeq reagent cartridge was thawed overnight at 4 
O
C. The foil of reservoir 17 
was pierced with a long pipette tip. 600 µl of denatured DNA library with 10 % Phi 
X was loaded into the well and mixed gently by pipetting. 3.4 µl of 100 µM Index 
Sequencing Primer (5’-GAGGAAGGHGGGGAYGACGTTTAAAACGTGTT – 3’) 
was added to reservoir 13, 3.4 µl of 100 µM  Read 1 Sequencing Primer (5’ -
TACCGGGACT TA GGATTAGATACCCBRGTAGTC – 3’) was added to 
reservoir 12 and 3.4 µl of 100 µM Read 2 Sequencing Primer (5- 
AACACGTTTTAAACGTCRTCCCCDCCTTCCTC – 3’) to reservoir 14 and each 
was gently mixed by pipetting. 
2.10.2.6 Loading the flow cell and buffer. 
The flow cell (part of the MiSeq Reagent Kit v2) was removed from its buffer and 
washed with ddH2O. It was dried with a lint-free wipe, ensuring that the inlet and 
outlet ports were clear and the surface was clean and smudge-free. The flow cell was 
loaded onto the MiSeq instrument. The chiller compartment was opened and wash 
bottle removed and replaced with PR2 buffer bottle. The reagent cartridge was 
loaded into the machine and the run started.  
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2.10.2.7 Low concentration DNA library preparation 
Due to difficulties with sample preparation (detailed in Chapter 3), in addition to the 
protocol given in section 2.10.2.2, an alternative protocol for the preparation of DNA 
libraries was also used. The method, developed by Tony Brooks (Institute of Child 
Health) is designed for preparation of low concentration DNA libraries. The pooled 
library was quantified using the Qubit
®
. The appropriate volume of library was 
mixed with water and NaOH. This was then vortexed briefly, pulse-centrifuged and 
incubated at room temperature for 5 minutes. 2 l hydrochloric acid (HCL) was then 
added and the tube was again vortexed and pulse-centrifuged. A library of 9 pM 
concentration was prepared in a final volume of 750 l and Phi X spiked in as 
before.  
2.10.3 Sequencing analysis and Bioinformatics 
2.10.3.1 Sanger sequencing analysis 
Sequence data were visualised using the Chromas LITE v2.01 software package 
(Technelesyium Pty Ltd, Australia) and compared to sequences in the GenBank 
database using the on-line BLAST program (http://www.ncbi.nlm.nih.gov). 
Sequences that showed 99–100 % similarity over the amplified region of the 16S 
rRNA gene were considered to be the same species and those showing 97–99 %, 




The Quantitative Insights Into Microbial Ecology package (QIIME) version 1.6.0 
(www.qiime.org) was used (217). This contains all the relevant databases and 
programmes to analyse 16S rRNA gene sequencing data. 
Paired reads were joined using FASTQ-Join. Sequences were de-multiplexed and 
quality filtered using the default pipline in QIIME and reads with a quality score (Q-
score) of > 20 were selected. Operational Taxonomic Units (OTU) were picked with 
UCLUST which identifies 97 % difference as indicative of individual OTUs (218). 
OTU sequences were taxonomically classified by aligning to the Greengenes 
reference database, version 12-10, using PyNAST (145), (219). QIIME assigns 
taxonomy using the RDP Classifier 2.2 (220), using a naïve Bayesian classifier with 
a 0.80 confidence threshold. Minimum abundance thresholds were set to 0.005 % 
based on quality-filtering analysis reported by Bokulich et al. (2012) (221); all 
sequences representing  < 0.005 % of the total reads for that sample were discarded.  
2.11 Statistical analysis 
Statistical analysis was carried out using the IBM SPSS Statistics software package 








3.1 Introduction  
A wide variety of tools and techniques exist for sampling the microbial component 
of indoor environments. Samples can be taken from the air or surfaces and dust or 
other materials can also be collected. Sampling methods can create a bias in the 
numbers and types of microorganisms recovered and can interfere with downstream 
processing methods. Therefore, it is important to choose a strategy carefully and one 
that is relevant to the questions being asked of the study. An overview of different 
sampling methods was given in Chapter 1. The methods chosen for a study must 
provide an accurate as possible representation of microbial communities from the 
given environment. The selection of methods is dependent on the environment being 
assessed and the overall aims of the project. Post-sampling analysis methods are also 
wide-ranging and currently, largely involve the use of PCR. Various different PCR 
targets are used for microbial community analysis, commonly within the bacterial 
16S rRNA gene. It is known however, that available primer sets can often fail to 
amplify some members of complex microbial communities (153), (222), (223). 
Therefore primer choice is a factor that must be considered when conducting 
community analysis work. The application of NGS to microbial community analysis 
studies is currently the most rapid way to identify large numbers of bacterial taxa in 
3. Method validation 
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a single sample. Due to the lack of published methods for the chosen platform at the 
time of conducting the study (discussed further in Chapter 6), method development 
for this project was necessary and is discussed below.  
3.1.1 Chapter Aims 
The aim of this chapter was to ensure the best data collection possible by 
determining optimum sampling and sample processing methods. The work aimed to 
test environmental sampling techniques for use in the project and post-sampling 
analysis methods. The specific aims are given below. 
1. To compare recovery of viable bacteria and free DNA from a surface with 
different swab types. 
2. To test the recovery of microorganisms from the air with the chosen air 
sampler. 
3. To compare microbial cell lysis and DNA extraction techniques. 
4. To ensure maximum DNA recovery from samples. 
5. To choose the correct 16S rRNA gene hypervariable region for the project 
6. To optimise PCR conditions for NGS 





3.2 Development of sampling methods 
3.2.1 Bacterial recovery and DNA yield from surfaces and 
filters 
To determine which swab type would be used, sterile, UV-irradiated household tiles 
were inoculated with free bacterial DNA or whole viable bacteria and swabbed with 
either cotton swabs (MWE, Medical Wire) or flocked nylon swabs (Copan Flock 
Technologies, Italy). In order to test recovery from gelatine filters, filters were 
inoculated with known concentrations of microorganisms and nucleic acid extraction 
and amplification was performed.   
3.2.1.1 Methods for testing bacterial and DNA recovery from 
swabs and filters 
Swabbing tiles for recovery of viable bacteria 
Both a Gram positive and a Gram negative bacterial strain were used due to the 
difference in cell wall characteristics and potentially different recovery rates and 
survival times on surfaces (67).  
Overnight cultures of K. pneumoniae and S. aureus were prepared on blood agar 
plates and bacteria were removed from each plate into 5 ml of sterile PBS.  A Miles 
and Misra dilution series was prepared (Section 2.3.2) to allow the quantity 
inoculated onto tiles to be determined. Tiles were divided into quarters (Figure 3.1) 
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to provide 4 replicates per condition. This suspension was applied in 5 x 50 l drops 
on each quarter of the tile, using separate tiles for each organism. The drops were left 
to dry for 2 hours at room temperature. Once drops of bacterial suspension were dry, 
swab tips were moistened in sterile PBS and run over the whole swab site (tile 
quarter) horizontally, vertically and diagonally, before snapping off (cotton) or 
cutting off with sterile scissors (nylon) into a sterile microcentrifuge tube containing 
1 ml PBS. The tube, with swab inside was then vortexed for 30 seconds.   
100 l of the suspension was serially ten-fold diluted in 900 l PBS to a 10-8 
dilution. A Miles and Misra dilution series was performed on blood agar to 
determine the CFU of viable bacteria recovered from the tiles.  The remainder of the 





Figure 3.1: Example of a tile divided into 4 sections for inoculation of 
bacteria or free DNA. 
Swabbing tiles for recovery of nucleic acid  
DNA was extracted from bacteria as described (Section 2.5.2). Extracted DNA was 






 dilutions from the neat suspension and 
each dilution was inoculated onto tiles as above. Tiles were swabbed as above but 
using AE buffer as a wetting solution. After vortexing the swab in AE, the 
suspensions were used directly for qPCR as described in Tables 2.6 and 2.7. Blank 
swabs were also tested by qPCR to check for contamination. 
Recovery of bacterial DNA from gelatine filters 
The Sartorius MD8
®
 air sampler was chosen for this project as it was deemed the 
most suitable given its portability, ease of use and quiet operation. Gelatine filters 
were chosen for use with this sampler due to the reported ability to recover 100 % of 
collected material. Over-night plate cultures of S. aureus and K. pneumoniae were 
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prepared on blood agar; bacteria were removed from each plate and diluted into 20 
ml of sterile PBS. Miles and Misra plates were prepared as before to determine the 
total number of bacteria present.  
Bacterial suspensions were adjusted to stock concentrations of 1 x 10
8
. These were 
then serially ten-fold diluted in PBS to a concentration of 1 x 10
3
 in a final volume of 
1 ml. Gelatine filters were placed inside individual sterile 90 mm petri dishes in a 
class II microbiological safety cabinet (MSC) and UV-irradiated for 30 minutes on 
each side prior to use. Two filters were used per dilution per microorganism and 
blank, negative control filters were included (n =26). Each 1 ml suspension was 
applied to a filter and a further 9 ml sterile pre-warmed PBS was added to each dish. 
Dishes were sealed with Parafilm and placed inside an orbital incubator (Stuart, UK) 
with gentle agitation at 30 
O
C for 10 minutes to dissolve the gelatine.  
Each suspension was transferred to a 15 ml tube and centrifuged at 4,500 x g for 20 
minutes at 30 
O
C. Gelatine supernatant was poured off and the pellet resuspended in 
1 ml sterile PBS. This was then centrifuged at 40,200 x g (15,000 rpm) for 5 
minutes. The supernatant was removed and discarded and the pellet resuspended in 1 
ml sterile, UV-irradiated AE buffer.  DNA was extracted (Section 2.5.3) and qPCR 




3.2.1.2 Results of bacteria and DNA recovery from swabs and 
filters 
Recovery of viable bacteria 
Recovery of viable bacteria was calculated by Miles and Misra dilutions of swab 
solution. Table 3.1 shows the recovery of each type of bacteria from tiles with each 
type of swab. Four replicates are shown for each swab type corresponding to four 
quarters of each tile. Different starting concentrations of each bacterial suspension 
were loaded onto tiles, therefore the recovery was adjusted to show the percentage of 
the initial inoculum recovered.  
Overall recovery for both swab types and both bacteria was low. Mean recovery 
rates for cotton swabs were 4.6 % for S. aureus and 6.2 % for K. pneumoniae and for 
nylon swabs; 4 % and 9.3 % respectively.  A two-sample independent Student’s t-
test showed there was no significant difference in recovery of viable bacteria 
between swab type (P = 0.643). Although there was a slightly better recovery overall 



































Cotton 1 5.6 x 10
7
 6.3 
Cotton 2 2.3 x 10
7
 2.6 
Cotton 3 4.8 x 10
7
 5.4 
Cotton 4 3.8 x 10
7
 4.3 
Nylon 1 3.2 x 10
7
 3.6 
Nylon 2 4.8 x 10
7
 5.4 
Nylon 3 2.4 x 10
7
 2.7 





















Cotton 1 1.2 x 10
7
 3.5 
Cotton 2 3.0 x 10
7
 8.9 
Cotton 3 1.0 x 10
7
 2.9 
Cotton 4 3.2 x 10
7
 9.4 
Nylon 1 3.0 x 10
7
 8.9 
Nylon 2 3.4 x 10
7
 10 
Nylon 3 3.4 x 10
7
 10 
Nylon 4 2.9 x 10
7
 8.5 
Recovery of bacterial nucleic acid  
Mean threshold cycle (Ct) values for each type of swab for each microorganism can 
be seen in Table 3.2. Figure 3.2 shows qPCR amplification plots of recovery of       
S. aureus (a, b) and K. pneumoniae (c, d) DNA at 3 decreasing concentrations when 
swabbing with cotton and nylon swabs. Standard curves were not included therefore 
this is not a quantitative measure of recovery; however a comparison can be made 
between swabs of the cycle number at which amplification for each dilution 
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occurred. This provides a relative estimate of the DNA present in each sample. A 
lower Ct value corresponds to more DNA being present.   
Table 3.2: Mean threshold cycle (Ct) values for three dilutions of        
S. aureus and K. pneumoniae DNA recovered from tiles. 
    Ct 








Cotton 19.32 22.14 25.22 34.45 
Nylon 19.15 21.89 26.28 37.28 
K. pneumoniae 
Cotton 18.06 24.42 26.01 36.73 
Nylon 18.81 24.6 26.11 38.02 
There was little difference between cotton and nylon swabs in recovery of DNA for 
either organism at each dilution. Cotton and nylon swabs both had a Ct value of 19 
for the 10
-1
 dilution of S. aureus DNA and 18 for K. pneumoniae DNA at the same 
dilution, meaning that there was no difference in recovery of the two types of nucleic 




 dilutions also had little or no difference in 





Figure 3.2: Amplification plots for bacterial DNA after swabbing.       



















 cotton swab.                   






 nylon swab. 
DNA recovery from filters   
Table 3.3 shows the mean Ct values and copy number for the DNA recovered from 
filters inoculated with S. aureus and K. pneumoniae DNA dilutions. There appeared 
to be less total loss at higher dilutions with K. pneumoniae than with S.aureus. At the 
10
-3
 dilution, copy number was less than for the negative controls for both types of 
bacteria. Indicating that the limit of detection for each assay is approximately 10
4 
gene copies, for this assay. The step-wise decrease in Ct was slightly smoother for  
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K. pneumoniae (Figure 3.3). Overall recovery appeared better for K. pneumoniae 
with higher Ct and copy number values being recovered than for S. aureus. However, 
both strains were able to be recovered from gelatine filters over a dilution series and 
detected using the qPCR methods used. 
Table 3.3: Mean Ct values for DNA recovered from filters inoculated 
with S.aureus and K.pneumoniae DNA dilutions. 
 
 Ct Copy number 
Dilution S.aureus K.pneumoniae S.aureus K.pneumoniae 
10
8
 26 21 21984588 197356440 
10
7
 33 25 572759 20156341 
10
6
 33 28 416001 2706967 
10
5
 37 33 12925 131829 
10
4
 40 34 1399 4287 
10
3
 41 37 558 2680 




Figure 3.3: Ct and copy number for S. aureus and K. pneumoniae DNA 
extraction from filters over a dilution series.  
3.2.1.3 Bacteria and DNA recovery discussion 
Swab type  
There has been suggestion in the literature that flocked nylon swabs allow for greater 
recovery of viable microorganisms from surfaces than do cotton swabs (105). This is 
due to the suggestion that microorganisms can become trapped in the fibres of cotton 
swabs and therefore less will be released into the swabbing solution for further 
processing, leading to an underestimate of microorganism numbers. This is reported 
not to happen with flocked swabs as they do not have tightly wound fibres which 






































S.aureus (Ct) K.pneumoniae (Ct)
S.aureus (Copies) K.pneumoniae (Copies)
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Based on the above experiments however, it was determined that no significant 
advantage would be gained by using flocked nylon swabs for the current 
investigations. Cotton and nylon swabs performed equally when recovering viable 
bacteria and free bacterial DNA from tiles. There was slightly better overall recovery 
of viable K. pneumoniae from tiles than S. aureus. Both S. aureus and                     
K. pneumoniae have been reported to be able to survive on surfaces for months (67) 
and Gram negative bacteria have been shown to survive longer overall than Gram 
positives (90). The swab recovery rates compare with other published reports in that 
recovery is low (106), (107), (224).  
Cotton swabs provide a ‘general-purpose’ swab and are easy to use in the field. 
Flocked nylon swabs have a plastic shaft which means they must be cut off into the 
microcentrifuge tube; this is difficult to do in the field and is a source of potential 
contamination. Cotton swabs have a wooden shaft which is easily snapped off and 
this reduces the risk of contamination. Currently, there are no commercially 
available flocked nylon swabs with wooden shafts.  This fact combined with the data 
obtained during the validation experiments lead to the decision to use cotton swabs 
for sampling the environment for the remainder of the study.  Overall recovery was 
low and this is accepted as a limitation of the method, however, the method is still 
widely used and is a standard method for infection control screening at Great 




Recovery of DNA from gelatine filters 
There appears to be good recovery of bacterial DNA from gelatine filters at higher 
concentrations. At lower concentrations, particularly with S. aureus, sensitivity of 
the method begins to decrease. Given that bacteria are reported to be present in the 
air in high concentrations, the ease of use of the sampler and its relevance for use in 
the environments under investigation, it was determined that the loss of sensitivity at 
lower concentrations was acceptable.  
3.2.2 Comparison of DNA extraction methods 
Pure cultures of S. aureus and K. pneumoniae were tested and analysed by qPCR to 
determine the best DNA extraction method for the work.  
3.2.2.1 Comparison of DNA extraction methods 
Overnight cultures of S. aureus and K. pneumoniae were prepared as before (Section 
2.3.1) and concentrations adjusted to 1 x 10
8
 cells / ml.
 
Cell suspensions were 
processed in duplicate using each of 4 methods; 1) AGOWA
®
 mag magnetic bead kit 
(AGOWA
®
 GmbH, Germany), 2) Modified Qiagen QIAamp DNA mini kit (Qiagen, 
UK), 3) crude heat lysis and 4) Phenol:Chloroform extraction. Nucleic acid extracts 




AGOWA® mag kit 
The kit was used according to manufacturer’s instructions. Briefly; cells were 
mechanically lysed by bead-beating with 0.1 mm diameter silica beads in the 
presence of lysis buffer and phenol.  10 l magnetic beads were added to the sample 
along with binding buffer and the sample was incubated in a magnetic separator.  
Beads were then washed and separated twice before drying and eluting nucleic acid 
into AE buffer.  
QIAamp DNA mini kit 
The manufacturer’s protocol for DNA extraction was followed with modifications. 
Briefly; 20 l proteinase K, 10 l mouse cell IPC, 200 l 0.1 mm diameter silica 
beads and 200 l Qiagen buffer ATL were added to 200 l bacterial cell suspension.  
Samples were incubated for 10 minutes at 56 
O
C before bead-beating at full speed 
for 10 minutes on a Disruptor Genie (Scientific Industries, Inc.). 200 l of 70 % 
ethanol was added and the lysate was mixed and applied to a Qiagen column. The 
protocol was then followed by washing the column twice prior to nucleic acid 





Crude DNA extraction by heat lysis 
200 l of silica beads were added to 500 l of cell suspension. The sample was then 
heated to 95 
O
C for 10 minutes before bead-beating at full speed as above. The 
supernatant was removed and used as a crude nucleic acid extract.  
Phenol: Chloroform extraction (P:C:I) 
The cell suspension was centrifuged for 10 minutes at 16,300 x g (13,300 rpm). The 
supernatant was removed and the pellet was resuspended in 0.5 ml 120 mM 
phosphate buffer with 5% hexadecyltrimethylammonium bromide (CTAB). The 
solution was transferred to a sterile 2 ml screw-cap microcentrifuge tube containing 
200 l silica beads. An equal volume of phenol: chloroform: isoamyl alcohol 
(25:24:1) (Sigma Aldrich, UK) was added and bead-beating carried out as above.  
Tubes were cooled on ice and centrifuged at 16,300x g (13,300 rpm) for 5 minutes at 
4 
O
C. The top aqueous layer was transferred to a new microcentrifuge tube. An equal 
volume of chloroform: isoamyl alcohol (24:1) was added and the solution mixed. 
Tubes were centrifuged again as above and the top layer was removed to a new tube. 
Two volumes of PEG solution was added and the solution was mixed and left for 1-2 
hours at room temperature or overnight at 4
O
C to allow the DNA to precipitate. 
Tubes were then centrifuged for 10 minutes at 16,300 x g (13,300 rpm), the 
supernatant was carefully removed and the pellet washed twice with 200 l 70 % 
ethanol and centrifugation for 5 minutes.  The pellet was left to dry for 20 minutes 
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and resuspended in 50 ml sterile, UV-irradiated TE buffer.  The resultant solution 
was used as DNA template for further analysis.  
3.2.2.2 Comparison of DNA extraction methods results 
Gram positive bacteria 
DNA from samples containing 9.5 x 10
8 S. aureus cells was extracted and processed 
in duplicate using each of the 4 methods described above. Amplification occurred 
around 5 cycles earlier with the column-based extraction method than for both the 
AGOWA
®
 and P:C:I methods (Figure 3.4), meaning more DNA was present. 
The crude extract was detected at around cycle 7 on the amplification plot but it was 
not a true amplification curve (Figure 3.4), indicating that there was either too much 
nucleic acid material in the sample or contaminating material was present. Replicate 
Ct values were almost identical for the column-based method but differed by 1 cycle 
for the P:C:I methods and by over 2 cycle for the AGOWA
®
 kit (Table 3.4). All 





Figure 3.4: Fluorescence vs. cycle number for different S. aureus DNA 
extraction methods 
 
Table 3.4: Ct values for different DNA extraction methods for S.aureus 




S. aureus 1 21.46 
S. aureus 2 19.15 
Negative control Undetected 
Column 
S. aureus 1 15.28 
S. aureus 2 15.3 
Negative control Undetected 
Crude 
S. aureus 1 Undetected  (too high) 
S. aureus 2 Undetected (too high) 
Negative control Undetected 
P:C:I 
S. aureus 1 21.92 
S. aureus 2 20.62 




Gram negative bacteria 
DNA from samples containing 2.0 x 108 K. pneumoniae cells was extracted and 
processed in duplicate using each of the 4 methods described above. Amplification 
from the crude DNA extraction occurred earliest at cycle 16 (Figure 3.5). This was 
followed by the column-based method amplifying at around a cycle number of 17. 
The replicates for each of the 2 methods amplified at the same time.  
 
Figure 3.5: Fluorescence vs. cycle number for different K. pneumoniae 
DNA extraction methods. 
The AGOWA
®
 and P:C:I methods had amplification at later cycles (between 18 and 
22) with a difference in 3 cycles between replicates for the AGOWA
®




Table 3.5: Ct results for different DNA extraction methods for             
K. pneumoniae. 




K. pneumoniae 1 18.8 
K. pneumoniae 2 22.33 
Negative Control Undetected 
Column 
K. pneumoniae 1 17.24 
K. pneumoniae 2 17.3 
Negative Control Undetected 
Crude 
K. pneumoniae 1 16.86 
K. pneumoniae 2 16.46 
Negative Control Undetected 
P:C:I 
K. pneumoniae 1 19.68 
K. pneumoniae 2 20.99 
Negative control Undetected 
 
3.2.2.3 Comparison of DNA extraction methods discussion 
The modified Qiagen column-based DNA extraction protocol appeared to be the best 
method of those tested. Amplification of DNA extracted using the columns occurred 
earlier than other methods for S. aureus and the second earliest for K. pneumoniae. 
The crude method would be unsuitable for many downstream techniques due to the 
presence of inhibitors which would not be removed. Column based methods are 
widely used and are capable of removing a large proportion of compounds that may 
inhibit PCR through binding of nucleic acid to the silica membrane and optimisation 
of buffers to neutralise inhibitors (225). Phenol and chloroform-based methods can 
have the risk of chemical carry-over if care is not taken, which could interfere with 
PCR amplification. Also, the method does not lend itself well to higher throughput 
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sample processing, along with the AGOWA
®
 method, which has the disadvantage of 
only being able to process 6 samples at once on a magnetic strip. Moreover, the 
latter two methods did not produce accurate replicate data and could therefore not be 
relied upon to produce consistent results in the study. 
3.2.3 Optimisation of DNA extraction method for swab 
samples 
In order to test the suitability of the chosen DNA extraction method for the project, 
test swab samples were taken from the hospital to be sampled in the study. DNA 
extractions were performed using the Qiagen column method as described above and 
end-point PCR was carried out to determine if nucleic acid was present and if the 
method was sensitive enough for the sample type.  
3.2.3.1 Optimisation of DNA extraction for swab samples method 
Swabs were taken at each of the following sites: 
1. Chair arm   7. Table 
2. Bed rail   8. Chair arm 
3. Floor    9. Top of alcohol dispenser 
4. Sink    10. Top of drug cabinet 
5. Windowsill   11. Entertainment monitor   
6. Bin    12. Air sample on gelatine filter 
Swabs were taken as described in Section 2.2.2.1. The swabs in AE buffer were 
vortexed for 30 seconds and 200 l was taken to be used for DNA extraction using 
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the Qiagen column method as described in Section 3.2.2.1. End-point PCR was 
carried out on the samples using 16S rDNA primers 8A, 8B and 3R as described in 
Table 2.3. The PCR products were then analysed by gel electrophoresis (Section 
2.7.1). 
3.2.3.2 Optimisation of DNA extraction for swab samples results  
All samples failed to show a band on a gel, indicating the absence of DNA.  
3.2.3.3 Optimisation of DNA extraction for swab samples 
discussion 
The failure of the above experiment could have been due to a number of reasons. 
The DNA extraction may have failed for this sample type, the PCR conditions may 
not have been optimum, inhibitors may have been present, or there may have been 
insufficient template added to the reaction. The Molzyme brand of Taq polymerase, 
used for this assay, is reported to lose activity rapidly and also to vary between 
batches (Kathryn Harris, personal communication 2012) and could be a reason for 
lack of amplification. 
3.2.4 Comparison of polymerase brands for DNA 
amplification and testing for inhibition 
The Molzyme brand of Taq polymerase, MolTaq, has been found to lose activity 
over time. An alternative Taq polymerase: BIOTAQTM (Bioline, UK), was tested with 
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the same samples as before and E. coli DNA was added to samples as an IPC to 
check for inhibition.  
3.2.4.1 Comparison of polymerase brands for DNA amplification 
and testing for inhibition method 
End-point 16S rRNA gene PCR was carried out on the same test swab extracts as 
before (Section 3.2.3.1) with double the amount of MolTaq added. PCR was also 
carried out on the same samples using BIOTAQTM Taq polymerase in place of 
MolTaq. Four samples had 1 l E. coli genomic DNA IPC added and were included 
in the PCR run with each polymerase.  
3.2.4.2 Comparison of polymerase brands for DNA amplification 
and testing for inhibition results 
Amplification only occurred with the use of double concentration MolTaq 
polymerase. Figure 3.6 shows the gel image of PCR products. Lane 2 of the top row 
(MolTaq) shows the sample from a bin (Sample 6) and was very weakly positive. 
Lanes 7- 10 contained spiked E. coli DNA and a positive result occurred in 3 out of 4 




Figure 3.6: Gel electrophoresis image of 16S rDNA PCR products 
comparing Taq polymerases. Top line MolTaq, bottom line BIOTAQ 
3.2.4.3 Comparison of polymerase brands for DNA amplification 
and testing for inhibition discussion 
Amplification was only observed in one sample when using double the 
recommended concentration of MolTaq polymerase. The use of BIOTAQTM yielded 
no positive results. The IPC was positive for 3 of 4 samples when using MolTaq, 
indicating that PCR conditions were sufficient for DNA amplification and that 
inhibition was not the reason for failure to amplify, at least in 3 samples. The lack of 
any amplification when using the BIOTAQTM could be explained by sub-optimal 
PCR conditions. Given that IPC amplification occurred with MolTaq, this indicated 
that the samples may have been the problem, perhaps due to low DNA concentration 
and not necessarily the type of polymerase. Although, the use of double the 
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recommended concentration of MolTaq indicated a loss of enzyme activity and a 
new batch was acquired. 
3.2.5 Repeat testing of swabbing, DNA extraction and PCR 
methods 
A new set of swabs were taken as before and the DNA extraction and PCR repeated 
as before but with new reagents.  
3.2.5.1 Repeat testing of swabbing, DNA extraction and PCR 
method 
Swabs were taken, DNA extracted using the modified Qiagen method and end-point 
PCR carried out using the 8a/8b and 3F primers, all as before. All swabs samples 
also had 1 l IPC DNA added in a separate PCR reaction. 
3.2.5.2 Repeat testing of swabbing, DNA extraction and PCR 
results and discussion 
The gel image is shown in Figure 3.7. Lanes 1 – 11 show swab samples, lane 12 
shows an air sample and lane 13 shows a blank swab. Lanes 14 – 26 show samples 
with IPC added. Lanes 27 and 28 are NTCs and positive controls are in lanes 29 and 





Figure 3.7: Gel electrophoresis picture showing amplified DNA 
from test swabs. 
Lane 1: Chair arm, 2: Window ledge, 3: Floor, 4: Sink, 5: Bed rail, 6: 
Alcohol gel dispenser, 7: Drug cabinet, 8: Bin, 9: Entertainment 
monitor, 10: Patient table, 11: Light, 12: Air sample, 13: Blank swab, 
14 – 26 as before with 1 l E.coli DNA, 27 & 28: NTC, 29 & 30:  
Positive control. 
The majority of the swab samples were positive but in comparison to positive 
controls and samples with IPC, had much weaker bands (Figure 3.7), indicating the 
presence of less starting template DNA. The drug cabinet (Lane 7) and entertainment 
monitor (Lane 9) did not amplify well and the IPCs for these samples only showed 
weak amplification (Lanes 20 and 22), indicating the presence of inhibitors. Some 
samples that were expected to have large quantities of DNA present, such as the 
chair arm did not amplify. However, the air sample showed good amplification. 
NTCs did not amplify and positive controls had amplification. The extraction 
method appeared to work for the sample type; however, DNA yield was low 




3.2.6 Comparison of methods to increase DNA yield from 
swabs 
The DNA yield from swabs was low in the above experiment. In order to attempt to 
improve DNA yield from environmental swabs, the DNA extraction method used in 
the above experiments was further modified.   
3.2.6.1 Comparison of methods to increase DNA yield from swabs 
method 
Further test swabs were taken from the hospital: 1) Floor, 2) Table, 3) Light, 4) Sink, 
5) Chair arm, 6) Bed rail and 7) Air. A set of swabs was extracted using each of the 
methods given below. End-point 16S rRNA gene PCR was carried out as before and 
16S rRNA gene qPCR was also carried out as it is a more sensitive method for DNA 
detection (Table 2.9). IPC DNA was added to each set for end-point PCR. Air 
samples were only processed with Method A. 
Method A: Increased proteinase K incubation time. 
The Qiagen column method as described in Section 3.2.2.1 with proteinase K 




Method B: QIAshredder column with increased proteinase K 
incubation. 
Swab lysate and swab tips were placed in a QIAshredder column (Qiagen, UK) and 
centrifuged for 5 minutes at 16,300 x g (13,300 rpm). The eluate was then extracted 
using the method given in Section 3.2.2.1, with 1 hour proteinase K incubation.  
Method C: QIAamp column method 
Qiagen column extraction method as described per Section 3.2.2.1. With a 10 minute 
proteinase K incubation. 
Method D: No bead beat, QIAshredder column with increased 
proteinase K incubation  
Method as before (Section 3.2.2.1) but without the initial bead-beat of samples and 
with 1 hour proteinase K incubation. 
In order to check for inhibition, PCRs were repeated, with samples from methods A 
and B at a 1: 10 dilution and at a 1: 10 dilution with IPC added.  
3.2.6.2 Comparison of methods to increase DNA yield from swabs 
results 
When analysing by qPCR, all samples amplified earlier with method D than the 
other methods (Table 3.6). Samples processed with method C, the original method, 
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amplified latest overall. Samples that were expected to have less DNA present, such 
as the bed rail, amplified at later cycles than those expected to have more DNA, such 
as the light, when using method D. This trend was not as pronounced for the other 
methods and the bed rail sample amplified before the light when using method B and 
at the same time as the floor and light when using method C (Table 3.6). NTCs run 
on this assay had Ct values of around 22, similar to many of the samples, particularly 
for method C. 
The end-point PCR results indicated that methods A and B were better for all sample 
types (Table 3.7). However, some IPCs failed to amplify for all methods.   
 
Table 3.6: Average Ct values for different methods of DNA extraction 
from test swabs 
  Average Ct value 
  Method 
Sample A B C D 
Floor 19.88 19.07 22.81 19.17 
Table 21.96 19 22.96 18.96 
Light 19.48 22.47 22.22 17.85 
Sink 20.13 21.12 21.37 19.17 
Chair 
arm 
20.29 19.06 20.33 18.88 
Bed rail 21.38 21.58 22.19 20.31 




Table 3.7: Comparison of DNA extraction methods by end-point 16S 
rDNA PCR 
  Method 
Sample A B C D 
Floor + + - + 
Table - + - + 
Light + - - - 
Sink + + - - 
Chair arm + + - - 
Bed rail - - - - 
Air + N/A - N/A 
Due to the lack of IPC amplification in some samples, those samples were all diluted 
to 1:10 and PCR was repeated as normal and with IPC added.  
Samples diluted to 1:10 showed very little or no amplification but IPCs, which had 
previously all been negative. The samples with IPC showed a lot of smearing and 
some non-specific bands (Figure 3.8). 
3.2.6.3 Comparison of methods to increase DNA yield from swabs 
discussion 
Method D appeared to be the best extraction method when using qPCR to amplify 
16S rDNA. The DNA from most samples amplified earlier than with other methods, 
indicating the presence of more DNA in the sample. The QIAShredder used in 
methods B and D is designed to break up swabs in order to release more cells for 




Figure 3.8: 1:10 dilutions of samples extracted with methods A& B and 
1:10 samples spiked with IPC DNA. Lanes 1, 15 & 29: NTCs. Lanes 2 – 
8: 1:10 dilutions of samples extracted with method A, lanes 9–15: 1:10 
dilutions of samples extracted with method B. Lanes 16 – 28: samples 
as before at a 1:10 dilution with 1 l IPC DNA spiked into the reaction. 
Methods A and B gave best results when using end-point 16S rRNA gene PCR. Both 
of these methods used an extended proteinase K step and this may allow more DNA 
to be freed from protein associations which may prevent amplification. Diluting 
samples to 1:10 did not produce positive results from samples that were previously 
negative but expected to have sufficient DNA present. However, in some cases, 
diluting did lead to the amplification of IPC DNA, indicating that inhibition might be 
causing false negatives. The above experiments indicated that the QIAshredder did 
not provide a large improvement in DNA yield but that extended incubation with 
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proteinase K did. The experiments also indicated that further PCR optimisation was 
required to provide better results from swab samples. 
3.3 PCR optimisation for the detection of DNA 
from environmental swab samples 
During the method development so far discussed, 16S rRNA gene end-point PCR 
was carried out using primers 8A, 8B and 3R. Other primer sets are available and at 
this stage in project development, primer choice for next-generation sequencing was 
considered.  Primer sets 8A, 8B and 3R (‘GOSH’ primers) (141), which target the 
V1-V3 hypervariable regions of the 16S rRNA gene, were tested along with 785F 
and 1175R (‘Eastman’ primers), which target the V5-V7 regions (214) and a set 
developed by Caporaso et al. for NGS on environmental samples, targeting the V4 
region (145). PCR cycling conditions were altered along with types of Taq. The 
experiments are outlined below.  
3.3.1 GOSH vs. Caporaso primers with DNA from pure 
bacterial cultures 
GOSH primers had previously been used in order to test DNA extraction methods as 
these were in use routinely at GOSH and this aided troubleshooting. However, at the 
time of conducting the study and of writing, the V4 region is the most common 
region amplified when investigating microbial communities (71,145,226). Therefore, 
a primer set to amplify this region was obtained from the literature (145). In order to 
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test ‘best-case scenario’ PCR amplification, a dilution series from 1 X 1012 to 1 X 
10
1
 of K. pneumoniae DNA was amplified with Caporaso and GOSH primers. 
3.3.1.1 Method 
A ten-fold DNA dilution series was prepared by diluting DNA in AE buffer. PCR 
reagents and cycling conditions are detailed in Table 2.3 for GOSH primers. 
Caporaso primers were used with the same parameters. 
3.3.1.2 GOSH vs. Caporaso primers with DNA from pure bacterial 
cultures results 




 could be visualised on an agarose gel when GOSH 
primers were used as shown in the top row of Figure 3.9. Only the highest 3 
dilutions amplified when using Caporaso primers and the 10
10






Figure 3.9: Dilution series of K. pneumoniae DNA amplified using 























, 12) AE 
control 
 
3.3.2 GOSH vs. Eastman vs. Caporaso primers on DNA from 
swab extracts 
A third primer set; 785F and 1175R (Eastman primers) was added to those to be 
tested as they amplify the V5-V7 hypervariable regions of the 16S rRNA gene. The 
V6 region, in particular, is known to be highly discriminatory in bacterial 






3.3.2.1 GOSH vs. Eastman vs. Caporaso primers on DNA from swab 
extracts method 
Test swabs were taken from 2 of each of the following items on the ward: chair arm, 
floor, bed rail, sink and bin. These were extracted and as before and PCRs carried 
out using the conditions described in Tables 2.3 and 2.4. Extraction controls in the 
form of un-used swabs, NTCs and positive controls were included.   
3.3.2.2 GOSH vs. Eastman vs. Caporaso primers on DNA from swab 
extracts results 
No amplification occurred except for the air sample with both GOSH and Eastman 
primers. The use of alternative PCR conditions was therefore considered. 
3.3.3 Use of a proof-reading polymerase for improved PCR 
MolTaq polymerase batches vary considerably in their activity and this may have 
been a contributing factor to inconsistent results. KAPA Hi-Fi Taq polymerase 
(KAPA Biosystems, UK) was tested due to its reported ability to amplify low 
concentration DNA and increase yield. It is a proof-reading Taq polymerase and as 





3.3.3.1 Use of a proof-reading polymerase for improved PCR 
method 
Swab extracts were used as before and DNA amplified with the GOSH primer set 
using KAPA Taq in place of MolTaq. Cycling conditions were as follows; 1 initial 
denaturation at 95 
O
C for 5 minutes, followed by 35 cycles of 98 
O
C for 20 seconds, 
60 
O
C for 30 seconds, 72 
O
C for 1 minute and a final elongation at 72 
O
C for 5 
minutes.  
3.3.1.2 Use of a proof-reading polymerase for improved PCR 
results 
All samples showed excessive non-specific bands on an agarose gel, as did the 
extraction controls and NTC (Figure 3.10). Therefore, the KAPA Taq was not tested 




Figure 3.10: PCR amplification with KAPA Taq of test swabs with 
GOSH primer set M: Hyperladder, Lanes 1 & 2: chair arm, 3 & 4: 
floor, 5 & 6: bedrail, 7 & 8: sink, 9 & 10: bin, 11 & 12: extraction 
control. 13: NTC, 14: positive control 
 
3.3.4 Eastman primer PCR with DNA from swab extracts and 
altered PCR conditions 
Test swabs, as before, were amplified using the Eastman primer set, MolTaq 
polymerase and altering the PCR annealing temperature to 60 
O
C. 
3.3.4.1 Eastman primer PCR with DNA from swab extracts and 
altered PCR conditions results 
Bands were observed for all swab samples, except the bed rails (Figure 3.11). The 




Figure 3.11: Test swabs amplified with MolTaq and higher annealing 
temperature. M: Hyperladder, 1 & 2: chair arm, 3 & 4: floor, 5 & 6: 
sink, 7 & 8: bed rail, 9: positive control, 10: NTC 
3.3.4.1 Eastman primer PCR with DNA from swab extracts and 
altered PCR conditions discussion 
Altering the annealing temperature of the PCR reaction appeared to result in 
improved DNA amplification. Bed rail samples still failed to amplify but these 
samples were expected to have lower numbers of bacteria present and this may 
explain the lack of amplification. 
3.4 Method development for MiSeq NGS 
Due to the significant cost involved with NGS, it was not possible to conduct ‘trial 
runs’ of sequencing in order to optimise methods. The Illumina MiSeq was chosen 
for this project due to the low relative cost and long read-length in comparison to 
other available technologies. A review of NGS platforms is given in Chapter 6. 
MiSeq protocols were designed using available literature, Illumina methods and 
advice from colleagues using the technology and developed throughout the project. 
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For clarity, the final method used is presented in Chapters 2 and 6 but challenges and 
method development for the MiSeq are discussed below. Results of successful 
sequencing runs are presented in Chapter 6.  
The workflow for the NGS of DNA from swab samples is shown below (Figure 
3.12), this is also discussed in further detail in Chapter 6 but an overview is provided 
here to aid the method development information to be better understood.  DNA is 
extracted and amplified by PCR to add barcode sequences which allow sequenced 
amplicons to be traced back to their original sample. PCR products are purified, 
adjusted to equimolar concentrations and pooled to form a library. The library is 
quantified and chemically denatured with sodium hydroxide (NaOH). The library is 
then bound to a flow cell which is a glass slide with oligonucleotides bound where 




Figure 3.12: Workflow for sample preparation for next-generation 
sequencing. 
 
3.4.1 Initial MiSeq sequencing run method 
Barcode PCRs were carried out on 96 pooled DNA samples from the ward as 
detailed in Section 2.6.1.4 (details of pooling given in Section 2.10.2.1). PCR 
products were purified on Size Select
®
 gels and samples were recovered and 
quantified using the Qubit
®
 (Section 2.9.2.1). Only 53 of a potential 96 samples were 
carried forward as the remainder did not amplify to a high enough concentration. The 
sequencing protocol, as detailed in Sections 2.10.2.2 – 2.10.2.6 was carried out. 
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3.4.1.1 Results of initial MiSeq run  
The samples failed to cluster on the Illumina flow cell after starting the MiSeq run 
and no data were recovered.  
3.4.1.2 Discussion of initial MiSeq Run 
After extensive research, a reason for run failure could not be determined. It is 
known that residual NaOH from the library denaturation stages may prevent samples 
binding to the flow cell and the presence of traces of other chemicals has not been 
investigated. The presence of residual chemicals from the swab samples may have 
been a reason for the samples failing to bind to the flow cell. Therefore, all samples 
which showed inhibitory effects by IPC qPCR assay (Section 2.6.2.7) were removed 
from their respective pools, the samples re-pooled and re-processed. 
3.4.2 Optimisation of protocol for further MiSeq runs 
Barcode PCRs were carried out as before on fresh pools of samples but failed to 
amplify well, possibly due to lower concentrations of DNA present in the pool.  The 
protocol and workflow were adjusted to compensate for the lower concentrations of 
DNA. PCRs were repeated, adding more template sequentially in order to obtain 
amplification and the reaction volume was increased to 50 µl by doubling the 
amounts of each reaction component.  
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Some samples showed positive results but others still failed to amplify to a 
concentration that could be recovered from a Size Select
®
 gel. Despite bands initially 
being visible on a gel, when they reached the collection well, bands were no longer 
present. The purification step, as carried out by Size Select
®
 gel, is to ensure the 
accurate loading of DNA library onto the MiSeq flow cell. The Qubit
® 
method 
quantifies all dsDNA, including primer-dimers, which if not removed by gel 
purification, will lead to an underestimate of DNA concentration. This will cause 
further steps in the sequencing process to be inaccurate and may lead to run failure. 
Alternative purification methods were tested to attempt the recovery of lower 
concentration samples. 
3.4.3 Alternative DNA purification methods 
GE illustra SephadexTM columns as described in Section 2.8.2 were tested against a 




 XP magnetic beads 
(Beckman Coulter, UK). Two sample pools which had shown previous positive 
bands on a gel were used to test the purification methods. Samples A and B were 
amplified in quadruplicate using barcode PCR and quantified. Duplicates of each 
sample were purified using SephadexTM columns or using AmPure
®
 beads (protocol 





3.4.3.1. AmPure® XP Magnetic Bead method  
AmPure
®
 XP magnetic beads were equilibrated to room temperature and vortexed 
for 30 seconds to resuspend. 1.8 µl of AmPure
®
 XP beads per 1 µl PCR product 
were added to the well of a conical-bottom 96 well plate (ABI, UK). In this case, 49 
µl was used (1 µl was used to quantify); therefore 88.2 µl beads were added. 
PCR product and beads were mixed thoroughly by gentle pipetting and incubated at 
room temperature for 5 minutes to allow DNA binding. The plate was then placed on 
an Agencourt
®
 Solid Phase Reversible Immobilisation (SPRI) 96 Super Magnet 
Plate (Figure 3.13) for 2 minutes to allow the beads to cluster to one side of each 
well. The supernatant was removed and discarded.  
The beads were washed twice with 70 % ethanol to remove contaminants whilst 
remaining on the magnetic plate. The beads were then gently rinsed from the side of 
the well with 40 µl PCR-grade water (elution fluid), mixed well, incubated for 2 
minutes at room temperature then placed back on the magnetic plate. The 
supernatant was removed and stored at 4 
O




Figure 3.13: Solid Phase Reversible Immobilisation magnetic plate 
with conical-bottom 96 well plate 
3.4.3.2 Results of alternative DNA purification methods 
Table 3.6 shows the DNA concentration (ng / µl) prior to PCR purification and then 
after purification by the SephadexTM column or magnetic bead method. It can be seen 
that after PCR, the samples were of similar concentration and the NTC had very little 
DNA present. Both methods of purification reduced the DNA concentration to very 
low levels, on one occasion the bead method reduced the DNA to undetectable levels 
(Sample A). Concentration in nM is also shown, Illumina recommend a starting 
concentration of 4 nM or 2 nM in their MiSeq sample preparation protocol 




Table 3.6: DNA concentration before and after different purification 
methods 
    DNA concentration (ng / l) DNA concentration 
(nM) 








2.64 0.144 0.4 




2.9 Too low - 
2.78 0.14 0.44 
B 
SephadexTM 
2.96 0.144 0.46 




2.66 0.206 0.65 
2.94 0.232 0.74 
AE SephadexTM 0.242 Too low - 
 AmPure
®
 0.304 Too low - 
In order to compare DNA loss between the two above methods and the Size Select
®
 
gel method, the same samples were repeated using the barcode PCR and run on a 
gel. The bands were very faint and after recovery, all were too low for detection on 
the Qubit
®
. None of these methods would allow library preparation for NGS to be 
achieved. 
3.4.3.3 Testing higher concentration PCR products 
In order to identify whether the purification methods were appropriate when higher 
concentrations of PCR product were used, two further samples which had previously 
amplified well were then compared using the methods above (samples C and D). 
Results are shown in Table 3.7. Despite sample C having similar starting DNA 
concentrations to samples A and B, recovery after purification was better in this 
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instance. However, recovery of both samples using the AmPure
®
 beads was much 
lower than when using SephadexTM columns.   
Table 3.7: DNA concentration before and after purification methods 
using higher starting concentrations.  
    










SephadexTM 1.97 0.666 2 
AmPure
®
 1.92 0.108 0.33 
D 
SephadexTM 4.12 1.43 4.4 
AmPure
®
 4.46 0.492 1.51 
SephadexTM purified sample D was then run on a Size Select
®
 gel to check for primer 
dimers and other non-specific bands. After recovery from the gel, DNA 
concentration was recorded at 1.4 nM, meaning that approximately ¾ of the starting 
DNA was lost in the gel. A secondary band was observed when running the gel 
which was smaller than the amplicon size and this was assumed to be primer-dimer 
and accounted for some of the loss. 
3.4.3.4 Purification comparison discussion 
Based on the above experiments, neither the SephadexTM columns nor AmPure
®
 bead 
method appeared appropriate for use when beginning with low concentration PCR 
products, the loss was too great. Higher DNA concentrations post-PCR offered 
sufficient DNA recovery for the Illumina library preparation protocol when using the 
SephadexTM columns. However, these columns do not allow volumes of PCR product 
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added to be adjusted, meaning that they could not be concentrated in order to achieve 
the highest possible yield. Also, the matrix size used in these columns may allow 
DNA fragments of 50 bp to be co-purified. Given that the primers used in the 
barcode PCR are 62 and 68 bp long, there is potential for primer dimers to also be 
purified when using this method, which would lead to incorrect library 
quantification.  
Bands smaller than the 16S rDNA indexed amplicon were observed when running 
sample D (and other later samples) on a Size Select
® 
gel after SephadexTM 
purification, indicating that purification using this method was not complete and it 
could not be used alone when preparing a DNA library. Concentrations of DNA 
recovered were lower when using the AmPure
®
 beads. This method also has the 
potential to carry over smaller DNA fragments and is not well suited to high 
throughput applications. It was therefore determined that a Size Select
®
 gel must still 
be run prior to library pooling and that alternative purification methods would not 
provide an advantage. However, Size Select
®
 gels had previously been shown to not 
be suitable for purification of low concentration PCR products and this required 
further investigation. 
3.4.4 Recovery from Size Select E-gels® 
To attempt to improve recovery of PCR products when using Size select
®
 gels, 
barcode PCR using 10 µl of template was conducted as before on 9 pooled samples. 
The PCR products were quantified and then run on a Size Select
®
 gel. The results 
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showing starting DNA concentration and concentration after gel purification are 
presented in Table 3.8. 
It can be seen that over half of the samples run on the gel did not have enough DNA 
recovered for the NGS protocol (E – K & N). The remainder of the samples were at a 
high enough concentration (> 1nM) after purification to construct a MiSeq DNA 
library. 




  DNA concentration (ng / l) DNA concentration (nM) 
Sample PCR product After gel After gel 
E 1.63 Too low Too low 
F 1.79 Too low Too low 
G 1.81 0.1 0.32 
H 2.32 0.16 0.51 
I 2.28 0.21 0.67 
J 1.88 0.22 0.7 
K 1.98 Too low Too low 
L 4.36 1.17 3.59 
M 5.06 0.72 2.3 
N 13.5 0.28 0.89 
O 13.9 1.5 4.77 
P 12.8 1.23 3.91 
Q 13.4 1.13 3.59 
R 14.5 1.73 5.5 





3.4.4.1 Gel recovery discussion 
The above experiment showed that if the concentration of DNA after PCR 
amplification was above 4 ng / µl, enough DNA was present to run through a Size 
Select
®
 gel and recover for MiSeq NGS. Lower concentration PCR products were 
lost when using Size Select
®
 gels.  
3.4.5 Purification method for low DNA concentration samples.  
Low concentration barcode PCR products had thus far been unable to be purified 
whilst retaining a concentration appropriate for MiSeq NGS library construction. For 
reasons previously mentioned, samples must be purified before MiSeq NGS, so an 
alternative was sought.  
SephadexTM columns do not allow the concentration of DNA by alteration of the 
elution buffer volume. It was considered that if the concentration of PCR products 
was low, they could be concentrated using a QIAquick PCR clean-up column, in 
which DNA is bound to a membrane and can be eluted in a smaller volume (30 µl). 
The method, outlined in Section 2.8.1, was used to purify PCR products and the 
concentration was determined, as before, prior to and after purification. The results 




Table 3.9: DNA concentration before and after QIAquick column 
purification 







T 1.74 0.29 0.92 
U 1.93 0.28 0.89 
V 2.53 0.76 2.41 
W 1.55 0.25 0.79 
X 3.02 0.68 2.16 
Y 3.6 0.89 2.83 
Z 2.06 0.32 1.02 
Here, again it can be seen that for higher starting concentration PCR products, as in 
the case of samples V, X, Y and Z, recovery was high enough for NGS library 
preparation (> 1nM). However, given that the previous non-gel based purification 
methods had failed to adequately ‘clean-up’ the samples, the higher concentration 
samples were run on a Size Select
® 
gel to check for non-specific bands (Figure 3.14). 
Samples V, X, Y and Z produced small bands on a Size Select
®
 gel but also a large 
band between the 50 and 100 bp marks. This indicates the presence of 
unincorporated primers and possible primer-dimers, further highlighting the 










A high proportion of samples still had a DNA concentration after PCR that was too 
low to purify using any of the methods tested thus far. Excluding these samples 
would have resulted in a large loss of data for the study presented in Chapter 6. 
Therefore, it was decided to carry out barcode PCR on each of these samples and 
quantify them post-PCR. Each sample would then be adjusted to an equivalent 
concentration (4 nM) prior to purification. These samples would then be pooled and 
purified as a single sample on a QIAquick column, eluting in 30 µl of PCR-grade 
water, thereby concentrating all of the samples. The purified product would then be 




3.4.6 Discussion and conclusions 
The method validation and testing for the project was extensive. The choices made 
were based on existing knowledge, standard operating procedures and published 
protocols. They were altered and tested in a logical step-wise process in order to 
ensure that the final methods chosen would enable any data collected to be the best 
quality and provide the most information for the study.  
3.4.6.1 Environmental sampling methods and PCR development 
Of the two types of swab tested, neither proved to perform better than the other when 
recovering viable bacteria nor free DNA from tile surfaces. Cotton swabs had the 
advantage as they can be more easily used in the field.  
16S rRNA gene PCR worked well for amplifying pure bacterial DNA but with field 
samples, proved to be problematic. The 16S rRNA gene qPCR did not provide useful 
information as everything, including the NTCs amplified. Reagent contamination is 
common, despite the manufacturer’s claims that products are PCR-clean. The level 
of ‘cleanliness’ is adequate for specific PCRs in which particular microorganisms are 
targeted but when using a broad-spectrum assay designed to amplify all bacteria, the 
reagents appear to not be as ‘clean’ as reported. This is particularly apparent in 16S 
rRNA gene qPCR which is more sensitive than end-point PCR and shows 




Due to the reduced sensitivity of end-point PCR compared to qPCR, weakly positive 
samples may not be visible on agarose gels. The samples used in the method 
development study were from an environment where various types of inhibitors may 
be present and this, coupled with low bacterial load proved to make amplification 
problematic. However, after adjustment of methods, DNA was amplified from all 
test sample types. From the above experiments, the extension of proteinase K 
incubation time from 10 minutes to 1 hour appears to be the best of the methods 
tested at improving DNA yield. This is likely due to the increased digestion of 
protein in the samples, leading to more DNA being available for the PCR reaction. 
It was decided that the best amplification of DNA from swabs taken from the 
hospital environment occurred when using the 785F and 1175R (Eastman) primer set 
with higher annealing temperature than previously used. The primers were also 
considered a better candidate for NGS protocols than the other primer sets tested 
with these samples.  
The Caporaso primer sets were designed for NGS use, with added barcodes and 
adapter sequences; this may explain their poor performance when used as standard 
primers. They were also designed for amplification of microorganisms from soil 




It is now known that proof-reading Taq polymerase, such as KAPA Hi-Fi Taq, can 
contribute to much higher incidences of chimera formation (227) and this appears to 
have been shown in the above experiment. Standard ultra-clean Taq polymerase is 
suitable for 16S rRNA gene PCR, despite reported issues with batch-to-batch 
inconsistencies, which can be mitigated by testing of each batch.  
Low quantities of DNA were obtained after PCR from test swab extracts and this 
was considered likely to also be the case with the samples taken throughout the year 
for the work presented in Chapter 6, making PCR difficult. It was decided to pool 
samples from the ward into 4 sample types for each time point; bed space areas, non-
bed space areas, sinks and floors.  
3.4.6.2 Development of methods for MiSeq NGS 
The main obstacle in preparing DNA libraries for NGS was the low concentrations 
of DNA present and the difficultly in purification of this DNA. Reasons for low 
concentrations after PCR could include the initial overall low numbers of 
microorganisms present on swabbed surfaces, or the incomplete removal from 
swabs, as reported in this chapter. Also, the cleaning agents used in UK hospitals 
include chlorine, which may have an inhibitory effect on PCR but no knowledge is 
available on how chemicals or other inhibitors may affect NGS. The presence of low 
levels of microorganisms, coupled with the presence of inhibitors may have made 
the amplification of DNA difficult and despite pooling bed space samples, some 
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pools did not amplify or amplify to the concentrations required to follow the 
Illumina MiSeq protocol.  
Optimisation and standardisation of a method for preparing samples for MiSeq 
library preparation was troublesome. DNA concentration in samples was not uniform 
and some samples had undetectable levels prior to PCR (Table 3.10). 
Table 3.10: DNA concentration in samples prior to amplification by 
PCR 




H  0.602 
I 0.208 
L 0.35 
Q Too low 
Y Too low 
Z 0.586 
No pattern was observed regarding starting DNA concentration and the optimum 
amount of DNA template to use for barcode PCR; quantity to use could not be 
predicted by starting concentration. This may have been due to a number of factors, 
including the barcode sequences themselves as some may amplify with greater 
efficiency than others. Also, the samples were not necessarily uniform. They were 
pools of other samples and may therefore have contained PCR inhibitors that varied 
between pools. Inhibitors have been shown to have different effects in different 
reactions, having no effect in one but complete suppression in another (228) and 
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could possibly play a role in the difficulty of amplification. The samples also likely 
contained different communities of bacteria, some of which may amplify with 
greater efficiency than others. Despite 2 samples having similar starting DNA 
concentrations, other factors may have affected amplification. Butler et al. have 
reported that stochastic variation is a “fundamental physical law of the PCR 
amplification process when examining low amounts of DNA”. They note that these 
random effects are reflected in the irreproducibility of results when analysing the 
same sample (229). Random fluctuations in efficiency of priming has also been 
reported (230) and the work presented here appears to be in agreement with both of 
these authors comments. The additional length of the barcode primers likely added to 
the inefficiency of the reaction. Each barcode PCR was therefore a ‘trial and error’ 
process in order to achieve amplification.  
NGS, as with other sequencing techniques, requires that PCR products be purified 
prior to sequencing. This is to remove salts and other unincorporated PCR reaction 
components to ensure they do not interfere with the sequencing reaction. In the case 
of the MiSeq NGS protocol, accurate knowledge of the amount of DNA being 
sequenced is required. This is largely due to the need to use NaOH to denature the 
DNA and the quantity used depends on the DNA library concentration. If remaining 
in excess, NaOH will prevent the DNA library from binding to the flow cell and 
therefore the calculations must be accurate. Post-sequencing analysis also requires 
knowledge of library concentration and all samples should be pooled at an equivalent 
concentration to make relative quantification possible.  
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The use of a Size Select
®
 gel to remove non-target DNA from PCR reactions was the 
method of choice as it was quick and required less sample handling. However, when 
running low concentration PCR products on the gels, faint bands became lost and 
very little DNA was recovered. Therefore a different clean up method was sought for 
those low concentration samples. SephadexTM columns and AmPure
®
 beads were 
tested but the losses were still too high for low concentration samples. They were not 
used for high concentration samples as these could be purified on a gel. QIAquick 
columns allowed the concentration of DNA sample by eluting in less volume than 
initially applied. This was often enough to provide a high enough DNA 
concentration for a 1 nM MiSeq library. There were still a number of samples that 
were too low.  These samples were pooled together, purified and concentrated by 
column and quantified.  
Through the testing of various methods, a solid environmental sampling strategy and 
method for sample preparation for MiSeq NGS, including for low concentration 










A study was conducted in order to gain a preliminary understanding of bacterial 
counts and identities in 3 different indoor environments where children spend time. 
The purpose of the study was to determine if observed levels of bacteria were high 
enough to warrant a more in-depth screening protocol and to assess the suitability of 
different locations for sampling, as an indicator of how to proceed with the project. 
Introductions to sampling methods and the microbiology of clinical environments 
are given elsewhere (Chapters 1 and 6) but an overview of educational environments 
and the importance of sampling is given below. 
4.2. Microbes in schools 
Along with hospitals, schools are critical social infrastructures in a society therefore, 
maintaining a healthy environment and reducing disease transmission risk should 
inarguably be one of the key agendas in school operation. Currently, low rates of 
microbiological testing in schools and in other public areas can lead to incomplete 
4. Comparing microbial density and 
diversity in 3 indoor locations 
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information regarding occurrence of disease transmission related to these locations 
(231). It is important to understand the microbial communities within public areas 
and in particular, in schools as poor health in children impacts on wider society. 
Outbreaks of infection can lead to closure of schools meaning parents may take time 
off work to care for them, thus impacting on the economy (232). Children attending 
schools are at particular risk of infectious disease as they spend the majority of their 
day in close proximity to a large number of other people. Infectious diseases are 
easily spread when large groups of people congregate (233). Another risk factor for 
children in particular, is a fall in vaccination rates. In London, for example, there has 
been a much lower uptake of the 5 in 1 (Diptheria, tetanus, pertussis, polio and 
Haemophilus influenzae), measles, mumps and rubella (MMR) and meningitis C 
vaccinations over recent years (234). There have also been reports of increased risk 
of contracting disease, particularly tuberculosis (TB), on public transport due to 
being in prolonged close proximity to others and poor air quality (235), (236). With 
UK class sizes increasing beyond government guidelines (234), many British 
children living in poverty (237), increasing use of public transport, particularly in 
London (238) and changing profiles of infectious disease due to immigration and 
drug-resistance (239), (240), children are at an ever growing risk of becoming ill in 
an environment which is intended to be protective and nurturing.  
4.3 Aims of the study 
The aims of this part of the project were to compare number and identities of 
bacteria in three locations to determine if different environments had different 
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microbial profiles. It was also to determine the overall suitability of sampling 
methods in preparation for the year-long investigation on a hospital ward presented 
in Chapter 6. 
4.4 Materials and methods 
4.4.1 Site selection 
Three locations were chosen: a four bed neurology ward (Tiger ward) at GOSH, an 
outpatient area in the same hospital and a classroom for approximately 30 Year 6 
school children age 10-11. Table 4.1 and Figure 4.1 show sampling sites for Tiger 
ward, Table 4.2 and Figure 4.2 show sampling sites for the outpatient area and Table 
4.3 and Figure 4.3 show sampling sites for the classroom. Each location was divided 
into 4 areas, roughly quarters and treated as sections A-D to facilitate sample 
collection. Samples were taken once at each location at 09.00 on Mondays of 
consecutive weeks. Contact plates and swabs were taken at 12 sites in each section (a 
total of 48 per location). Each sample was given a unique identifying code as 
follows: 
 Prefix: Contact plate (C ), Swab (S) 
 Location codes: W = Ward  S = School  O = Outpatient waiting area 
 Month Code:  ‘Pil’ for pilot in this instance 
 Area of room: Quadrant A, B, C or D. 
 Sample number: 1-12 
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 Sample Process: PCR (PCR), Culture (Cul)  
Each sample was therefore given an identifier e.g.: SWPilA1Cul 
Samples were taken at varying heights, from objects made from different materials 
and from those differing in use; i.e. high and low hand-touch sites (45), (241). Where 
possible, equivalents were sampled in each location; chairs, window sills, floors and 
sinks. As the three locations were used for very different purposes, it was not 




Table 4.1: Sampling sites on Tiger Ward 
 
 
Figure 4.1: Sampling sites on Tiger Ward 
 
Sample Number Sample Site Sample Number Sample Site
A1 Floor under bed C1 Floor under bed
A2 Monitor shelf C2 Monitor shelf
A3 Chair C3 No sample
A4 Trolley top C4 No sample
A5 Monitor top C5 Monitor top
A6 Drawer front C6 Drawer front
A7 Top of light C7 Top of light
A8 Bed rail C8 Bed rail
A9 Sink (right) C9 Trolley top
A10 Window (right) C10 Window (left)
A11 Sink (left) C11 Bed pedal   
A12 Bed pedal   C12 No sample
B1 Floor under bed D1 Floor under bed
B2 Monitor shelf D2 Monitor shelf
B3 Chair D3 Chair
B4 No sample D4 No sample
B5 Monitor top D5 Monitor top
B6 Drawer front D6 No sample
B7 Top of light D7 No sample
B8 Bed rail D8 No sample
B9 Trolley top D9 Trolley top
B10 Window (left) D10 Window (right)
B11 Bed pedal   D11 Bed pedal   
B12 No sample D12 No sample
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Table 4.2: Sampling sites in the outpatient’s area  
 
 
Figure 4.2: Sampling sites in the outpatient’s area  
 
Sample Number Sample Site Sample Number Sample Site
A1 Windowsill C1 Play table
A2 Heating ledge C2 Heating vent
A3 Drawers C3 Toy
A4 Football table C4 Table 2
A5 Main table C5 Chair leg 1
A6 Main table 2 C6 Chair leg 2
A7 Top of cupboard 1 C7 Door
A8 Front of cupboard 2 C8 Handle female WC
A9 Under main table C9 Sign
A10 Chair C10 Chair
A11 Floor under football table C11 Corner trunking
A12 Top of cupboard 2 C12 Floor by female WC
B1 Top of cupboard 3 D1 Table 1
B2 Main desk 1 D2 Table 2
B3 Main desk 2 D3 Top of TV
B4 Top of bin D4 TV stand base
B5 Foot pedal of bin D5 Steering wheel toy car
B6 Trunking between doors D6 Base of toy car
B7 Handle of assisted WC D7 Chair
B8 Floor by exit door D8 Chair
B9 Seat of rocking horse D9 Floor by pillar
B10 Floor under desk D10 Wall trunking
B11 Chair D11 Table 3
B12 Trunking under cupboard D12 Floor under table
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Table 4.3: Sampling sites in the classroom 
 
 
Figure 4.3: Sampling sites in the classroom
Sample Number Location Sample Number Location
A1 Door handle C1 Bookshelf
A2 Top of drawers C2 Time Out' desk
A3 Bookshelf C3 Windowsill
A4 Top of whiteboard C4 Towel dispenser
A5 Top of speaker C5 Sink
A6 Desk 1 C6 Tap
A7 Desk 2 C7 Desk 6
A8 Top of projector C8 Desk 7
A9 Bookshelf C9 Windowsill
A10 Floor by door C10 Desk 8
A11 Light switch C11 Desk 9
A12 Drawers C12 Under sink 
B1 Top of speaker D1 Windowsill
B2 Desk 3 D2 Computer tower
B3 Computer keypad D3 Key cupboard
B4 Pipes D4 Mini projector
B5 Bookstand D5 Windowsill
B6 Drawers D6 Drawer
B7 Drawer front D7 Desk 10
B8 Desk 4 D8 Desk 11
B9 Desk 5 D9 Desk 12
B10 Windowsill D10 Coat hook
B11 Floor by drawers D11 Floor by drawers
B12 Computer desk D12 Pipes
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4.4.2 Culture methods 
TSA contact plates and charcoal enrichment swabs were taken as outlined in sections 
2.2.1 and 2.2.2.2, respectively. Colonies on TSA plates were counted and recorded 
as CFU per plate and pure cultures from enrichment swabs were harvested from 
blood agar and stored at -80 
O
C in glycerol for subsequent processing.  
4.4.3 Identification 
Gram stains were performed on isolates obtained by enrichment culture to provide 
basic identification (Section 2.4.1). Isolates that had a similar morphology to an         
S. aureus reference strain on agar plates and by staining were tested using the 
catalase test and Pastorex
®
 Staph Plus kit as described (2.4.2.1 and 2.4.2.2). 
4.4.4 DNA extraction 
Glycerol stocks of pure cultures were thawed and a loop-full (approximately 10 l) 
of bacterial suspension was streaked out onto blood agar. The plates were incubated 
at 37 
O
C for 24 hours. DNA extraction was carried out as in Section 2.5.1.  
4.4.5 16S rRNA gene PCR 
End-point PCR was carried out on the DNA extracts from all isolates from all 
locations using universal primers 27F and 1492R to amplify a region within the 




Sequence data were analysed using the method given in Section 2.10.4.1, using the 
Chromas LITE V2.01 software package and on-line BLAST program. 
4.5 Results 
4.5.1 Total viable count results 
Full sets of 48 total viable count (TVC) plates were collected from the classroom and 
outpatient’s area. However, on Tiger ward, some sites were not available for 
sampling due to the presence of staff or parents. Extra samples, not in the designated 
sampling plan were taken, on the ward to make up for this shortfall (prefix ‘E’). A 
total of 43 samples were taken on the ward. 
Colony counts were divided into 4 categories; < 50, 50-100, 101-200 and > 200 CFU 
and given a colour code. TVC results obtained using contact plates for each site are 
presented in Table 4.4. Cells are colour-coded as described. If colonies on TSA 
plates had merged, TVC was estimated based on the percentage of plate that the 
colonies covered. 
More sites in the classroom had > 200 CFU than in the other locations and more sites 
on the ward had < 50 CFU. However, due to the diverse nature of the locations, 
absolute numbers of plates taken at each location varied. The data have been 
corrected to account for this by expressing as percentages (Figure 4.4).
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Table 4.4: Bacterial total viable counts recovered from sampling sites on a hospital ward, outpatient’s area and classroom  










A1 Floor under bed 146 A1 Door handle 1 A1 Windowsill 128 
A2 Monitor shelf 1 A2 Top of drawers 52 A2 Heating ledge 11 
A3 Chair  >200 A3 Bookshelf >200 A3 Drawers 128 
A4 Trolley top 1 A4 Top of whiteboard >200 A4 Football table 31 
A5 Monitor top 0 A5 Top of speaker 41 A5 Main table 0 
A6 Drawer front 0 A6 Desk 1 57 A6 Main table 2  1 
A7 Top of light 26 A7 Desk 2 3 A7 Top of cupboard 1 184 
A8 Bed rail 33 A8 Top of projector >200 A8 Front of cupboard 2 11 
A9 Sink (right) 72 A9 Bookshelf >200 A9 Under main table 146 
A10 Window (right) 27 A10 Floor by door >200 A10 Chair 29 
A11 Sink (left) 26 A11 Light switch 7 A11 Floor under football table 87 
A12 Bed pedal    Merged A12 Drawers >200 A12 Top of cupboard 2 >200 















B2 Monitor shelf 0 B2 Desk 3 28 B2 Main desk 1 2 
B3 Chair  80 B3 Computer keypad >200 B3 Main desk 2 0 
B4 NO SAMPLE - B4 Pipes >200 B4 Top of bin 64 
B5 Monitor top 0 B5 Bookstand >200 B5 Foot pedal of bin 37 
B6 Drawer front 1 B6 Drawers  174 B6 Trunking between doors 81 
B7 Top of light 8 B7 Drawer front 131 B7 Handle of assisted WC 65 
B8 Bed rail 0 B8 Desk 4 18 B8 Floor by exit door 53 
B9 Trolley top 67 B9 Desk 5 13 B9 Seat of rocking horse 22 
B10 Window (left) 15 B10 Windowsill >200 B10 Floor under desk 71 
B11 Bed pedal    Merged B11 Floor by drawers >200 B11 Chair 101 
B12 NO SAMPLE - B12 Computer desk 108 B12 Trunking under cupboard 167 
C1 Floor under bed >200 C1 Bookshelf 188 C1 Play table 1 
C2 Monitor shelf 0 C2 ‘Time Out' desk 24 C2 Heating vent >200 
C3 NO SAMPLE - C3 Windowsill 49 C3 Toy 5 
C4 NO SAMPLE - C4 Towel dispenser >200 C4 Table 2 37 
C5 Monitor top 1 C5 Sink >200 C5 Chair leg 1 >200 
C6 Drawer front 0 C6 Tap >200 C6 Chair leg 2 159 
C7 Top of light 2 C7 Desk 6 16 C7 Door 2 
C8 Bed rail 52 C8 Desk 7 14 C8 Handle female WC 88 
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C9 Trolley top 0 C9 Windowsill 46 C9 Sign 17 
C10 Window (left) Merged C10 Desk 8 7 C10 Chair 46 
C11 Bed pedal    Merged C11 Desk 9 10 C11 Corner trunking 46 
C12 NO SAMPLE - C12 Under sink  >200 C12 Floor by female WC 98 
D1 Floor under bed >200 D1 Windowsill 89 D1 Table 1 8 
D2 Monitor shelf 22 D2 Computer tower >200 D2 Table 2 0 
D3 Chair 16 D3 Key cupboard 73 D3 Top of TV 161 
D4 NO SAMPLE - D4 Mini projector 67 D4 TV stand base 141 
D5 Monitor top 8 D5 Windowsill >200 D5 Steering wheel toy car 32 
D6 NO SAMPLE - D6 Drawer 47 D6 Base of toy car 163 
D7 NO SAMPLE - D7 Desk 10 1 D7 Chair >200 
D8 NO SAMPLE - D8 Desk 11 17 D8 Chair 23 
D9 Trolley top 4 D9 Desk 12 2 D9 Floor by pillar 109 
D10 Window (right) 17 D10 Coat hook 23 D10 Wall trunking 53 
D11 Bed pedal    Merged D11 Floor by drawers >200 D11 Table 3 102 
D12 NO SAMPLE - D12 Pipes >200 D12 Floor under table 129 
E1 Alcohol dispenser 176       
E2 TV shelf Merged       
E3 Towel dispenser Merged  
E4 Towel dispenser Merged       
E5 Alcohol dispenser 139 Green: < 50 CFU, Yellow: 50 – 100 CFU, Orange: 101 – 200 CFU, Red: > 200 CFU 
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Figure 4.4 shows the percentages of sites with TVCs in each category. It can be seen 
that the majority of TVCs obtained across all sites were low (<50 CFU).  However, 
over half of the sites in the classroom and outpatient’s and just under half in the ward 
were in the medium to higher categories. 
 
Figure 4.4: Percentage of sampling sites at each of 3 locations with 
bacterial total viable counts in each of 4 numerical categories . 
The percentage of sites with high CFUs was much greater in the school (40 %) than 
the ward and outpatient’s area which had similar levels of sites in this category of      
7 % and 8 % respectively.  
The ward had the least environmental contamination with 56 % of sites having < 50 
CFU. Only 3 sites from the ward had counts > 200 CFU, two of these were floor 
sites and the other was a chair seat (Figure 4.5). The remainder of the sites with 
higher counts on the ward were items such as bed foot pedals and the tops of non-
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clinical items like the shelf that held the television. All clinical items such as trolleys 
and monitors and items near to the beds showed low CFU recovery (Figure 4.5).  
The classroom had a much higher number of sites with colony counts of > 200 CFU 
(Figure 4.6). The contact plates taken at many sites within the classroom, in fact, 
were almost confluent after 24 hours of incubation. These high TVCs tended to be 
found on items such as floors, bookshelves and the tops of items. Desks and student 
drawers in this location tended to have low colony counts of < 50 CFU.  
The outpatient’s area had only 4 sites that showed > 200 CFU but had a high 
percentage (29 %) of sites with 101-200 CFU (Figure 4.7). As observed in the 
classroom, desks and tables showed lower counts.  
Sampling sites can be seen in Figures 4.5 – 4.7, showing CFUs recovered and the 




Figure 4.5: Sampling sites on the ward showing height, touch-frequency and 
recovered colony-forming units   
Colours are indicative of CFU counts 
as given in the figure. The shape of 
the colour block corresponds to object 
height, circles for high (>1.5 m), 
squares for medium (1-1.5 m) and 
triangles for low (<1 m). Internal 
shapes correspond to touch-
frequency, circles for high, squares 










Figure 4.6: Sampling sites in the classroom showing height, touch-frequency and 
recovered colony-forming units      
Colours are indicative of CFU counts 
as given in the figure. The shape of 
the colour block corresponds to object 
height, circles for high (>1.5 m), 
squares for medium (1-1.5 m) and 
triangles for low (<1 m). Internal 
shapes correspond to touch-
frequency, circles for high, squares 










Figure 4.7: Sampling sites on the ward showing height, touch-frequency and 
recovered colony-forming units                                                                          
Colours are indicative of CFU counts 
as given in the figure. The shape of 
the colour block corresponds to object 
height, circles for high (>1.5 m), 
squares for medium (1-1.5 m) and 
triangles for low (< 1 m). Internal 
shapes correspond to touch-
frequency, circles for high, squares 
for medium, and triangles for low.                                                                                                                                                              





4.5.1.1 Total viable counts by sample site height 
In order to determine if sample site height had an effect on CFU recovery, sites were 
categorised into low (< 1 m), medium (1-1.5 m) and high (> 1.5 m). Due to the 
diverse nature of the locations, equipment and items within them, absolute numbers 
of contact plates taken at each height varied. The data have been corrected to account 
for this by expressing as percentages (Figure 4.8). 
Sampling sites in the high height category included shelves, window ledges and tops 
of cupboards. Medium level items were desks, chairs and trolley tops and low items 
were floors and bases of floor-standing equipment. Of the high sites sampled on the 
ward, 60 % had low TVC counts, of the high sites sampled in the classroom, 50 % 
had high TVCs and for the outpatient’s area, the majority of high sites had 
intermediate-to-high CFUs (Figure 4.8).  
Of the low sites sampled, only the outpatient’s area had some sites with low TVCs, 
100 % of low sites in the classroom had > 200 CFU. For the ward, low sites mostly 
had low-intermediate CFUs but a small percentage of sites showed higher counts. 
For the most part, at all locations, medium height sampling sites had low TVC 
recovery but the outpatient’s area had a greater range of counts for this height 




Figure 4.8: Percentage of sites sampled with bacterial colony forming units in different categories, recovered at 3 different 
heights on the ward, in the classroom and outpatient’s area .
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4.5.1.2 Total viable counts by touch-frequency 
The data were arranged with regard to touch-frequency; high-touch being items such 
as desks or door handles and low-touch items including hard-to-reach areas such as 
high windowsills. Medium-touch items were items such as chairs, trolleys and 
drawer fronts. 
High-touch sites had low CFU recovery in all locations with the majority of TVC 
plates falling into this category. 75 % of high-touch sites sampled on the ward and 
outpatient’s area and 82 % of high-touch sites in the classroom had < 50 CFUs. 
Medium touch sites showed a range of CFUs in the ward and classroom but all 
medium-touch sites had < 50 CFUs in the outpatient’s area. Low touch sites 
appeared to show no trend, showing a range of CFU recovery, except in the 





Figure 4.9: Percentage of sites sampled with bacterial colony forming units in different categories, recovered from 
different touch-frequency items on the ward, in the classroom and outpatient’s area .
188 
 
4.5.2 Sequencing identification results 
Bacillus was the most frequently isolated genus in both the outpatient’s area and 
classroom occurring at 42 % and 50 % of sites respectively (Figure 4.10). The next 
most frequently isolated genus in both of these locations was Staphylococcus 
occurring at 25 % and 19 % of sites respectively. On the ward, Staphylococcus was 
most frequently isolated, found at 26 % of sites and Bacillus was isolated from 23 %. 
The staphylococci were mostly coagulase-negative (CNS) in all locations but 
biochemical testing identified the presence of S. aureus on a chair on the ward, desk 
in the classroom and the handle of a game, toilet door handle and floor in the 
outpatient’s area. 
9 % of sites sampled on the ward had Pseudomonas spp. present, compared to 2 % 
and 4 % in the classroom and outpatient’s area. Sequence data and biochemical tests 
confirmed the presence of P. aeruginosa on a sink on the ward. Enterobacteriaceae 
were isolated from all locations, most frequently from the outpatient’s area (Table 
4.5), Klebsiella sp. was isolated from both the classroom and outpatient’s area and 
Enterobacter sp. was common to all 3 locations. A. baumanii, E. cloacae and           






Figure 4.10: Bacterial genera and frequency of isolation from the 




































Table 4.5: Number of sites from which selected clinically-relevant 
pathogens were identified in each of 3 locations: ward, classroom and 
outpatient’s waiting area.  
  Number of sites  
Identification Ward Classroom Outpatient's 
Pseudomonas aeruginosa 1 - - 
Staphylococcus aureus 1 1 3 
Acinetobacter baumanii 1 - - 
Acinetobacter lwoffii - 1 1 
Enterobacter cloacae 2 - - 
Enterococcus sp - 2 1 
Streptococcus sp - 1 2 
Kelbsiella sp - 1 1 
Other Enterobacteriaceae 3 2 8 
 
4.5.2.1 Ward sequencing data results 
A total of 9 different genera were isolated from Tiger ward at the time of sampling 
(Table 4.6). Staphylococcus was the most common genus, occurring at 26 % of 
sampling sites analysed and Bacillus occurred with similar frequency at 23 % of 
sites. S. aureus was found on a chair (A3). Pseudomonas DNA was isolated from 9 
% of sites, with one of these isolates from a sink (A9) being identified by 
biochemical means as P. aeruginosa, other isolates could not be identified to 
species-level but belonged to the P. aeruginosa group. Other clinically-relevant 
bacteria identified included A. baumanii from a bed pedal (C11) and E. cloacae from 
the floor (D1). 
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Table 4.6: Identification of bacteria from the ward, showing known 
pathogens in red, *-confirmed biochemically. 
Sample 
number 
Sample site Bacteria ID 
Max. Identity 
(%) 
A1 Floor under bed 
Bacillus sp. 100 
Staphylococcus sp. (CNS) 100 
A2 Monitor shelf Staphylococcus sp. (CNS) 100 
A3 Chair 
Bacillus sp. 100 
Staphylococcus aureus* 100 
A4 Trolley top Bacillus sp. 100 
A6 Drawer front Paenibacillus sp. 100 
A9 Sink 
Pseudomonas aeruginosa* 100 
P. aeruginosa-group 100 
A10 Window Staphylococcus sp. (CNS) 100 
A11 Sink Exiguobacterium marinum 99 
A12 Wheel of bed Enterobacter cloacae complex 99 
B1 Floor 
Bacillus sp. 99 
P. aeruginosa-group 100 
B5 Monitor P. aeruginosa-group 100 
B6 Chair Staphylococcus sp. (CNS) 100 
B7 Top of light Pectobacterium cypripedii 98 
B9 Floor Staphylococcus sp. (CNS) 100 
B10 Windowsill Staphylococcus sp. (CNS) 100 
B11 Wheel of bed Bacillus sp. 100 
B12 Bed pedal Bacillus sp. 100 
C1 Floor Bacillus sp. 100 
C11 Pedal Acinetobacter baumanii 99 
D1 Floor Enterobacter cloacae 99 
D3 Chair Staphylococcus sp. (CNS) 99 
D10 Window 
Bacillus sp. 100 
Staphylococcus sp. (CNS) 100 
D11 Bed pedal Bacillus sp. 100 
D12 Pedal Citrobacter sp. 97 
E2 TV shelf Staphylococcus sp. 100 
E3 Towel dispenser Bacillus sp. 100 
E4 Towel dispenser Staphylococcus sp. (CNS) 100 
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4.5.2.2 Outpatient’s area sequencing data results 
A total of 11 different bacterial genera were isolated from the outpatient’s waiting 
area at the time of sampling. Bacillus was the predominant genus, occurring at 42 % 
of sampling sites analysed (Table 4.7).  Staphylococcus was the next most frequent, 
occurring at 25 % of sites, 3 isolates of which were identified as S. aureus. 
Clinically-relevant strains, identified to species-level, were found at 23 % of 
analysed sites. This number was the highest of all 3 areas sampled. Six of the 
clinically-relevant isolates were members of the Enterobacteriaceae family and are 
associated with animal or human faeces and opportunistic infection. Klebsiella is 
also a member of the Enterobacteriaceae and was isolated from the wall trunking and 
this genus contains a number of human pathogens. Streptococcus, Acetobacter, 
Acinetobacter and Pseudomonas were also identified and these genera are also 
known to contain members which are potential pathogens.   
There was a widespread distribution of clinically-relevant bacteria identified to 
species-level throughout the outpatient’s area. No apparent clustering occurred and 
they were not solely associated with sampling sites near to toilets, which may have 
been expected, given the number of isolates associated with the gut and faecal matter 
(Figure 4.11). Five of these bacteria were isolated from high-touch sites including 




Table 4.7: Identification of bacteria from the outpatient’s area, 
showing known pathogens in red, *-confirmed biochemically 
Sample 
number 




A2 Heating ledge Staphylococcus sp. (CNS) 99 
A4 Football table Staphylococcus aureus* 99 
A6 Main table 2 Pantoea agglomerans  99 
A7 Top of cupboard 1 
Acetobacter sp. 99 
Staphylococcus sp. (CNS) 99 
A8 Front of cupboard 2 Staphylococcus sp. (CNS)  99 
A9 Under main table Bacillus sp. 99 
A10 Chair  Staphylococcus sp. (CNS) 99 
A11 
Floor under football 
table 
Bacillus sp. 100 
Staphylococcus sp. (CNS) 99 
Acinetobacter sp. 96 
B1 Top of cupboard 3 Bacillus sp. 99 
B2 Main desk 1 Acinetobacter lwoffii  99 
B4 Top of bin 
Bacillus sp. 99 
Staphylococcus sp. (CNS) 99 




Bacillus sp. 99 
Pseudomonas sp. 99 
B8 Floor by exit door 
Bacillus sp. 99 
Lysinibacillus sp. 99 
B9 Seat of rocking horse 
Staphylococcus sp. (CNS) 100 
Pseudomonas luteola  99 
B10 Floor under desk 
Staphylococcus sp. (CNS) 99 
Streptococcus sp. (bovis group) 100 
B11 Chair   
Bacillus sp. 99 




Bacillus sp. 99 










C1 Play table Bacillus sp. 94 
C2 Heating vent 
Bacillus sp. 99 
Pseudomonas sp. 99 
Enterococcus faecalis  99 
C3 Toy Pantoea sp. 99 
C5 Chair leg 1 Bacillus sp. 100 
C6 Chair leg 2 
Bacillus sp. 99 
Staphylococcus sp. (CNS) 99 
C8 Handle female WC 
Bacillus sp. 99 
Enterobacter ludwigii  99 
Staphylococcus aureus* 99 
C10 Chair Staphylococcus sp. (CNS) 99 
C11 Corner trunking Staphylococcus sp. (CNS) 99 
C12 Floor by female WC Enterobacter hormaechei  99 
  Staphylococcus aureus* 99 
D1 Table 1 Enterobacter sp.  99 
D3 Top of TV Lysinibacillus sp.  99 
D4 TV stand base 
Bacillus sp. 99 
Pantoea dispersa  99 
D6 Base of toy car Bacillus sp. 99 
D7 Chair 
Bacillus sp. 99 
Enterobacter asburiae  98 
Staphylococcus sp. (CNS) 99 
D8 Chair 
Streptococcus sp. (bovis group) 99 
Bacillus sp. 99 
D9 Floor by pillar Bacillus sp. 99 
D10 Wall trunking 
Klebsiella sp.  97 
Bacillus sp. 99 
D12 Floor under table 
Enterobacter ludwigii  99 




Figure 4.11: Distribution of clinically-relevant bacterial species in the 
outpatient’s waiting area at GOSH  
4.5.2.3 Classroom sequencing data results 
Bacillus was the most frequently isolated genus from the classroom samples, 
occurring at 50 % of sampling sites analysed (Table 4.8).  Staphylococcus was again 
the next most frequent, occurring at 19 % of sites. S. aureus was present on a desk, 
as confirmed by biochemical methods. Klebsiella sp. and Enterococcus faecalis / 
faeceium were found on tops of speakers and Enterobacter sp. was found on a light 
switch and nearby drawers. 
196 
 
Table 4.8: Identification of bacteria from the classroom, showing 
known pathogens in red, *-confirmed biochemically 
Sample 
number 




A2 Top of drawers Exigubacterium 99 
A3 Bookshelf 
Bacillus spp. 99 
Streptococcus sp. 99 
A4 Top of whiteboard 
Bacillus sp. 99 
Enterococcus sp. 98 
A5 Top of speaker 
Bacillus sp. 98 
Klebsiella sp. 97 
A6 Desk 1 Staphylococcus aureus* 98 
A9 Bookshelf Bacillus sp. 95 
A10 Floor by door Bacillus sp. 98 
A11 Light switch Enterobacter sp. 97 
A12 Drawers Enterobacter sp. 97 
B1 Top of speaker 
Enterococcus faecalis / 
faeceium 
100 
B2 Desk 3 Bacillus sp. 92 
B3 Computer keyboard Bacillus sp. 100 
B4 Pipes 
Bacillus sp. 100 
Lysinibacillus fusiformis 100 
Staphylococcus sp. (CNS) 100 
B5 Bookstand Bacillus sp. 100 
B6 Drawers Bacillus sp. 99 
B7 Drawer front Bacillus sp. 99 
B9 Desk 5 Acinetobacter sp. 97 
B10 Windowsill Bacillus sp. 100 
B12 Computer desk 
Bacillus sp. 100 
Staphylococcus sp. (CNS) 100 
Acinetobacter lwoffii 99 
C4 Towel dispenser Bacillus sp. 100 










C7 Desk 6 Staphylococcus sp. 99 
C9 Windowsill 
Acinetobacter johnsonii 99 
Bacillus sp. 99 
C10 Desk 8 Agrobacterium sp. 99 
C11 Desk 9 
Pseudomonas sp. 99 
Staphylococcus sp. (CNS) 99 
C12 Under sink Bacillus sp. 99 
D1 Windowsill 
Staphylococcus sp. (CNS) 99 
Brevibacterium frigoritolerans 100 
D2 Computer tower Bacillus sp. 99 
D3 Key cupboard 
Bacillus sp. 99 
Staphylococcus sp. (CNS) 99 
D4 Mini projector 
Staphylococcus sp. (CNS) 99 
Bacillus sp. 100 
D5 Windowsill Bacillus sp. 99 
D6 Drawer  Bacillus sp. 99 
D8 Desk 11 
Staphylococcus sp. 99 
Bacillus sp. 99 
D10 Coat hook Bacillus sp. 99 
D11 Floor by drawers Bacillus sp. 99 
 
4.6 Discussion 
The main source of microbial particles in indoor environments such as homes, 
hospitals, and schools is the presence of humans (10), (48), (49). The outpatient’s 
area has a high frequency of transient human use with approximately 350 patients 
passing through per day, each with parents, outside clothing, bags, shoes and various 
food items. There are toilets and a baby-changing area in this location and 
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consequently, a large number of individuals enter the space from other areas of the 
hospital to use these facilities. The classroom is occupied by approximately 30 
children for much of the day and despite this being less than the outpatient’s area, 
contrasts with the lower volume of people on the ward and may explain the 
differences in overall TVC counts. Within the section of the ward analysed, there 
was space for only four patients and their parents, and there were regular visits from 
a small team of doctors and nurses. It has previously been shown that greater human 
traffic appears to be associated with higher rates of microbial contamination (44) and 
the data presented in this study appear to support this. 
The classroom had higher bacterial counts overall than the other 2 locations, 
meaning that occupancy alone could not account for levels of contamination. The 
lower numbers of bacteria present in the hospital environments and lower counts on 
the ward than in the outpatient’s area could be due to other factors. For example, the 
school was not subject to the same rigorous cleaning regimes as the hospital 
environments. Cleaners vacuumed the classroom carpet and cleaned easy-to-reach 
designated areas once a day. Areas with less easy access such as bookcases and high 
windowsills were not routinely cleaned. All sites that were cleaned less frequently 
such as bookshelves, pipes, high windowsills, tops of projectors and book stands had 
> 200 CFUs. This was in contrast to the desks, all of which had < 50 CFU except 
one, which had 57 CFUs. Other objects that were cleaned less frequently than daily 
such as the floor, computer key pads and the tops of items had intermediate to high 
CFU counts. This suggests that without regular cleaning, bacteria can accumulate on 
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objects. The presence of carpets and other soft furnishings is known to contribute to 
higher bacteria load within indoor environments  (55), (62) and this, along with less 
frequent cleaning may account for higher numbers of bacteria being present in the 
classroom. 
A similar pattern was observed in the outpatient’s area, with objects such as the 
windowsill, tops of cupboards, chair legs and wall-mounted plastic trunking having 
higher numbers of bacteria than other items. These sites may well be over-looked 
and not as frequently cleaned as play areas or easier to reach sites. The pattern was 
once again repeated on the ward but with lower overall CFU counts observed. High-
touch items or those within easy reach had lower CFUs than other sites. Gaudart et 
al. reported that items  > 1.2 m high were often more heavily contaminated in an 
ICU than lower items (45), also suggesting that difficult to reach areas may not be 
cleaned as well or as frequently as other sites. The only sites sampled that did not fit 
this pattern in the current study were floors. Despite being frequently cleaned, 
particularly in the hospital, floors showed high bacterial counts and this was also 
observed by  Gaudart et al. (45).  
On the ward, infection control practices such as hand washing, cleaning and wearing 
of appropriate clothing are strictly observed. As such, the people present are aware 
of reducing microbial contamination and this may contribute to the lower numbers of 
bacteria found in this area. 
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4.6.1 Sample height and touch-frequency 
It might be expected that higher bacterial counts would be found in higher, harder to 
clean areas and this appears to be the case in the school and outpatient’s area. 
However, low areas such as floors, which may be frequently cleaned, also had high 
bacterial counts. The continual replenishment of bacteria by footfall, trolleys and the 
settlement of bacteria from skin or clothing may account for high CFUs observed on 
floors. It was observed that when beds were present on the ward, floor areas under 
the beds were not mopped during routine cleaning.   
High-touch objects may be expected to be more highly contaminated but in all 
locations, the majority of high-touch items had low bacterial counts. On the ward 
and the outpatient’s areas, these high-touch items tended to be the focus for cleaning. 
On the ward, for example, clinical staff are required to wipe down items such as 
trolleys, tables and bedrails throughout the day. This likely results in reduced overall 
contamination. In the outpatient’s area, play co-ordinators are often present and they 
are also responsible for wiping high-touch areas. It would appear from the data that 
high-touch areas in the classroom such as desks may also be the focus for cleaning.  
4.6.2 Sample site material  
The data could not be assessed with regards to the material type of each object 
sampled due to the high variability of materials between and within locations. 
However, the presence of many more fabrics in the classroom, rugs and curtains for 
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example, may lead to TVCs being higher than in other locations. Gravesen et al. 
found that overall concentrations of airborne bacteria in schools and offices doubled 
when carpets were in place than when not (242). This was not observed in another 
study by Bartlett et al., although they did report higher numbers of airborne bacteria 
when more clutter was present (36). Where the ward and outpatients floor may be 
comprised of the same material, this is likely to be the only site that is directly 
comparable between all locations. Whilst it is acknowledged that materials retain or 
release bacteria differently, it was beyond the scope of this preliminary study to 
address this.  
4.6.3 Bacterial identification 
Staphylococcus and Bacillus were the most frequently isolated genera in all 
locations. This may have been expected as they are associated with the skin and 
environment respectively and are ubiquitous. The observations are in agreement with 
other culture-based studies regarding indoor bacteria. Okten and Asan found the 
predominant bacteria in a paediatric hospital to be Gram positive cocci (63 %) 
followed by Gram positive-bacilli (34 %) (42). Obbard and Fang reported similar 
results, finding skin commensals such as CNS and Acinetobacter, and environmental 
taxa including Pseudomonas in a hospital (35). Gut-associated microorganisms such 
as E. cloacae were observed in all locations, more so in the classroom and 
outpatient’s area, suggesting the presence of faecal material in these locations. Such 
organisms may not be pathogenic for immunocompetent children in a school but in 
healthcare environments, they may be clinically-relevant. Importantly, people 
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passing through the outpatient’s area, for example, may travel to other areas of the 
hospital, leading to potential spread of pathogens to susceptible people.  
Very little research has been conducted with regard to surface sampling and 
microbial community analysis in the school environment; therefore it is difficult to 
compare results obtained in this study with the literature. Most investigative studies 
have focussed on indoor air quality and the presence of bacteria or microbial 
components in the air (31), (47), (151). However, surface bacteria may reflect 
airborne communities and Bartlett et al. reported Micrococcus, Staphylococcus and 
Bacillus to be the predominant genera in classroom air (36). They found no Gram 
negative species however, possibly due to damage caused by sampling. Qian et al. 
also reported skin-associated taxa being present in air (47). The similarity of surface 
and air samples may suggest a link between them. Further studies must be 
conducted, simultaneously sampling both air and surfaces however and this is 
reported in Chapters 5 and 6.   
Bacterial taxa may have been underestimated in this study, given that enrichment 
culture was used prior to sequencing. This study was intended to be a preliminary 
assessment of bacteria within 3 environments in order to determine information 
regarding any similarities or differences but also to inform a more long-term 
sampling strategy.  However, despite the limitations of culture methods, the results 
presented do show important differences in the 3 locations investigated. They also 
show that a variety of bacterial taxa can be isolated, even with a method known to 
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underestimate diversity. The aims of the chapter were achieved, in that the study 
provided results to inform the remainder of the work. 
4.7 Conclusion  
The concept of a characteristic microbial community associated with different indoor 
environments is worth further thought. It might be that the microbial community 
structure in each of these environments is driven by a number of parameters similar 
to classic microbial environments in the gut or oral cavity, for example. Population 
shifts due to changing parameters such as nutrient availability or desiccation, are 
well documented for many microbial systems and may occur in larger areas such as 
indoor environments. 
This study highlights the difficulty in preventing the accumulation of potentially 
pathogenic microorganisms in environments frequented by children. There is a 
current emphasis by the World Health Organisation on utilising the ‘Five moments 
for hand hygiene’ strategy which takes into consideration cleaning hands when 
touching patient surroundings in healthcare environments (243). This strategy might 
help to limit spread of infectious organisms to susceptible individuals in clinical 
environments; however it will remain unlikely that surfaces will ever be totally free 
from microbial presence. The concepts behind environmental cleaning and hand 
hygiene strategies are useful and could be of benefit if disseminated out of the 
healthcare environment into the community.  This could extend to schools, where 
high levels of bacteria have been reported. Perhaps a more global microbial 
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ecological view is required if we are to modulate the potentially dangerous microbial 
environments frequented by at risk individuals such as children. 
Overall, the hospital environment appears to have less environmental bacterial 
contamination than a classroom and this may be due to cleaning and types of objects 
present. However, different areas within the same hospital have differences in 
bacterial numbers, taxa and distribution. Height seems to have a small effect on CFU 
recovery in each location, as does touch frequency.  
The techniques used in this small comparative study appeared sufficient to capture a 
broad range of organisms from the environment and were considered suitable for the 
subsequent studies along with the addition of techniques such as processing swabs 
by molecular methods and air sampling. Different bacterial taxa were isolated from 
all environments and demonstrated the presence of known pathogens; therefore it 










Outbreaks of infection of viral aetiology are common in healthcare environments. 
This is particularly true of paediatric hospitals as children are more likely to be 
admitted with infections that are related to community epidemics, such as those 
caused by respiratory and gastrointestinal viruses. Viral disease may not be the 
primary reason for admission but the patient may carry virus with them, remaining 
asymptomatic and shedding infectious particles for lengthened periods of time (167), 
(208), (209), (210), (244). This is also true for visitors and healthcare workers, who 
can unwittingly bring viruses into the environment.  
Nosocomial outbreaks of viral disease have significant financial impacts on the 
NHS. For example, Norovirus (NV) outbreaks are estimated to cost over £100 
million in high incidence years (245), (246). In addition to being a financial burden, 
virus outbreaks can affect staffing levels on wards and have substantial impacts on 
clinical outcome, recovery time and psychological health of patients. Acquisition of 
rotavirus (RV), for example, is associated with increased duration of hospital stay, 




increasing costs, decreased available beds and increasing pressure on staff.  
Hospitalization of children can have long-term psychological effects, including post-
traumatic stress disorder (PTSD), intrusive thoughts and avoidance behaviours 
following discharge (247). 
Great Ormond Street hospital is a large paediatric hospital and centre for heart and 
brain surgery in addition to being a specialist oncology treatment centre. As such, a 
large proportion of patients are present with congenital conditions, 
immunosuppression due to various factors; oncological conditions, primary immune 
deficiencies, transplant recipients and those on immunosuppressive drugs for 
rheumatologic conditions and severe asthma and co-morbidities that make them 
particularly vulnerable to viral disease. For example, respiratory syncytial virus 
(RSV) infection has long been known to present more severely in children with 
congenital heart disease, increasing the likelihood of assisted ventilation being 
necessary and increasing mortality rates (248). Also, NV has been shown to be the 
most common pathogen associated with gastroenteritis in paediatric patients with 
immune deficiencies (244).  
Given the high infection rates and high transmissibility of viruses and the large 
number of susceptible hosts in the location under investigation, it was appropriate to 




5.2 Clinically significant viruses in paediatrics 
5.2.1 Norovirus  
Norovirus is a single-stranded RNA (ssRNA) virus that does not have a viral 
envelope. Five genotypes are currently recognised with genotypes GI, GII and GIV 
containing human pathogens (249). Clinical symptoms of NV infection include 
gastroenteritis and low-grade fever with recovery of symptoms in 12-72 hours. 
Prolonged shedding of viral particles occurs after infection and can lead to 
substantial environmental contamination. Young children, older adults and the 
immunocompromised have higher morbidity and mortality rates than other persons 
who become infected. NV has high infectivity and a low dose of < 10 virions is 
required for infection (250).  
NV particles have been isolated from the air (20) and it is thought the virus is 
transmitted as airborne droplets from vomiting episodes that enter the oral mucosa, 
as well as via the faecal-oral route and contact with contaminated surfaces (11). 
Outbreaks tend to occur in the winter and are common in healthcare facilities, 
frequently resulting in the closure of wards. NV is stable in the environment and 
relatively resistant to commonly used disinfectants (11), (251). Due to the lack of a 
widely used cell culture system for human NV, detection relies on nucleic acid 





Adenovirus (AV) is a non-enveloped dsDNA virus. Fifty-seven serotypes have 
currently been identified and categorised into subgroups A-G. Subtypes A and F 
cause gastrointestinal infection, B, C and E cause respiratory tract infection and 
subgroup D causes epidemic keratoconjunctivitis (252), (253).   
Infections with AV tend to occur in the first 5 years of life and generally cause self-
limiting and mild symptoms in the immunocompetent  host, including pharyngitis, 
gastroenteritis and otitis media (253), (254), (255). However, in the 
immunocompromised host, more severe symptoms often develop and can lead to 
poor outcomes, particularly in stem-cell and solid organ transplant recipients (253), 
(254), (256). Rates of infection in stem cell transplant recipients range from 5 to     
37 %, with the highest number in paediatric patients (255). Once excreted into the 
environment, AV can remain infectious for up to 35 days (257). 
Nosocomial AV outbreaks have been reported in hospital settings with equipment 
being associated with transmission, particularly in the case of epidemic 
keratoconjuncitivitis (258). Direct transmission via droplets is the most common 
method of transmission but the faecal-oral route has also been reported (253), (259). 
Virus particles can be shed in the stool or nasopharyngeal secretions for weeks to 




5.2.3 Respiratory Syncytial Virus 
RSV is an enveloped, ssRNA virus belonging to the family Paramyxoviridae (260). 
Currently, two major subgroups are recognised; RSV-A and RSV-B, with RSV-A 
generally being the most prevalent. It is a major cause of lower respiratory tract 
infections (RTI) in children, causing bronchiolitis and pneumonia and peaking in the 
winter months (260), (261), (262). Figure 5.1 shows the latest Health Protection 
Agency (HPA) data on UK cases of RSV and it can be seen that the majority of 
reported cases occur in young children, especially those less than 4 years of age. 
RSV infection is the most common cause of hospitalisation of children with 
respiratory illness and between 53,000 and 199,000 deaths are reported globally per 
year (261). Symptoms are clinically very similar to influenza A infection therefore it 
is likely that RSV infection is under-reported (263).  RSV is reported not to be 
transmitted via the aerosol route as might be expected of a respiratory virus, but by 
contact transmission (264). 
Data regarding RSV survival time on surfaces is lacking  but various studies have 
been conducted investigating the relationship between RSV infections and 




Figure 5.1: Health Protection Agency reports of Respiratory syncytial 
virus cases 2012/13 (267). 
Temperature and atmospheric pressure appear to be the most important factors 
associated with the activity of RSV and the number of reported infections (268). 
Rechsteiner et al. experimentally aerosolised RSV and found that after 1 minute at  
20 
O
C, the droplets were most stable at 40 % RH (265). They observed that the virus 
survived best at lower RH than other viruses such as measles, for example (265). 
This could have been due to a number of factors however and experimental 
aerosolisation and sampling experiments such as this do not accurately reflect field 
conditions. This is demonstrated in a study by Nair et al. in their investigation into 
whether meteorological factors can predict RSV outbreaks. They recorded peak 
activity of RSV at around 63 % in outdoor air. They also acknowledged that the 
transmission of RSV and other respiratory viruses is likely multifactorial and cannot 
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be correlated to just one physical factor (261). Yusuf et al. did find however that 
RSV activity was greatest at 45 – 65 %  RH in a field-based study across 9 cities 
(266).  The experimental data obtained by Rechsteiner et al., Yusuf et al. and 
possibly others, may have implications for indoor transmission. If RSV truly does 
survive better at temperatures of around 20 
O
C and RH of 40 %, these conditions are 
frequently reached in hospital and other indoor environments and coupled with 
potentially infected people in close proximity to each other, could facilitate 
transmission of RSV.   
5.2.4 Human Metapneumovirus 
Human metapneumovirus (hMPV) is an enveloped, ssRNA virus, belonging to the 
family Paramyxoviridae. It was first isolated from children with RTI in 2001 (269) 
and is thought to be the second most common cause of childhood RTI, after RSV 
(270). Despite only being recently isolated, research has shown that the virus had 
been circulating for at least 50 years prior to its discovery and almost 100 % of 
children under 5 years of age have been exposed to it (271), (272). Clinical 
symptoms range from coughs to flu-like symptoms and severe respiratory distress 
and seizures (270), (271), (273) and can affect both the upper and lower respiratory 
tracts, mostly in the elderly, young and immunocompromised (274). The virus can 
lead to lower respiratory tract complications in stem-cell transplant recipients, 5 % of 
whom become infected with hMPV post-transplant (274). The mechanisms of 
transmission are yet to be discovered for this virus but it is suggested that contact 




Rotavirus (RV) is a non-enveloped, double-stranded RNA virus of the family 
Reoviridae and is up to 100 nm in size (275), (276). Seven groups of RV are 
currently recognised (Groups A – G) but only groups A, B and C are known to cause 
human disease, with group A being the most common (277). The majority of cases 
of childhood severe acute diarrhoea are caused by RV and it is the most common 
reason for hospitalisation due to diarrhoea in younger children (276), (277), (278). A 
range of symptoms can occur during RV infection; the patient may be asymptomatic 
or may suffer from severe diarrhoea, leading to dehydration and possibly death 
(276). It is estimated that approximately 570,000 children die each year from RV-
associated dehydration (277), (276). Approximately 100 – 1000 virions can be shed 
per millilitre of stool during diarrhoea episodes (277). Given that the infectious dose 
of RV is between 10 and 100 virions, it is unsurprising that it spreads rapidly and the 
environment becomes heavily contaminated during outbreaks (277), (279). 
Respiratory symptoms occur in 30 – 50 % of infected children and RV RNA has 
been isolated from the air, with aerosolisation being recognised as a means of disease 
transmission (279). Transmission  primarily occurs via the faecal-oral route but the 
virus survives for prolonged periods on surfaces and fomites are also a recognised 





5.2.6 Influenza  
Influenza viruses are enveloped ssRNA viruses from the family Orthomyxoviridae 
and are approximately 100 nm in diameter (282). Three types of influenza virus are 
known; A, B and C. Influenza A has 15 sub-types and causes annual epidemics, 
whereas influenza B circulates less frequently (282). During community outbreaks, 
influenza has the highest attack-rates (up to 70 %) in children from the ages of 5 – 18 
years of age (282). Hospital-acquired influenza has been reported in a number of 
ward types (283) and results in increased length of stay, mortality and as with other 
HCAIs, increased financial loss  (284). During the H1N1 influenza pandemic in 
2009, rates of hospital-acquired influenza infection increased and this lead to cases 
of severe illness and a number of deaths (283).  
Influenza transmission occurs via respiratory droplets that are ejected into the air by 
coughing and sneezing. These droplets are either directly inhaled by or absorbed by 
mucous membranes of a new host or can deposit on surfaces and be indirectly 
transmitted via the hands (285), (286). The transmission and survival of influenza 
virus in the environment has been extensively studied, more so than any other human 
pathogenic virus (285), (286), (287). Despite this, nosocomial and community 
outbreaks are still common and reports show conflicting information about 
temperature, humidity levels, UV-light exposure and other factors on the survival 
and transmissibility of the virus (287), (288). This shows that the acquisition of viral 
disease is incredibly complex and must rely on host factors as well as environmental 
conditions.    
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5.2.7 Other viruses 
The viruses discussed above are only a very small selection of viruses that are of 
significance in paediatric healthcare environments. Among others, measles, Varicella 
zoster virus (VZV), parainfluenza viruses, bocavirus, sapovirus and astrovirus are all 
of concern and have the potential to cause nosocomial outbreaks. Cytomegalovirus 
(CMV) is the most commonly acquired congenital infection and the majority of 
cases are subclinical but infection or activation of latent disease during pregnancy 
can cause severe birth defects such as deafness (289), (290) and as such, control of 
transmission is important. CMV has been isolated from saliva and can cause 
pneumonia (289), virus can be shed for months to years after primary infection. 
Infected neonates can shed virus for up to 6 years (290). CMV rarely causes disease 
in the immunocompetent but cases of severe CMV pneumonia in otherwise healthy 
children have been reported (291), (292).  
The presence of immunocompromised children and children who have pre-existing 
conditions make the presence of any virus, not just those that cause large-scale 
outbreaks, a concern for health and clinical outcome.  
5.3 Viruses in the environment 
As the concept of different environmental and human microbiomes is gaining 
popularity and more work is being carried out to identify bacterial and fungal 
components, references to the ‘virome’ are also beginning to appear. The use of 
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powerful NGS technologies is allowing the identification of previously unknown 
viruses and there is, understandably, great interest in the human ‘virobiota’ (293), 
(294). Environmental virome NGS investigation is currently largely focussed on 
samples such as sewage, water and soil (18), (295) (296). The lack of data 
investigating the total indoor virome is likely due to a number of reasons. Viruses are 
very diverse and as such, there is no universal gene target analogous to the 16S 
rRNA gene found in bacteria and Archaea, making the simultaneous detection of 
multiple viruses costly and time-consuming. Also, once amplified, viral sequences 
must be compared to public databases such as BLAST. However, there are far fewer 
virus genomes in such databases than for other microorganisms and this can make 
identification difficult (294), (296). Also, viruses present in indoor locations will 
likely be in very low numbers, especially in non-outbreak situations and sampling 
methods may not be sufficient to capture their presence. The identification of RNA 
viruses and viruses with very small genomes also poses technical challenges. The 
concept of an ‘indoor virome’ may not be as relevant as the virome of other 
environmental samples and as such, previous work has focussed on determining the 
presence of specific viruses in indoor locations. 
Routine microbiological screening does not often consider contamination with 
viruses and as previously mentioned, relies on the use of total viable counts of 
bacteria. Carducci et al. have investigated the use of the recently discovered torque 
teno virus (TTV) as a marker of viral environmental contamination (19). TTV has 
not, as yet, been associated with a specific disease state but has been isolated from 
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all bodily secretions and tissue types tested and has been reported to be present in 
over 90 % of the human population (297). Carducci et al. claim that despite a lack of 
data from indoor environments, microbial indicators currently used for 
environmental monitoring in the form of bacterial TVCs, do not provide a useful 
marker for viral presence and suggest that a viral marker may be more appropriate. 
Bacteria and viruses have different structures and properties and therefore it could be 
assumed that they have different survival characteristics in the environment.  
5.4 Sampling for viruses  
Sampling for viruses from the environment is problematic, this is particularly true of 
air sampling, as virions are easily damaged by most air samplers (5). Recovery of 
live virus from air and surface samples is not feasible if conducting a large sampling 
protocol or if checking a bed space is sufficiently decontaminated prior to a new 
patient admission.  This is due to the need to grow virus in cell culture and often 
when recovering virus from environmental sources, the cultures are easily 
contaminated. Some clinically relevant viruses cannot currently be cultured in vitro, 
for example NV (20), (250). This means that molecular methods such as PCR are 
much more suited to the analysis of viruses in the environment.   
5.4.1 Air sampling and analysis  
Viruses are an important cause of RTIs (272), (298) and aerosol transmission is 
thought to play a role in the spread of many viruses of clinical significance  (10), 
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(299). Non-respiratory viruses have also been isolated from the air (20), (250), (279) 
and the air may serve as a medium for spread of virus to surfaces where they can be 
picked up by hands and ingested, for example. The number of infections caused by 
inhalation of viral aerosols is not currently known (300).  
There is no standard method available for the detection of virus bioaerosols  (102), 
(299).  Impinger and slit samplers (see Chapter 3) have been used when attempting 
to isolate viruses from the air as they may allow the collection of live, viable virus 
into a liquid medium (5), (299). However, these methods are not particularly suited 
for the detection of low virus concentrations partially due to the fact that to collect 
lower concentrations, the sampling time must be relatively long, which increases the 
risk of bacterial contamination. Also, these methods rely on the ability to culture 
captured viruses which is a time-consuming technique and some respiratory 
infections may be caused by viruses without optimised culturing protocols.  
As with bacterial sampling, there has been a move towards the use of molecular 
techniques for environmental virus sampling. While the lack of demonstration of 
live, growing virus means that available molecular techniques cannot currently prove 
the presence of infectious virus, these techniques could indicate that if found in high 
quantities, at least a proportion might be infectious (21). A recent study showed 
significant positive correlations with the number of patients with upper and lower 
RTIs and the concentration of influenza A virus and AV isolated from the air. 
Enteroviruses were also isolated, although this was not correlated to clinical cases 
218 
 
(299). Molecular techniques do not require virions to remain undamaged through the 
sampling process as they only require the nucleic acid to be preserved.   
5.5 Chapter aims 
This was a proof-of-concept study, intended to determine if viral nucleic acids could 
be recovered from environmental surfaces and the air of the hospital being 
investigated. It was also to determine if bacterial TVCs could be used as an indicator 
for viral contamination and to investigate the use of torque teno virus (TTV) as an 
alternative marker.  
5.6 Methods 
5.6.1 Study design 
Virus species were chosen based on the assumption that they may be present in a 
paediatric environment during the sampling period and for their clinical significance 
in this environment; NV, AV, RSV A, RSV B, RV and hMPV. CMV was included 
as a potential marker of mucosal contamination and as herpes viruses do not survive 
as long in the environment as AV, for example, CMV may provide a reference for 
recent contamination (301). TTV was included to investigate its use as a marker of 
contamination. A three-month screening protocol for the presence of these viruses 
was carried out. 
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Samples were taken from fixed high-touch sites and equivalent sites that have been 
shown to be contaminated with virus in previous studies. They were taken from a 
busy outpatient’s waiting area during an infectious disease clinic and nephrology 
clinic (Clinic B) (Table 5.1 and Figure 5.2) once per month with a total of 78 
samples being collected. Contact plates were also taken to determine bacterial TVCs.  
Table 5.1: Virus screening sites in Clinic B outpatient’s area 
Sample Number Sample Site Sample Number Sample Site 
CB1 Chair CB14 Toy cooker (bottom) 
CB2 Heater CB15 Plastic toy 
CB3 Reception desk CB16 Floor by toilet 
CB4 Trolley top CB17 Floor by room 9 
CB5 Bin lid CB19 Top of TV 
CB6 Nurse desk H1 Door handle WC 
CB7 Nurse chair arm H2 Door handle room 5 
CB8 Chair arm H3 Door handle room 6 
CB9 Chair top H4 Door handle room 7 
CB10 Small table H5 Door handle room 8 
CB11 Large table H6 Door handle room 9 
CB12 Book H7 Door handle room 10 
CB13 Toy cooker (top) Air Nurse’s station 
The outpatient’s area was chosen as it is small and self-contained with a high number 
of people attending on the clinic day chosen. Figure 5.3 shows the lay out of this area 




Figure 5.2: Diagram of Clinic B waiting area showing sampling sites. 
Air sampler is indicated by a blue triangle. CB18 is missing due to the 
site becoming unavailable for screening 
 




Figure 5.4: Images showing sampling sites on Clinic B 
 
5.6.2 Surface sampling 
5.6.2.1 Swabbing 
Surface swabbing was carried out as detailed in section 2.2.2.1 except with RNAlater 
stabilisation buffer (Qiagen, UK) as a wetting and storage solution. 
5.6.2.2 Contact plates 
TSA contact plates were taken using the method described in section 2.2.1. 
222 
 
5.6.3 Air sampling 
Air sampling was carried out using a Burkard C90M cyclone sampler (Burkard, 
UK), placed on the nurse’s station as indicated in Figure 4.3. The sampler was set at 
a flow rate of 16.6 l / min and left to run for 10 hours, starting 1 hour prior to the 
clinic start and ending 1 hour after the final patient vacated the area. Air samples 
were collected in 1 ml RNAlater buffer (302). 
5.6.4 Temperature and relative humidity  
Temperature and RH were measured as described in section 2.2.4. HOBO samplers 
were left in three locations in the clinic; on the nurse’s desk at the entrance to the 
area, on a trolley in the middle of the clinic and on top of the door frame to Room 10 
at the back of the area.  
5.6.5 Nucleic acid extraction 
DNA and RNA were co-extracted using the AllPrep Mini Kit (Qiagen, UK). 10 l of 
mouse cell IPC was added to serve as a DNA extraction and amplification control. 3 
l of phocine distemper virus (PDV) RNA was added to serve as an extraction and 
reverse transcription (RT) control. DNA and RNA were eluted in 50 l of AE buffer 





5.6.6 Virus qPCRs 
qPCR was carried out according to in-house Standard Operating Procedures (SOPs) 
at GOSH. DNA assays were prepared by adding 12.5 l QuantiFast Mastermix 
(Qiagen, UK) per reaction and RNA assays by adding 12.5 l QuantiFast RT 
Mastermix and 0.2 l reverse transcriptase enzyme (both Qiagen, UK) per reaction. 
Primer and probe mixes (MWG Eurofins, Germany) were added at a final 
concentration of 10 pmol / l and cycling conditions carried out according to SOPs 
or Qiagen protocols. Table 5.2 shows primer and probe sequences.  
Standard curves were made for AV and CMV as described in Chapter 2. Plasmid 
standards were provided by GOSH Virology department for RV, hMPV, NV GI and 
GII serotypes and RSV A and B. No standards were available for TTV.  Samples 
were run on ABI 7500 Real-Time PCR system (Life Technologies, UK). DNA assay 
conditions were as follows; 1 cycle of 95 
O
C for 5 minutes followed by 45 cycles of 
95 
O
C for 30 seconds and 60 
O
C for 30 seconds.  RNA cycling consisted of 1 cycle 
of 50 
O
C for 20 minutes, one cycle of 95 
O
C for 5 minutes, followed by 45 cycles of 
95 
O
C for 15 seconds and 60 
O
C for 30 seconds.  
Amplification curves were viewed with ABI Sequence Detection Software (SDS) 
version 4.1. Results were plotted by SDS as fluorescence (nm) vs. number of qPCR 
cycles, with a threshold for detection of DNA-based fluorescence set just above 
background, as determined by the NTC. The cycle number at which the sample 
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fluorescence exceeded the background was recorded (Ct) and either compared to 
standards to provide a copy number or recorded as number of cycles taken to 
produce a positive result. 
Table 5.2: Primer and probe sequences used for assessing viral 
contamination of surfaces and air in Clinic B 









GCC ACS GTG GGG TTT CTA 
AAC TT   
Adeno 
UCL-R 
GCC CCA GTG GKC TTA CAT 
GCA CAT C 
  Adeno 
UCl-Pr 
TGC ACC AGA CCC GGR CTC 








GTT ACT TTG AGC GCC ATC 
TGT TCC T 
  
CMV-Pr 
TGC GCC GTA TGC TGC TCG 




Unpublished, provided by Kathryn 
Harris at GOSH 
  IPC  
(Mus)-R 
Unpublished, provided by Kathryn 
Harris at GOSH 
  IPC  
(Mus)-Pr 
Unpublished, provided by Kathryn 
Harris at GOSH CY5 BHQ-1 
RSVA (305) 
RSVA-F 








CAC CAT CCA ACG GAG CAC 
AGG AGA T CY5 BHQ-2 
RSVB (305) 
RSVB-F 
AAG ATG CAA ATC ATA AAT 
TCA CAG GA 
  
RSVB-R 




TTT CCC TTC CTA ACC TGG 
ACAB TA JOE BHQ-1 
hMPV 
HMPV1 
CAT ATA AGC ATG CTA TAT 
TAA AAG AGT CTC 
  
HMPV2 
CCT ATT TCT GCA GCA TAT 













TGY AAT GAT GAG GGT GTC 




CGY TGG ATG CGN TTY CAT 
GA 
  COG-1R 
(GI R) 






AGA TYG CGA TCY CCT GCT 





AGA TCG CGG TCT CCT GTC 




ATG TTC AGR TGG ATG AGR 




TGC ACG CCA TCT TCA TTC 




AGC ACG TGG GAG GGC GAT 
CG CY5 BHQ-2 
Rotavirus ROTA F 
ACC ATC TWC ACR TRA CCC 
TCT ATG AG   
 ROTA R 
GGT CAC ATA ACG CCC CTA 
TAG C   
 ROTA Pr 
AGT TAA AAG CTA ACA CTG 
TCA AA FAM MGB 
PDV PDV F 
GCG GGT GCC TTT TAC AAG 
AAC   
 PDV R 
CAG AAT AAG CAA AAT TGA 
TAG GAA CCA T   
 PDV Pr 
TCT TTC CTC AAC CTC GTC 








5.7.1 Virus-related outbreaks and incidents at GOSH, 2012 
The outbreaks and incidents of viral aetiology at GOSH for the year in which 
sampling took place can be seen in Table 5.3. NV was the leading cause of outbreaks 
throughout the sampling period. 
 
Table 5.3: Virus-related outbreaks and incidents at GOSH 2012 























































AV - - L3 clean 




Cardiac Rash VZV 4 0 
Contact 
screen 
BMT & HOU Un-notified VZV 1 0 Contact 
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Outpatients chickenpox screen 
General 
surgery 
Chickenpox VZV 2 0 Immunisation 
Respiratory D&V NV 4 0 
L3 clean of 
sluice room 
Spinal surgery Chickenpox VZV 4 0 
Contact 
screen 





– failure to 
notify 














3 0 Ward closure 
Neurology D&V NV 7 0 Ward closure 






















AV 0 0 L3 clean 
Investigative Chickenpox VZV 1 0 
Contact 
screen 
Rheumology D&V NV 1 0 L3 clean 







AV 0 0 L3 clean 
a) Diarrhoea and vomiting b) Level 3 clean (chlorine, intensive) c) High-dependency unit 
d) Bone marrow transplant e) Haematology and Oncology 
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5.7.2 Standards and controls for virus qPCRs 
All standards and controls were within GOSH SOP recommended parameters.  IPC 
and PDV controls were within ranges used by GOSH Virology to ensure that the 
samples were not inhibited. Any sample with a DNA IPC of > 30 Ct was repeated at 
a 1:10 dilution. Any sample with an RNA IPC (PDV) Ct of > 30 was repeated at a 
1:10 dilution. All NTCs were negative.  
5.7.3 Temperature and relative humidity 
The average temperature for the November sampling period was 23 
O
C with an 
average RH of 27 %. For December, the average temperature was slightly higher at 
26 
O
C and RH a little lower at 25 %. Large differences were observed in January, 
with an average temperature of 18 
O
C and RH of 53 % 
5.7.4 Bacterial total viable counts 
CFUs recovered from each site at each time point can be seen in Table 5.4. Table 
cells are colour coded to provide an indication of low, intermediate, high and very 
high bacterial contamination. The majority of sites sampled had < 50 CFU across all 
three time points. The top of the toy cooker (CB13) had 0 CFU at all time points, the 
bottom of the toy cooker (CB14), plastic toy (CB15) and trolley top (CB4) all had 0 
or very low CFUs also. The chair arm (CB8) had high levels of contamination at all 
time points. The top of the TV (CB19) in January was the only site to have very high 
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CFUs at any time point but the reception desk (CB3) and chair (CB1) each had high 
levels at one or more time points. 
Table 5.4: Total bacterial counts recovered from Clinic B sampling 
sites over 3 time points 
  CFU Count 
Sample Site November December January 
CB1 Chair 26 109 64 
CB2 Heater 22 24 21 
CB3 Reception desk 109 1 44 
CB4 Trolley top 2 0 0 
CB5 Bin 70 4 56 
CB6 Nurse desk 2 9 34 
CB7 Nurse chair arm 33 1 3 
CB8 Chair arm 153 152 106 
CB9 Chair top 119 56 142 
CB10 Small table 39 56 1 
CB11 Big table 0 1 0 
CB12 Book 14 38 40 
CB13 Toy cooker (top) 0 0 0 
CB14 Toy cooker (bottom) 0 1 0 
CB15 Plastic toy 1 0 0 
CB16 Floor by WC 72 36 99 
CB17 Floor room 9 38 56 53 
CB19 Top of TV 56 60 300 
Green: < 50 CFU, Yellow: 50–100 CFU, Orange: 101–200 CFU, Red: > 200 CFU 
 
5.7.5 Virus qPCR results 
5.7.5.1 Adenovirus 
The AV qPCR Ct results are shown in Table 5.5. AV was found throughout the clinic 
waiting area for all months sampled. Of 78 samples taken, 29 (37 %) were positive 
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for the presence of AV DNA. More sites were positive in November (38 %) and 
December (61 %) than in January (11 %).  AV DNA was only isolated from the air 
at the November time point.  
Table 5.6 shows Ct values translated into copy number of AV for positive sites. Copy 
number per ml of sample, as reported, is only semi-quantitative as it assumes all 
virus particles were released from the cotton swab. This is unlikely to be the case and 
as such, the figures are possibly an underestimate of virus copy number at each site. 
The highest copy number was recovered from the top of the TV (CB19) in 
November (20625 copies / ml). Lower numbers (but still relatively high) were found 
on top of the chair (CB9) (7711 copies / ml) and the nurse’s desk (CB7) and chair 
arm (CB8). Similar numbers of around 4000 copies / ml were recovered from 2 door 
handles, the nurse’s desk and the bin in December and overall copy numbers were 








Table 5.5: Adenovirus detection by qPCR over three months obtained 
from outpatient’s clinic at GOSH. 
  Ct 
Sample Site November December January 
CB1 Chair Undetermined 40.53 Undetermined 
CB2 Heater Undetermined 38.7 Undetermined 
CB3 Reception desk 30.601 34.96 Undetermined 
CB4 Trolley top Undetermined 33.54 Undetermined 
CB5 Bin lid Undetermined 34.88 40.14 
CB6 Nurse desk Undetermined 35.27 Undetermined 
CB7 Nurse chair arm 30.53 36.52 Undetermined 
CB8 Chair arm Undetermined Undetermined Undetermined 
CB9 Top of chair 31.33 39.25 Undetermined 
CB10 Small table Undetermined Undetermined Undetermined 
CB11 Large table Undetermined Undetermined 41.48 
CB12 Book Undetermined 39.6 Undetermined 
CB13 Toy cooker (top) 41.79 42.29 Undetermined 
CB14 Toy cooker (bottom) Undetermined 39.98 Undetermined 
CB15 Plastic toy 37.67 Undetermined Undetermined 
CB16 Floor by WC 34.73 Undetermined Undetermined 
CB17 Floor by room 9 Undetermined Undetermined Undetermined 
CB19 Top of TV 31.39 Undetermined Undetermined 
H1 Handle to WC Undetermined 38 Undetermined 
H2 Handle  room 5 Undetermined 34.67 Undetermined 
H3 Handle  room 6 43.48 37.14 Undetermined 
H4 Handle  room 7 Undetermined 34.25 Undetermined 
H5 Handle  room 8 Undetermined 36.48 Undetermined 
H6 Handle room 9 43.19 Undetermined Undetermined 
H7  Handle  room 10 Undetermined Undetermined 44.23 







Table 5.6:  Adenovirus copy number at each positive site over three 
month sampling period of an outpatient’s area at GOSH.  
Sample Site Copies / ml 
CB3 Nov Reception desk 1450 
CB7 Nov Nurse chair arm 1255 
CB9 Nov Top of chair 7711 
CB13 Nov Toy cooker (top) 4 
CB15 Nov Plastic toy 205 
CB16 Nov Floor by WC 344 
CB19 Nov Top of TV 20625 
H3 Nov Handle room 6 2 
H6 Nov Handle room 9 4 
Air Nov Air 6 
CB1 Dec Chair 2 
CB2 Dec Heater 10 
CB3 Dec Reception desk 4072 
CB4 Dec Trolley top 8281 
CB5 Dec Bin lid 4023 
CB6 Dec Nurse desk 349 
CB7 Dec Nurse chair arm 30 
CB9 Dec Top of chair 7 
CB12 Dec Book 8 
CB13 Dec Toy cooker (top) 4 
CB14 Dec Toy cooker (bottom) 8 
H1 Dec Handle to WC 12 
H2 Dec Handle room 5 4079 
H3 Dec Handle  room 6 14 
H4 Dec Handle  room 7 4057 
H5 Dec Handle  room 8 31 
CB5 Jan Bin lid 26 
CB11 Jan Large table 9 
H7 Jan Handle room 10 1 






Of 78 sites swabbed, 5 were positive for the presence of CMV DNA (6 %). These 
are shown in Table 5.7 along with copy number values as determined by comparing 
to the standard curve of known copy number. CMV was isolated from the air during 
the December time point and the highest copy number recovered was from the heater 
in November.  
 
Table 5.7: Cytomegalovirus positive sites over three month sampling 
period of outpatient’s area, showing Ct value and copy number / ml. 
Sample Site Ct Copies / ml 
CB2 Nov Heater 36.53 296 
CB19 Nov Top of TV 41.50 7 
CB17 Dec Floor by room 9 37.27 169 
CB Air Dec Air 37.65 128 
CB11 Jan Large table 38.74 56 
    
5.7.5.3 Rotavirus 
Two door handles were positive for the presence of RV nucleic acid; the door handle 
to the WC (H1 Nov) and the door handle to Consultant room 5 (H2 Nov).  They 
showed Cts of 38.30 and 41.19 respectively. These can be seen on the amplification 




Figure 5.5: Fluorescence vs. Cycle plot showing Rotavirus standards 
and positive sites from outpatient’s clinic  
5.7.5.4 Norovirus 
One site had the presence of NV nucleic acid, the November 16 swab taken from the 
floor outside the toilet. This sample was positive for NV serotype GII and had a Ct of 




Figure 5.6:  Fluorescence vs. Cycle plot showing Norovirus GII 
standard and positive sample from outpatient’s clinic  
5.7.5.5 Respiratory Syncytial Virus and Human Metapneumovirus 
Of 78 samples taken over the three month period, none were positive for the 
presence of RSV A, RSV B or hMPV nucleic acid.  
5.7.5.8 Torque Teno Virus 
Fifteen sites sampled were positive for the presence of TTV DNA (19 %). The TTV 
virus results are shown in Table 5.8. There were 5 TTV positive sites in November, 6 
in December and 4 in January. The book (CB12) was positive at all 3 time points. 
The heater (CB2) and plastic toy (CB15) were positive at the November and 
December time points but not at the January sampling.  As no standard curves were 
constructed for TTV, copy numbers could not be calculated. 
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Table 5.8: Torque teno virus positive sites over three month sampling 
period of outpatient’s area, showing Ct values 
Sample Site Ct 
CB2 Nov Heater 37.62 
CB12 Nov Book 40.1 
CB15 Nov Plastic toy 37.4 
CB16 Nov Floor by WC 40 
H2 Nov Handle room 5 40.76 
CB2 Dec Heater 39.66 
CB10 Dec Small table 36.8 
CB12 Dec Book 38.87 
CB14 Dec Toy cooker (bottom) 42.38 
CB15 Dec Plastic toy 39.4 
H1 Dec Handle WC 39.4 
CB1 Jan Chair 36.73 
CB5 Jan Bin lid 39.37 
CB11 Jan Large table 37.61 
CB12 Jan Book 38 
5.7.5.9 Collated results 
Figures 5.7 – 5.9 show schematics of the clinic area for each month with indicators 
of TVCs and sites from which virus was recovered. Air samples are not included. 
January had the least overall virus recovery whilst November and December were 
similar for the numbers of virus positive sites. Virus was recovered from a range of 
sites across the clinic area and CFUs were below 200 at all time points, except the 





Figure 5.7: Diagram of clinic area showing bacterial total viable counts 
and virus positive sites: November. A= Adenovirus, T= Torque teno 
virus, R = Rotavirus, C=Cytomegalovirus, N=Norovirus 
 
Figure 5.8: Diagram of clinic area showing bacterial total viable counts 
and virus positive sites: December A= Adenovirus, T= Torque teno 





Figure 5.9: Diagram of clinic area showing bacterial total viable counts 




A three month sampling protocol to detect viral nucleic acids was carried out in an 
infectious disease and nephrology clinic outpatient’s waiting area. Virus nucleic acid 
was found on a variety of surfaces and in the air. Of all sites sampled 46 % were 
positive for the presence of viral nucleic acids. Of these, 26 % were positive for 
more than one virus, with AV and TTV most commonly being identified together at 
the same location.  
Viruses have been detected by other researchers in similar environments and are a 
common cause of indoor-acquired infectious disease (306). Gallimore et al. 
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demonstrated the presence of NV nucleic acid in 18 % of swabs, RV in 14 % and 
Astrovirus (AsV) in 4 % of swabs on a UK children’s ward, despite correct infection 
control and cleaning procedures being in place. Ganime et al. also detected RV on   
14 % of environmental sites sampled, finding between 3.4 and 2.9 x 10
3
 copies / ml 
(307). A recent study by Pankhurst et al. (under review) reported extensive 
environmental contamination in hospital cubicles and detected NV at similar rates to 
the current work. The environmental presence of nucleic acid from viral pathogens is 
clearly a universal issue. Differences in species identified depend on detection assays 
performed but may also reflect unique regional viromes.  
Correlating environmental contamination with risk is difficult as infectious doses are 
often hard to determine for a number of viruses. They depend on a number of 
complex factors including host-related elements such as immune status. However, 
one study reported that only 6.6 AV type 4 viral particles were required to infect    
50 % of a test population via the aerosol route (308). For clinical diagnosis of AV 
infection at GOSH, any patient sample with a Ct of 40 or below is deemed as 
positive. The copy numbers of AV found in the current study were often far in 
excess of 6.6 and Cts were largely less than 40. Although no direct link can be made 
to AV DNA copy numbers on surfaces and infectious dose, it might be suggested 
that levels as high as were observed might pose a risk to the susceptible patient. 
NV was the leading cause of known viral outbreaks at GOSH during the sampling 
period (Table 5.3). This is likely to reflect data from other trusts but the actual case 
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number remains relatively low due to the ability to isolate patients quickly at GOSH. 
However, the virus does spread rapidly and it is often not possible to prevent it from 
passing from ward to ward. NV outbreaks at GOSH do not tend to follow the 
seasonal trend as observed in other hospitals and outbreaks occur throughout the 
year. This is due in part to the large numbers of immunocompromised children 
present in the hospital. These children will shed virus for a long period of time whilst 
possibly remaining asymptomatic, causing contamination of the environment and 
spread of disease. NV RNA was found in the outpatient’s clinic waiting area but no 
outbreaks were reported in the area. 
Figure 5.10 shows the number of cases of diarrhoea and vomiting (D&V) at GOSH 
during 2012. NV was the most commonly isolated organism during these outbreaks; 
however in some cases RV was the causative agent. Patients with D&V associated 
with known C. difficile or other bacterial aetiology have not been included in this 





Figure 5.10: Diarrhoea and vomiting cases at GOSH during 2012 
 
5.8.1 Sites most frequently contaminated 
Handles were frequently contaminated in this study and this is in agreement with 
previous work carried out in other areas of GOSH (Pankhurst et al., under review). 
The common contamination of door handles with bacteria was recently investigated 
by Wojgani et al. They found frequent contamination of door handles within 
healthcare environments and that use of a handle was correlated to levels of 
contamination (p= < 0.01) (44). Bacterial load on door handles was not investigated 
during the study presented in this thesis as the whole of each handle was swabbed for 
the identification of virus. However, the current findings suggest that bacteria may 
follow a similar contamination pattern. The two clinics have approximately 30 
patients per day and all enter Consultant’s rooms through doors which must be 






















via hands from a person infected with the virus or via another object within the clinic 
area.  
5.8.2 Frequency of contamination 
Overall, with the exception of AV, viruses were found with relatively low frequency, 
especially when compared to TVCs for bacteria in the same sampling period; 80 % 
of sites sampled were positive for bacterial growth. Unlike bacteria, viruses cannot 
replicate outside of a host and as such will not multiply in the inanimate 
environment. They are subject to degradation by various mechanisms including 
temperature fluctuations, desiccation and exposure to UV-light but viral nucleic 
acids can persist for prolonged periods of time on surfaces. The isolation of viral 
nucleic acids from the environment indicates that virus was present and even low Ct 
values could translate to copy numbers that might pose a risk for a number of viruses 
investigated.  
The potential presence of children who may have had asymptomatic NV or RV 
infection and who may have had a high proportion of respiratory viral infections, 
especially during the winter months, would perhaps have led to the expectation that 
the rates of recovery of viral nucleic acid might be higher. The lack of more sites 
contaminated with those viruses associated with acute disease (hMPV, NV, RV and 
RSV) could be due to the fact that the clinic area is for children and their families 
awaiting outpatient appointments. They would be less likely to attend an 
appointment if the child had acute clinical symptoms, such as diarrhoea or vomiting 
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in the case of RV or NV or were unwell with respiratory symptoms. Low numbers of 
virus positive sites could also be due to the number of sites sampled. A range of sites 
and all of those that could be accessed were swabbed but they still equate to only a 
small area within the whole clinic. By increasing the swab area, more sites may have 
shown viral contamination.  It must also be borne in mind that not all viruses present 
on a surface may be picked up by the swabbing method used and not all viruses on 
the swab would be released into solution. In Chapter 3, it was demonstrated that > 10 
% of bacteria were recovered from a test surface using swabs. Whilst viruses are 
smaller and may not be trapped so easily in the swab, it might be expected that virus 
recovery is also not complete, leading to an underestimation of virus present. 
Viruses may have been transported into the area by healthcare workers or visitors 
from another part of the hospital or even from an external location. Without 
screening patients and staff and carrying out molecular typing, it is impossible to 
know what the source of the viral contamination is, however the presence of these 
viruses in a clinical environment is of concern for patients and staff alike.  
5.8.3 Air sampling 
AV and CMV nucleic acid was found in air samples taken from the clinic. AV was 
isolated in November and CMV in December. There are many incidences of AV 
being isolated from the indoor air (19), (259), (299), (309) but only one study was 
identified that isolated CMV from the air. MCluskey et al. isolated CMV from the air 
of 3 rooms, two housing immunocompromised patients with active CMV infection 
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and one with a patient with latent CMV infection (310). The lack of data regarding 
the isolation of CMV from the air might be as a result of CMV not being considered 
an ‘airborne’ virus and not being associated with nosocomial outbreaks on the same 
scale as NV, for example.  
5.8.4 Markers for viral contamination 
Carducci et al. have suggested the identification of TTV nucleic acid as a marker of 
environmental virus contamination as opposed to relying on bacterial counts (19). 
Viral nucleic acid was found in 29 of 176 samples during their screening, with the 
majority of those being positive for only TTV (10 %) and only TTV DNA was found 
in air samples (19). The rates of NV and AV recovery were lower than previous 
studies and those found in Clinic B in the current study. This could be due to local 
differences or differences in carriage rates in the people present at or near the 
sampling time.  Carducci et al. concluded that TTV could be used more reliably as a 
marker but no other data are as yet available to compare their findings to. The use of 
TTV as a marker for viral contamination in drinking water has however also been 
proposed (311). 
The current study found TTV in 11.7 % of samples taken, suggesting that similar 
levels can be found in different indoor environments. Carducci et al. found no sites 
positive for RV compared with 1.6 % in the current study and only 0.8 % of sites 
positive for AV compared to 37 % but both studies found one site contaminated with 
NV (0.8 %).  The results between the two studies are remarkably similar (apart from 
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for AV) and perhaps suggest that TTV is present in a variety of indoor environments 
and could indicate cleaning failures, suggesting the possibility that other viruses may 
be present. TTV has been found in exhaled breath (312) and various other bodily 
secretions and has been found in over 90 % people tested regardless of age, sex or 
race (297) so it may be expected that it would be found in high levels in indoor 
environments.  However, as has been outlined in the current chapter, viruses are very 
varied in their abilities to survive in the environment and survival can be dependent 
on physical parameters such as humidity and temperature. Due to the lack of 
experimental survival data for TTV, it cannot be assumed that it behaves in the same 
way as viral pathogens. At all time points, nucleic acid from potentially pathogenic 
viruses was identified from sites that were negative for the presence of TTV. This 
suggests that if TTV is to be recommended as a marker, it must be taken into account 
that a variety of sites must be screened in order to ensure detection. TTV may 
however provide a better indication in a clinical environment for viral contamination 
than the use of bacterial markers. In the current study, virus was identified on a 
number of items which showed no or very little bacterial growth.  
5.8.5 Temperature and RH 
Temperature and relative RH are among the most commonly studied parameters 
when looking at virus stability in the environment (288). Abad et al. found that 
resistance to desiccation was one of the most important factors in determining 
environmental survival of virus (280). They also found the presence of faecal matter 
prolonged survival of poliovirus (PV) and AV but not of RV and that hepatitis, PV 
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and AV all survived better at 4 
O
C than RV. In their study, AV survival was not 
influenced by RH which is in contrast to other work showing that AV is more stable 
at high RH (313). In another study AV survived best at a medium RH of 50 % (87). 
Absolute humidity has also been shown to be more important in virus survival than 
RH, with low humidity often being a predictor of influenza A outbreaks (313). 
Irregular temperature and RH readings for January could be a reason for the lower 
number of virus-positive sites at that time point. Information regarding AV stability 
at different RH is conflicting with some reporting stability at high RH (280) and 
some at medium RH (297). The current study shows the presence of AV at lower RH 
of 25 and 27 % and a reduction in positive sites at a medium RH of 53 %. Different 
viruses behave differently at different temperatures and RH and in different studies; 
therefore it is difficult to know if these factors were the reason for lower numbers of 
positive sites in January. They could however, have been contributing factors. 
Methods of recovery are not always comparable across studies by different authors 
and further investigation specifically taking into account physical parameters is 
required in order for any firm conclusions to be made.  
5.9 Conclusion 
This study strengthens previous work carried out at GOSH and in other healthcare 
facilities, adding to the evidence that nucleic acids of pathogenic viruses can be 
found in hospital environments and may be indicative of infectious virus being 
present. The location sampled was not an area attended by patients at particular risk 
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but they often travelled to other areas of the hospital, as did doctors, consultants, and 
other staff and therefore, could have taken pathogenic viruses with them to more 
vulnerable patients. It has been suggested that in high-risk environments such as 
hospitals and with the ease and availability of molecular techniques, viruses should 
be included in routine infection control monitoring and the current study adds 
evidence to support that case. Virus transmission in the indoor environment is 
complex and is dependent on a number of factors including host immunity, 
infectious dose, survival times on fomites and physical parameters.  Surfaces and air 
undeniably contribute to the spread of viral infectious diseases and should be further 















The environment has been recognised as a source of pathogen dissemination in a 
number of hospital studies (14), (40), (66), (73), (86), (174), (314), (315), (316), 
(317). Transmission via the air has been demonstrated for clinically significant 
microorganisms, for example MRSA from skin shedding or the nasal passages (318), 
P. aeruginosa from water sources (66) and shedding from cystic fibrosis (CF) 
patients (40) . The airborne dispersal of C. difficile has also been reported in hospital 
environments and the organism has been found on items in patient bed spaces such 
as tables, bins and sinks (174). It has been suggested that approximately 10-20 % of 
HCAIs occur as a result of exposure to airborne microorganisms (319) and a recent 
study by Bernard et al. detected multidrug-resistant bacteria in the air of 66 % of 
tested hospital sites (14). Despite the implications of hospital outbreaks, there is no 
standard procedure for the routine monitoring of microbial contamination in UK 
healthcare environments (46). There have also been no studies concerned with the 
systematic, long-term analysis of sources and development of microbial communities 
in hospitals. There have been studies carried out calculating total microbial counts in 
hospital rooms (46) and the detection of bacteria through surface swabbing is 
6. Microbial life on a hospital ward 
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common, yet methods vary widely across the literature and still largely rely on 
culture techniques. 
There is a tendency to only consider the environment after an outbreak has begun. 
Environmental samples are collected in order to attempt to identify the outbreak 
source and measures are taken to prevent the incident happening again. There have 
been many published cases of this, for example environmental swabbing lead to a   
K. pneumoniae outbreak being linked to a sink that was being used as both a clean 
water source and for waste disposal in a report by Starlander and Melhus (33). 
Another study by Barbolla et al. found A. baumanii in the environment to be the 
same strain as was colonising and infecting patients in an intensive-care unit (ICU) 
(175). Multi-drug resistant P. aeruginosa was detected in sinks and tap water and 
proposed as the source of 2 outbreaks in different hospitals in South England, one of 
which reported a 40 % case fatality rate (66). Drug- resistant P. aeruginosa was also 
found in high levels in the air and on surfaces by Ferroni et al. when screening CF 
patient rooms (40). A great deal of research regarding microorganisms in hospitals 
and the role of the environment appears in the past, to have been concerned with 
bacterial and fungal counts, generally from the air. For example, a year-long study 
was carried out in Poland investigating the seasonal variability in airborne microbial 
counts by Augustowska et al. (38). They found statistically significant differences in 
the number of bacteria across the seasons but failed to identify what they had 
isolated. This also extends to the contamination of surfaces adjacent to patients who 
are mechanically ventilated  (320). 
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Another topic that is of interest in hospitals is the contamination of patient bed 
spaces, focusing on a pathogen of interest. A large-scale study was carried out in a 
UK teaching hospital assessing the role of the environment in the transmission of 
MRSA (321). Environmental swabs were taken from bed areas and from telephones 
and also healthcare workers hands. It was found that MRSA-colonised patients 
contaminated their surroundings but in this case, this was not linked to further 
transmission to other patients. This is contrary to other reports which suggest that a 
patient is around 70 % more likely to acquire S. aureus, VRE, P. aeruginosa, A. 
baumanii and C. difficile when admitted to a room that was previously occupied by 
an infected or colonised patient (162), (106). Petti et al. also claim the environment 
is key in the transmission and spread of MRSA and found that despite only detecting 
low levels in the hospital environment, the risk of acquiring the bacteria was high 
due to its long survival times (73). Other studies tend to look at specific equipment 
such as computer keyboards (322) or stethoscopes (323), for example. The above 
cases and others from the literature focus on contamination of hospital environments 
from an infection control perspective. As a result, microbial communities are 
generally not fully characterised  (324).  
Despite the wealth of information regarding specific pathogens and evidence for the 
environment as a key factor in the transmission of HCAIs, the rates of infection 
remain high and with factors such as increasing drug-resistance, risk to patients is 
ever-increasing. As previously discussed, the most common source of 
microorganisms in an indoor environment is the presence of humans. In recent 
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research using NGS technologies, it has been found that humans can alter the 
microbiome of homes within 4-6 days (63). Therefore, the opportunity to analyse the 
hospital environment prior to use and occupation to determine how and when the 
area becomes colonised by microorganisms is of great interest and value. The 
information gained regarding what bacterial taxa are present, if they have a specific 
niche and what their origins are could have important implications for infection 
control, and cleaning practices.  
Currently, culture-based screening is still used widely to monitor bacterial 
contamination within healthcare settings. It is a rapid, cheap method to indicate 
potential cleaning failures but cannot always be indicative of risk. However, this 
method can still provide important information. Long-term monitoring of bioburden 
may allow the discovery of problem areas, times of the year, or specific conditions 
that point to higher levels of contamination. 
Using a combination of culture and NGS technologies to investigate a hospital ward 
on a long-term basis will provide important information with a variety of 
applications. Culture methods in the form of total viable counts have been discussed 
elsewhere and an overview of NGS is given below.  
6.1.1 DNA sequencing 
DNA sequencing was developed in the 1970’s (120) and over the last 4 decades, has 
been widely used as powerful tool for genetic analysis. The original method, now 
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known as Sanger sequencing, became automated in 1987 and involves the use of 
modified, fluorescently-labelled nucleotides to provide sequence information. The 
wide-ranging implications of this technology inarguably peaked in 2001 with the 
sequencing of the human genome, where over the course of 13 years, the whole 
human ‘genetic code’ was mapped [151], [152].  
Despite its accuracy and continuing relevance, Sanger sequencing has numerous 
limitations; it is labour-intensive, relatively expensive and due to the need for a 
cloning step when analysing microbial communities, is subject to biases such as 
reduced ability to clone AT-rich regions (327). The method does however produce a 
long read length (the number of unbroken sequenced bases) of 1000-1200 base pairs 
(bp). This is good for bacterial identification purposes, especially when considering 
the 16S rRNA gene which is approximately 1500 bp long  (328). Despite remaining 
the gold-standard for sequencing in many laboratories and clinical environments, the 
cost and labour-intensive processes involved in Sanger sequencing have driven the 
development of faster and cheaper methods over recent years.   
6.1.2 Next-generation sequencing 
The new wave of sequencing technologies has become known as ‘next–generation 
sequencing’. NGS allows the sequencing of millions of fragments of DNA 
simultaneously in a process known as massively-parallel sequencing (MPS). 
Megabases (Mb) to gigabases (Gb) of sequence reads can be produced in a single 
run. MPS allows high-throughput applications to be achieved, meaning that a whole 
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microbial genome can currently be sequenced in a matter of days (329). At the time 
of writing, five main sequencing strategies were available in the form of automated 
platforms; pyrosequencing, sequencing-by-synthesis, sequencing-by-ligation, ion 
semi-conductor technology and single molecule real-time sequencing (SMRT). Each 
platform and its associated chemistries are constantly updated in order to provide the 
most information in the quickest time, for the lowest cost. This has largely been 
driven by the race to sequence a human genome for $1000 but bench-top sequencers 
including the Roche GS Junior and the Illumina MiSeq have also been developed 
allowing much wider access to NGS technologies.   
With the right platform, NGS allows the study of complex microbial communities 
which have been sampled directly from their environment, without culturing and 
their subsequent analysis in a single sequencing run. The depth of sequencing is so 
great that less abundant, rare species can be identified in a complex sample, provided 
that data analysis is performed correctly. NGS has been applied to a variety of 
research topics, including investigating the microbial component of various health 
conditions. For example, Blainey et al. reported a significant difference in lung 
microbial communities between healthy and CF patients, with that of healthy people 
being more diverse (330). The lung was previously thought to be a sterile site but 
NGS has proven this not to be the case (331), (332).  
NGS is also applicable to the study of microbial communities by 16S rDNA 
sequence analysis from complex pools. The pioneering work using NGS for this 
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application was conducted by Caporaso et al., who in 2010, published the first 
protocol for microbial community analysis on an Illumina platform using custom 
primer chemistry (145). They then went on to publish the first protocol for using the 
Illumina MiSeq in 2012 and determined that the scaled down version of previous 
technology could accurately and reproducibly identify differences in microbial 
communities and was suitable for routine environmental monitoring (226).  
Table 6.1 Shows a selection of the main NGS sequencing technologies available at 
the time of writing and gives examples of some commercially available platforms 
using each technology.  The type of sequencing carried out, read length, data output 
and average cost per sequencing run of various chemistries are given as is that of an 
ABI 3730 Sanger sequencer for comparison. Study type and funding are likely to be 
key factors when selecting a platform as costs, throughput and output vary greatly.  
Long reads tend to be preferable when conducting whole genome sequencing for 
example but lower cost, shorter reads are applicable for gene expression or 
community studies (333).  
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Table 6.1: Comparison of commercially available next-generation sequencing platforms. 
Method Template 
preparation 
Platform examples Bases / 
read 
Run time Millions 














Roche GS FLX Titanium 
XL+ 
700 23 hours 
1 700 3850 5.50 
Roche GS FLX Titanium 
XLR70 
450 10 hours 
1 450 2930 6.51 
Roche 454 GS Junior. 
Titanium 
400  10 hours 





Illumina HiSeq 2500 2 x 150 40 hours 600 180000 3816 0.02 
Illumina MiSeq v.2 2 x 250 39 hours 15 7500 700 0.09 




Life Technologies SOLiD 
5500 W Series V2.0 
75 + 53 8.5 days 





Life Technologies Ion 
PGM 318 
400 7.3 hours 
4 1500 459 0.31 
Ion Torrent 314 chip 

















ABI 3730 capillary 650 2 hours 
9.6 x 10-5 0.06 89 1490.45 
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generation are currently more widely used, including Roche 454 pyrosequencing and 
Illumina sequencing-by-synthesis and require the amplification by PCR of templates 
before sequencing. Third-generation technologies, including those supplied by 
Pacific Biosciences, directly sequence single molecules of DNA without prior 
amplification. The process of NGS typically occurs in three steps: DNA library 
preparation, DNA library amplification and sequencing.  
6.1.3 Library preparation for NGS 
Many methods are available for preparation of DNA libraries for sequencing and this 
is usually platform and application-dependent. Most sequencers require the addition 
of ‘barcode’ oligonucleotide sequences to the target DNA regions in order to identify 
each sequence from a pool after sequencing. Adapter sequences are also added to 
target DNA in order for it to bind to the substrate used for library amplification; 
typically a slide or bead. For whole genome sequencing, genomic DNA is 
fragmented and barcode and adapter sequences are added to the fragments.  
In the case of 16S rRNA amplicon sequencing, libraries can be prepared in 2 ways. 
The first method involves using custom primers; the region of interest is amplified 
with primers that have custom-designed barcode and adapter sequences attached. 
The Illumina method of library preparation using custom primers is shown in Figure 
6.1. Primers are designed that consist of a standard primer sequence for a region of 
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the 16S rRNA gene linked to a barcode sequence for identification of individual 
amplicons and to an adapter sequence complimentary to oligonucleotide fragments 
on a flow cell for the Illumina instrument (145), (334). These long primers are 
amplified with the target DNA and all amplicons are pooled to make a library. The 
advantages of this method include the capacity to sequence as many amplicons as 
barcodes can be designed, potentially allowing many hundreds of samples to be 
sequenced at once. However, barcode-adapter linked primers are currently relatively 
expensive (approximately £40 each), so this may be a limiting factor.  
In the alternative method, target DNA can be amplified using kit-provided primers, 
with barcodes and adapters ligated afterwards. The disadvantage of this method is 
that ligation of adapters often causes 50 bp of both ends of the amplicon to not be 
sequenced, as the adapters do not ligate exactly on the end of the fragments. This can 








6.1.4 Library amplification for NGS 
For most NGS platforms, sequencing involves the detection of a by-product created 
or cleaved when DNA strands are synthesised. Most detection systems within NGS 
platforms cannot currently identify single nucleotide incorporation or termination 
events and therefore target DNA regions are amplified prior to sequencing. The two 
most common amplification methods are emulsion PCR (emPCR) and solid-phase 
amplification, also known as ‘bridge PCR’. This pre-amplification is not required for 
3
rd
-generation platforms such as the PacBio RS as it can sequence from single 
molecules. 
6.1.4.1 Emulsion PCR  
The 454, Ion torrent and SOLiD systems use emPCR to amplify DNA libraries prior 
to sequencing. After library preparation, single strands of template DNA from the 
library are bound to beads by adapter-complimentary strands on the surface. PCR 
reagents and single beads are encapsulated in water-oil emulsion droplets and each 
droplet serves as a ‘micro-reactor’ in which clonal PCR occurs (335). It is thought 
that by separately containing each individual PCR reaction, the generation of 





6.1.4.2 Bridge amplification 
Illumina are currently the only company to use bridge PCR to amplify DNA 
libraries. A flow cell has bound oligonucleotide sequences which are complimentary 
to the adapter sequences present on template DNA after library preparation. DNA 
amplification occurs and the resulting dsDNA loops over to form a bridge by binding 
to another bound oligonucleotide. The dsDNA molecules are denatured and the 
process starts again. Each amplified strand is clonal and bound near to others in 
clusters, this can potentially occur at millions of sites (tiles) on the flow cell. After 
the last denaturation step, free DNA ends are available for sequencing primers to 
bind (Figure 6.2). 
 
Figure 6.2: Bridge amplification of DNA. 1) Oligonucleotides are 
bound to the flow cell. 2) Template DNA attaches. 3) Amplification 
occurs and strands loop over to form bridges. 4) Clusters of bridged 
DNA form on the flow cell. 5) DNA is denatured. 6) Sequencing 




6.1.5 Sequencing approaches for NGS  
Once DNA libraries have been prepared, they are applied to a platform for 
sequencing. Different strategies, as outlined in Table 6.1 are available for 
sequencing.  
6.1.5.1 Pyrosequencing 
Pyrosequencing, as carried out by the 454 platforms, measures the release of 
pyrophosphate molecules as new DNA strands are synthesised (338). Beads from the 
emPCR are applied to a picotitre plate (one bead per well) and 4 
deoxyribonucleotide triphosphates (dNTPs); dATP, dGTP, dCTP and dTTP are 
washed over the plate sequentially. If a dNTP is incorporated, it will release 
pyrophosphate and in a series of enzymatic reactions, results in the generation of 
light. As the target DNA has been amplified previously by emPCR, the light is given 
off from millions of the same strand providing levels that can be detected by an 
imager.  
6.1.5.2 Sequencing-by-synthesis: cyclic reversible terminator 
chemistry 
After DNA is amplified by bridge-PCR, clonal clusters of amplicons are denatured 
to form single strands. Sequencing primers, DNA polymerase and modified dNTPs 
are applied to the flow cell. dNTPs are bound to a dye and are modified to terminate 
DNA chain synthesis. After incorporation of a nucleotide, the flow cell is imaged to 
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detect the dye. The dye and terminating group are then removed, leaving a normal 
nucleotide which becomes incorporated into the growing strand, allowing the 
process to be repeated (339), (340).  
6.1.5.3 Sequencing-by-synthesis: ion semi-conductor technology 
Ion Torrent platforms use a unique method to detect nucleotide incorporation when 
sequencing-by-synthesis. Libraries are prepared by emPCR and beads are applied to 
wells on a conductive silicon chip. Nucleotides are washed over the chip and if 
incorporated, the naturally occurring chemical reaction to bind the nucleotide to the 
growing strand releases a hydrogen ion (H
+
). The proton alters the pH of the fluid 
surrounding the bead and detectors under the well register this and use it to call the 
base (341). This method does not rely on the use of expensive imaging hardware, 
making the cost of the machine cheaper than other platforms. 
6.1.5.4 Sequencing-by-ligation  
Sequencing-by-ligation is the strategy used by the SOLiD platforms. After emPCR, 
sequencing primers hybridise to adapters on the DNA template. Four fluorescently 
labelled probes compete to bind to the sequencing primers. They are attached by 
DNA ligase. After each sequential addition of the labelled probes, imaging is carried 
out to call the base and then the probes are cleaved, washed away and the cycle is 
repeated  (342). 
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6.1.5.5 Single-molecule templates 
The sequencing of single molecules of nucleic acid avoids biases introduced by PCR 
methods. DNA polymerase is hybridised to a solid support and produces a 
complimentary strand to the template, giving off fluorescence as each nucleotide is 
added (343). This method has only very recently been shown to be applicable to 
analysis of microbial communities due to reductions in error rates previously 
reported (344).   
6.1.6 NGS platform choice 
Very little independent verification and comparison work has been carried out on 
available NGS technologies, especially in the case of 16S rRNA microbial 
community analysis. This is largely due to the ever-changing chemistries, software 
and the cost of purchasing platforms and reagents (333). Even when studies are 
conducted, the results rapidly become redundant as new technologies emerge 
(329,345). Platforms give different data outputs and have different ways of assessing 
quality of sequencing. This means that a variety of bioinformatics tools are needed to 
analyse data obtained, making comparative work difficult (328).  
At the time of sample processing for this project, the Illumina MiSeq v.2 kit had just 
been launched which provided the longest read length (2 x 250 bp) and depth of 
sequencing at a relatively cheap price in comparison to other platforms. No work had 
been published using the Illumina MiSeq to investigate indoor environmental 
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bacteria and this is currently still the case with regard to hospitals. As such there was 
no direct reference material for protocols and experimental design. However, the 
Caporaso et al. protocols and the continued research by his and other groups 
facilitated the use of this new technology. NGS users have also developed a number 
of on-line communities in the form of blogs, news feeds and forums, which allows 
the rapid sharing of knowledge and information regarding these cutting edge 
techniques.  
6.1.7 Limitations of NGS for community analysis 
Despite the large increase in published work using NGS technologies in recent years, 
the techniques have a number of disadvantages. Microbial community studies still 
largely rely on PCR and this can introduce biases or lead to chimera generation and 
influence identification (216), (346), (347). Accurate identification of bacterial 
species is difficult with lower-cost, shorter read platforms and genus-level 
identification is most commonly reported. Also, error rates for NGS platforms are 
often higher than for Sanger sequencing (348). The rapid development and wide-
range of available technologies means that data obtained is very difficult to compare 
across the literature. For community studies, different regions of the 16S rRNA gene 
are often used with different library preparation and sequencing methods, meaning 
that comparisons are impossible. One of the main limitations to NGS lies in the data 
analysis. Many different pipelines are available, making research hard to compare 
but also the lack of skilled bioinformaticians in many laboratories means there is a 
risk of spurious information being added to public databases (349). The cost of data 
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analysis can also be prohibitive and must be taken into consideration when planning 
NGS studies.   
6.2 Chapter aims 
Understanding bioburden and spatial distribution of microorganisms within a 
hospital ward may allow the implementation of targeted intervention strategies to 
reduce environment-mediated transmission of pathogens. Part of the work presented 
in this chapter is the assessment of spatial and temporal variability of bacteria. TVCs 
taken over a year aim to determine if ‘problem areas’ are identifiable or if physical 
or temporal parameters have an influence on bioburden. Long-term data will also 
determine whether TVC counts are a useful method of assessing contamination on a 
ward and whether they can be used to assess risk to patients. The second main aim of 
this chapter is to understand more about the composition of microbial communities 
present within a hospital ward, using NGS and to determine if spatial and temporal 
differences occur.  
6.3 Methods 
6.3.1 Site selection 
Sampling of a high-dependency neurology ward (Koala ward) at GOSH was carried 




Samples were taken once a month on either a Monday or Tuesday at 09.00.  
Enrichment swabs, as used in Chapter 4 were no longer included. Sample size on 
Koala was increased to 16 swabs and 16 contact plates per bed space (total 64 per 
time point) due to the increased size of the ward compared to Tiger ward in Chapter 
4. Sample site choice was based upon the sites being fixed so as to be directly 
comparable between time points. A range of heights and materials were sampled 
across the ward as well as high and low touch frequencies. Table 6.2 lists the sample 
sites for Koala ward and they are shown in Figure 6.3 with Figure 6.4 showing a bed 
space in more detail.  







1 Chair arm 9 Bin 
2 Over-bed light 10 
Top of alcohol / soap 
dispenser 
3 Drawers, middle level 11 Sink 
4 Entertainment monitor 12 Patient table 
5 Middle window ledge 13 Bed rail 
6 Bottom window ledge 14 Patient extendable light 
7 Floor under bed 15 Drug cabinet 
8 Drawers, bottom level 16 
A & B: high window 
ledge, 
C& D: Trolley 
The ward was divided into 4 areas (A - D) to facilitate sample collection and each 




 Prefix: C (contact plate), S (swab) 
 Location code: W (ward) 
 Ward code: K (Koala) 
 Month Code:  Jan - Dec 
 Area of room: A - D 








Figure 6.4: Koala ward bed space showing sampling sites 
Information regarding whether the bed was occupied or unoccupied was recorded, as 
was whether the patient had an active bacterial infection and / or an infection control 
microbial alert.  
6.3.2 Environmental sampling 
TSA contact plates, swabs, air samples and temperature and RH readings were taken 







Cleaning was carried out in accordance to DH guidelines and local policies.  
Standard cleaning took place between 07:30 and 15:30 each day. Floors were dry-
mopped with a dust-control mop, bed rails, fixtures and fittings were wiped with a 
damp cloth containing detergent. At mid-day, cleaners were required to wipe sinks 
and damp-wipe other surfaces if necessary. Between 16:00 and 20:00, sinks were 
damp-wiped again and the floor was dry-mopped. Throughout the day, nursing staff 
were required to wipe bed space areas with ‘Tuffie’ bactericidal wipes. Weekly 
cleaning involved damp-wiping with detergent under bed frames and high surfaces, 
including walls. Cleaning was carried out to comply with visual inspection standards 
of being free of dust, debris and finger marks. Bed spaces were cleaned to a level 3 
standard on discharge of a patient with a microbial alert. This involves the use of 
1000 ppm chlorine and is also referred to as a ‘deep clean’.  
6.3.3 Identification of Pseudomonas aeruginosa from sinks 
Frozen colonies from TVC plates taken on the sinks were thawed onto MacConkey 
agar (Oxoid, UK) and incubated at 37 
O
C for 24 hours. Colonies were picked and 
streaked out again on MacConkey agar to obtain pure cultures. Those colonies with 
morphologies indicative of Pseudomonas growth (i.e. white / colourless / yellow and 
circular) were sub-cultured on to cetrimide agar (Oxoid, UK) and incubated at 42 
O
C 
overnight to select for P. aeruginosa.  
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Colonies were viewed under UV-light and those fluorescing were sub-cultured onto 
2 plates of ISO Sensitest agar and one plate of UTI-chromogenic agar (both Oxoid, 
UK). ISO Sensitest agar plates then had drug-impregnated discs added to them 
(Table 6.3) and were incubated at 37 
O
C overnight.  


















6.3.4 Sequencing of colonies from TVC plates 
In order to identify the most commonly observed bacterial colonies growing on TVC 
plates, colonies were picked and sequenced. DNA was extracted using the method 
given in Section 2.5.1. 16S rRNA PCR was performed as described in Table 2.2 and 
PCR clean-up carried out using SephadexTM columns (Section 2.8.2). Sequencing was 





6.3.5 PCR inhibition assay 
At the time of DNA extraction from swabs, mouse DNA was added as an extraction 
control (Section 2.5.2). A qPCR assay was carried out on each sample before pooling 
to check for the presence of inhibitors by amplification of the mouse DNA (Table 
2.8). Any samples with a Ct of > 30 were considered to be inhibited. These samples 
were diluted at 1:10 and the assay was run again. If the Ct was still > 30, the sample 
was not included in the pool, if it was < 30; the 1:10 dilution was added to the pool. 
Details of sample pooling are given in Section 2.10.2.1. 
6.3.6. MiSeq DNA sequencing  
A total of 2 MiSeq sequencing runs were carried out for the current project. The 
initial run was carried out using the protocol given in Section 2.10.2.2 and the 
second using the protocol for low concentration DNA libraries as given in Section 
2.10.2.7. A total of 96 samples were combined at a concentration of 2 nM for the 
initial run. For the second run 50 samples were used. 32 of these amplified well and 
were purified using the Size Select
®
 gel method. The remaining 19 did not amplify 
well and PCR products were pooled and concentrated on a QIAquick column. The 
samples that amplified well were each adjusted to 1 nM concentrations and 
combined. The concentrated pool of poorly amplifying samples was added to the 
library at the same concentration. Pooled libraries were checked for final 




6.3.7 Statistical analysis and bioinformatics 
Statistical analysis was performed using either IBM SPSS Version 21 or R-3.0.2. 
Bioinformatics was carried out as detailed in Section 2.10.3.2. 
6.4 Results 
6.4.1 Bed occupancy and microbial alerts.  
Table 6.4 shows the bed occupancy and microbial alert status of patients over the 
year-long sampling protocol. Patients with active bacterial infections or colonisations 
were recorded.   
Patients had a wide variety of bacterial infections during the sampling time period, 
including infection with pathogens commonly associated with HCAIs such as         
P. aeruginosa, S. aureus, K. pneumoniae and drug-resistant E. coli (Table 6.5). 
These were diagnosed by the Microbiology department at GOSH using standard 





Table 6.4: Bed occupancy and infection status on Koala ward during 
year-long sampling. 
 Bed space 
Time Point A B C D 
K1 Baseline No patient No patient No patient No patient 
K2 March Occupied Occupied Occupied Occupied 
K3 April No patient No patient Occupied No patient 
K4 May No patient No patient No patient No patient 
K5 June Occupied No patient Occupied No patient 
K6 July Occupied Occupied Occupied Occupied 
K7 August Occupied No patient Occupied No patient 
K8 September No patient No patient Occupied Occupied 
K9 October Occupied Occupied Occupied Occupied 
K10 November Occupied Occupied Occupied Occupied 
K11 December Occupied Occupied Occupied Occupied 
K12 January Occupied Occupied No patient No patient 
K13 February No patient No patient No patient No patient 
K14 March Occupied Occupied Occupied Occupied 
Blue; Patient had active bacterial infection or colonisation at time of sampling. Red; patient had active 








Table 6.5: Microorganisms isolated from infected or colonised patients 
during year-long screening of Koala ward. Bed spaces with patients 





Positive culture Organism 
K5 
A Tip culture Resistant CNS
1
 
C Wound swab Resistant CNS 
K6 
A Throat swab Coliforms 
C 
Umbilical swab Enterococcus, S. maltophilia 




 Burkholderia cepacia complex 
Throat swab B. cepacia 
Sputum Serratia spp., coliform, Candida 
Urine Unidentified growth 
Throat swab Serratia spp.   
K8 
C 
Wound swab CNS 
Pus P. aeruginosa, coliform 
Pus P. aeruginosa, coliform, Prevotella 
Wound swab S. marcesens, P. aeruginosa 
Scalp swab Coliform, P. aeruginosa 
D 
Nasal swab S. aureus   
CSF
3




Femoral line Coliform  
Faeces E.coli, other coliform 
Faeces Sapovirus 
Subdural fluid Group A Streptococcus 
Urine Mixed, Candida 
NPA
4
 B. cepacia complex, Gram negative rod 
K10 B Throat swab Coliform 
K11 
A Dermatoid cyst Kocuria kristinae 
B Faeces E.coli 
1) Coagulase-negative staphylococci. 2) Endotracheal aspirate. 3) Cerebrospinal fluid.                         
4) Nasopharyngeal aspirate. 
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6.4.2 Total viable count results 
Despite attempts to collect a full set of 64 TVC plates per time point from Koala 
ward, a range of between 34 and 62 plates were collected. A total of 701 plates were 
taken over the course of the year. An additional CFU count category of ‘zero CFU’ 
was added after the investigation presented in Chapter 4, due to there being a larger 
overall number of samples and a large number of plates having zero CFU.  
The percentage of sites with TVCs in each of 5 categories for 14 time points is 
shown in Figure 6.5. Overall, CFUs recovered tended to be in the zero or < 50 
categories. At K1, the baseline sampling, 7 % of plates had zero CFUs and 85 % had 
between 1 and 49 CFUs. This changed at the first time point after ward opening (K2) 
to 40 % of sites having between zero and 49 CFU, with the majority of the remaining 
sites having intermediate to high CFUs. By K3, the majority of sites again had 
returned to having low numbers of CFUs. This changed again over the next 2 time 
points but remained around 30 – 50 % for subsequent time points until declining 
again at K12 and K13 and increasing slightly at the final time point.  
Number of sites with > 200 CFUs recovered remained fairly constant with a small 
peak at time points K5 and K6, but they remained under 10 % of the total for the rest 
of the time points. This was also true of the numbers of sites with 101 – 200 CFUs, 
overall the percentage of sites was higher than for the > 200 category but after K6, 
the percentage of sites having this number of bacteria remained around or under 10 
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%. There was an increase at K2, and a larger peak to 26 % at K5. Number of sites 
having 50 –100 CFUs appeared inversely proportional to number of sites with 1–49 
CFUs. If the former was higher, the latter lower and vice versa.  
 
Figure 6.5: Percentage of sampling sites with bacterial colony-forming 
units in each of 5 categories over a year on Koala ward.  
At time point K13, 60 % of sites sampled had zero CFUs, giving it on average, the 
same TVC count as the baseline sampling point, prior to occupancy. K3 had the least 
number of sites with zero CFUs. From the first sampling time point after ward 
opening in March 2012 (K2) to the final sampling exactly a year later in March 2013 
(K14), the percentages of sites having CFUs in each category was similar, except for 
an increase in the percentage of sites having zero CFUs from 12 to 33 % and a 
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277 
 
67 % of all TVC contact plates taken from the ward over the year had low or no 
CFUs present (472 of 701 plates).  
When analysing total average TVCs from all sites sampled across time points, it can 
be seen that after the baseline screen, the total number of CFUs on the ward 
increased dramatically (Figure 6.6). However, at the next time point (K3), overall 
numbers declined again and returned to approximately baseline level at K4. There 
was a large increase in overall TVCs at K5 and K6 but this returned to baseline again 
at K7. The CFU numbers then began to rise slowly before dropping again at K13 to 
slightly higher than baseline numbers.  
 
Figure 6.6: Average total viable counts of bacterial colony-forming 
units on Koala ward over a year. 
In order to analyse any patterns that may occur with CFU recovery in relation to 



















immediately near to the bed space, non-bed space sites, floors and sinks.  Average 
CFUs per bed space were plotted to identify if bed space was correlated to CFU 
recovery (Figure 6.7). 
 
Figure 6.7: Bacterial counts recovered from each bed space on Koala 
ward over a year. 
Bed space B had slightly higher CFU counts than other bed spaces at the baseline 
time point and all bed spaces except C had the same large increase at K2 compared 
to K1 (Figure 6.7). CFUs then generally reduced at K3 and K4 time points but 
increased at K5 for all bed spaces. They were reduced again at K6, which differs 
from the pattern of total ward CFU averages (Figure 6.6). The small increase in total 
ward CFUs at K12 (Figure 6.6) can be observed in bed space C but the increase is 
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Figure 6.8 shows the average bacterial counts from bed space, non-bed space sites, 
floors and sinks for the year. Average TVCs for non-bed space areas had the same 
pattern as total TVC counts for the whole ward (Figure 6.8b). Bed spaces, sinks and 
floors did not show the same pattern. Floor TVCs remained low for the first 2 
months after baseline screening but then increased at K4 and peaked even higher at 
K5 (Figure 6.8c).  
This was followed by a steady decline to K9, after which CFU numbers increased 
and decreased each month. CFUs recovered from sinks showed no pattern and 
increased and decreased almost monthly but peaked in December at K11 (Figure 




Figure 6.8: Average total viable counts recovered from a) bed spaces, 
b) non-bed space sites, c) floors and d) sinks over a year.  
 
With relation to bed occupancy, average TVC counts showed no difference between 
occupied and unoccupied beds (p = > 0.05). Occupied bed spaces did not have 
higher TVCs than non-occupied bed spaces. However, when a patient with a 
microbial alert was present, TVC counts from their bed space were always 




Table 6.6: Bed space occupancy and average total viable counts 

















A No patient 21 
K8 
September 
A No patient 27 
B No patient 48 B No patient 27 
C No patient 12 C Occupied 2 
D No patient 18 D Occupied 8 
K2 
March 
A Occupied 87 
K9 
October 
A Occupied 27 
B Occupied 87 B Occupied 29 
C Occupied 20 C Occupied 0 
D Occupied 124 D Occupied 6 
K3 April 
A No patient 38 
K10 
November 
A Occupied 37 
B No patient 34 B Occupied 9 
C Occupied 13 C Occupied 31 
D No patient 14 D Occupied 8 
K4 May 
A No patient 5 
K11 
December 
A Occupied 13 
B No patient 30 B Occupied 9 
C No patient 4 C Occupied 16 
D No patient 26 D Occupied 14 
K5 June 
A Occupied 58 
K12 
January 
A Occupied 21 
B No patient 77 B Occupied 14 
C Occupied 54 C No patient 83 
D No patient 34 D No patient 30 
K6 July 
A Occupied 42 
K13 
February 
A No patient 14 
B Occupied 30 B No patient 41 
C Occupied 6 C No patient 9 
D Occupied 47 D No patient 7 
K7 
August 
A Occupied 44 
K14 
March 13 
A Occupied 14 
B No patient 6 B Occupied 39 
C Occupied 4 C Occupied 13 
D No patient 4 D Occupied 1 
Blue; Patient had active bacterial infection or colonisation at time of sampling. Red; patient had active 




In summary, the majority of sites sampled over the year had TVCs of between 0 - 49 
bacteria. Average ward TVCs were low at baseline with a sharp increase at K2 after 
occupancy and were also high at K5 and K6. This pattern was mirrored in average 
non-bed space TVCs, but not in bed space, floor or sink averages. No single bed 
space was consistently high but all except C were high at K2, likely contributing to 
the high total ward average. All bed spaces had high TVCs at K5 and bed space C 
was also high at K12. Bed space TVCs were generally lower than the total ward 
average, except at K2 where they were higher than all other areas. Floors had higher 
average TVCs than other areas sampled with a peak at K5 and sink TVCs showed no 
pattern.  
6.4.3 CFU counts and temperature and relative humidity 
Temperature and RH readings were taken at intervals a minute apart in each of the 4 
bed spaces of Koala ward (A – D) at each time point. The average temperature on 
Koala ward during the sampling period ranged from 21.1 
O
C to 25.5 
O
C (Figure 6.9). 
The highest recorded temperature was at K2 in March 2012 and the lowest at K4 in 
May. RH ranged from 20 % to around 50 % over the summer months (K5 – K7) 
peaking at 51 % in August (K7). RH declined gradually over the winter months from 
November (K11) and continued until its lowest value at the final time point. There 
appeared to be no correlation between temperature and RH in this study (Pearson’s 




Figure 6.9: Average temperature and relative humidity readings from 
Koala ward. 
6.4.3.1 Total viable count and temperature 
Figure 6.10 shows average ward temperature and average ward TVCs (measured as 
CFU), for the sampling period. Initially, temperature and recovered CFUs followed 
the same trend, CFUs increased with temperature and the same was true for a 
decrease. This pattern occurred from K1 until TVCs peaked dramatically in June 
(K5). At this point, temperature readings also increased but only slightly from the 
previous month. The temperature continued to rise steadily over the next 2 time 
points but only by 2 
O
C whereas TVC decreased. In September (K8), TVC and 
temperature began to follow the same pattern again until they became inversely 




































with temperature (Pearson’s correlation coefficient r = 0.084, p = > 0.05, df = n -2) 
and CFU count could not be predicted by temperature (R
2
 = 0.007). 
 
Figure 6.10: Average temperature and average total viable counts on 
Koala ward. 
6.4.3.2 Bed space area, total viable count and temperature 
In order to determine if small differences and fluctuations in temperature in local bed 
space area had an influence on TVC, each bed space was analysed individually. 
Temperature patterns appeared similar for each bed space, but bed space C had a 
temperature peak of 26 
O
C in August (K7) compared with temperatures of 24 
O
C in 
bed space D and 22 
O
C at bed spaces A and B (Figure 6.11). There was a marked 








































again in February (K13) at both bed space A and B (Figure 6.11 a & b). This was 
also observed in bed space C and D but not as markedly (Figure 6.11 c & d).  
Each bed space had the initial trend of TVCs increasing and decreasing with 
temperature until K5 when CFU numbers increased sharply but temperature only 
increased slightly. The pronounced temperature peaks at K7 (August) did not 
correlate with increases in CFUs, in fact CFUs decreased at all bed spaces at this 
time point. There was no statistical correlation between CFU count and temperature 







Figure 6.11: Average bed space temperature and total viable count on 
Koala ward. 
6.4.3.3 Total viable count and relative humidity 
Figure 6.12 shows average ward RH and average ward TVC (measured as CFU) for 
the sampling period. RH increased gradually after a small decrease at K2 (March), 
until an overall decline from K8 (September) to the final sampling point (K14) 
(Figure 6.12). There was no correlation between average TVC and RH on Koala 
ward for this sampling period (r = -2.83, p = > 0.05, df = n-2) and CFU count could 
not be predicted by RH (R
2




Figure 6.12: Average relative humidity (%) in relation to average 
bacterial total viable counts on Koala ward. 
6.4.3.4 Bed space area, total viable count and relative humidity. 
In order to determine if small differences and fluctuations in RH in local bed space 
area had an influence on TVC, each bed space was analysed separately. RH patterns 
appeared similar for each bed space, they increased gradually until K7 (August) and 
then decreased gradually for the remainder of the sampling period (Figure 6.13). 
TVCs from bed space C appeared to follow a similar trend to RH from K5, with 
peaks over the summer months until a decline after K8 (September), however, there 

































Figure 6.13: Average bacterial total viable counts in relation to 
relative humidity for each bed space on Koala ward. 
 
6.4.4 Identification of bacteria from TVC plates 
In order to understand which bacteria were commonly observed on TVC plates, the 
most frequently appearing types of colonies were Sanger sequenced. Results are 
presented in Table 6.7. Figure 6.14 shows the same sample numbers as Table 6.7 and 
contains images of the sequenced colonies. Colonies resembling Staphylococcus 
were commonly observed (Figure 6.14) and these were identified as coagulase-
negative by sequencing. Pseudomonas sp. colonies were also common, as were 
Bacillus sp. and Micrococcus sp.  
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Table 6.7: Identities obtained by DNA sequencing of commonly 
observed bacterial morphotypes on total viable count agar plates. 
Sample 
number 




1 White, flat round, glossy Staphylococcus (CNS) 99 
2 Small, yellow, round, smooth Micrococcus sp. 99 
3 Yellow / transparent, irregular Pseudomonas sp. 100 
4 Large, matt, off-white, flat Lysinibacillus sp. 98 
5 Off-white, flat, round, glossy Enhydrobacter sp.  99 
6 White, wet, sweet smell Pseudomonas sp. 100 
7 White, crackled, dry, raised Bacillus sp.  99 
8 Flat, wet, white, irregular Bacillus sp. 99 
9 Small, white, round, smooth Micrococcus sp. 99 
10 Yellow, translucent, round Staphylococcus (CNS) 99 
11 Round, flat, wet, grey Bacillus sp. 99 
12 Wet, irregular, off-white Bacillus sp. 99 
 
6.4.5 Pseudomonas identification 
One sink in April (K3) and both sinks in June (K5), July (K6) and August (K7) were 
positive for the presence of P. aeruginosa.  None of the isolates were resistant to any 




Figure 6.14: Images of total viable count plates from the ward showing colonies sequenced (Numbers refer to Table 6.7).
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6.4.6 Next-generation sequencing of samples 
The initial sequencing run failed to cluster, meaning no data were retrieved, as 
discussed in Chapter 3. Fifty samples from Koala ward spanning multiple time 
points and sample types were included on a second run leading to a total of 629,136 
sequence reads passing quality filtering. Of the 50 samples, 24 did not produce an 
adequate number of reads to be analysed fully (> 1000), leaving 457,777 reads. Of 
those reads, 3032 were identified as chloroplast DNA and were therefore also 
excluded from further analysis. No air samples amplified well enough to be included 
on a MiSeq run. 
6.4.6.1 Phylum level identification of bacteria 
The 26 samples from Koala ward that were analysed included samples from all areas 
(bed space, non-bed space, sinks and floors) and multiple time points. They 
contained sequences which represented 23 known phyla or candidate phyla (those 
containing uncultured bacteria known only by metagenomics (350)), as seen in 
Figure 6.15. The highest number of sequence reads belonged the Firmicutes, 
followed by Proteobacteria and Actinobacteria. Bacteroidetes made up the majority 
of the remaining phyla with the other 18 phyla being represented by fewer 




Figure 6.15: Sequencing reads assigned to bacterial phyla isolated 
from Koala ward. 
19 different phyla were identified from bed spaces (Figure 6.16a) with the 
Actinobacteria comprising 35 % of the reads from the bed space samples. Firmicutes 
were identified in similar proportions and made up 33 % of the total. Proteobacteria 
made up 21 % of total bed space sequencing reads and 9 % were assigned to the 
Bacteroidetes. The remaining phyla, including Tenericutes, Fusobacterium, Thermi 
and TM7 were found in smaller proportions and others including Acidobacteria, 





Figure 6.16: Bacterial phyla isolated from bed spaces (a), non-bed space areas (b), Floors (c) and sinks (d) on Koala ward.
294 
 
17 phyla were identified from non-bed space samples (Figure 6.16b). The Firmicutes 
made up almost half of the phyla identified at 46 % of sequencing reads. 
Proteobacteria were present in a similar proportion to bed space samples (20 %) but 
Cyanobacteria were the next most frequently identified phylum in non-bed space 
samples at 11 % of reads, in contrast to only being found in 0.07 % of bed space 
samples. Bacteroidetes and Actinobacter were found in lower proportions in non-bed 
space areas than bed space areas (10 and 8 %), whilst Thermi and Fusobacteria were 
found in higher proportions. In contrast to bed space samples, no bacteria from the 
phyla TM7, Verrucomicrobia, Armatimonadetes or WPS-2 were identified from 
non-bed space samples but Nitrospirae and Chlamydiae were. 
20 phyla were identified from floor samples, with Firmicutes making up over half of 
all reads (53 %). Actinobacteria, Proteobacteria and Bacteroidetes were present in 
the next highest proportions, which was similar to the pattern observed in bed space 
samples (Figure 6.15c). All other phyla present were also either found in bed space 
and or non-bed space samples.   
20 phyla were also identified from sink samples (Figure 6.16d). These samples had a 
different profile to samples from other areas, with the majority of reads being 
assigned to the Proteobacteria (57 %). Firmicutes were still present in high 
proportions, making up 24 % of total sequencing reads. The next most frequent 
phylum was Bacteroidetes at 8 % of total sequencing reads and Actinobacteria was 
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found in much lower proportions than in bed space, non-bed space and floor 
samples, comprising only 2 % of total sequencing reads. 
6.4.6.2 Genus level identification of bacteria 
Genus-level identification of bacteria present in all samples was determined. Based 
on current literature and inspection of individual samples, sequences which 
comprised < 0.05 % of the total reads were discarded, leaving 402,866 reads, 
representing 231 taxa in the 26 samples analysed. The number of reads observed per 
sample can be seen in Table 6.8 along with bed occupancy information and the 
bacterial genus that was dominant, in terms of number of sequences. On average, 
more taxa were identified in bed space (n=74), non-bed space (n=100) and floor 
samples (n=94) than sink samples (n=41).  
The natural habitats of the identified taxa can be seen in Table 6.9. The majority of 
taxa isolated from Koala ward over all time points analysed were environmental in 
nature (122 of 231 identified taxa). These are bacteria normally associated with soil, 
water, plants or other environmental sources and include taxa such as Agrococcus, 
Devosia and Enhydrobacter. 63 taxa identified are normally associated with humans, 
including Helcococcus from the skin, Leptotrichia from the oral cavity, Dialister 




Table 6.8: Number of sequencing reads and taxa observed per sample 
showing the dominant taxon and bed occupancy.  
Sample Reads Genera Dominant taxon Occupancy 
K1.E 16012 117 Staphylococcus  
K2.A 5981 62 Streptococcus Occupied 
K2.E 37265 86 Staphylococcus  
K2.F 13675 94 Staphylococcus  
K2.S 17635 54 Streptococcus  
K3.B 27331 80 Acinetobacter Unoccupied 
K3.F 10419 100 Pseudomonas  
K3.S 151162 27 Pseudomonas  
K4.A 29425 73 Propionibacterium Unoccupied 
K4.E 44726 84 Pseudomonas  
K4.S 16354 69 Streptococcus  




K6.C 14286 96 Streptococcus Occupied 
K6.F 13074 111 Staphylococcus  
K6.S 13030 34 Methyloversatilis  
K7.A 24971 70 Propionibacterium Occupied 
K7.D 37908 76 Streptococcus Occupied 
K7.F 31519 102 Staphylococcus  
K7.S 11982 22 Methyloversatilis  
K8.A 20742 99 Staphylococcus Unoccupied 
K8.B 25259 53 Propionibacterium Unoccupied 
K8.C 13304 46 Propionibacterium Occupied 
K11.D 14429 84 Streptococcus Occupied 
K12.C 14764 66 Propionibacterium Unoccupied 
K12.E 12120 112 Acinetobacter  
K12.F 10391 85 Streptococcus  
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Table 6.9: Bacterial taxa isolated from Koala ward and their usual habitats.* represents extremophiles. 





























        
Achromobacter X      X        
Acidovorax 
      
X 
       
Acinetobacter 
      
X X 
      
Actinobacillus   X X           
Actinomyces 




       
Actinomycetospora       X        
Actinotalea            X   
Adhaeribacter X      X        
Aerococcus 
     
X 
        
Aeromicrobium X        X      
Aggregatibacter   X X          X 
Agrobacterium 
        
X 
     
Agrococcus       X  X X     
Alishewanella          X  X   
Alkanindiges            X   




           





























        
Anoxybacillus* X              
Aquabacterium X              
Arcanobacterium   X X  X  X      X 
Arthrobacter       X        
Azorhizobium       X        
Azospira       X        






         
Balneimonas             X  
Bdellovibrio X      X        
Bifidobacterium  X  X X X    X     




            
Bosea X      X     X   
Brachybacterium 
         
X 
    
Brevibacterium 
      
X X 
      
Brevundimonas X 
             
Brochothrix       X   X     
Buchnera              X 
Bulleidia 
   
X 
          
Burkholderia X      X  X      
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Candidatus 
Solibacter 
      X        
Capnocytophaga 
   
X 




           
Catenibacterium     X          
Catonella    X           
Cellulomonas       X        
Cellvibrio       X        
Chroococcidiopsis*         X      
Chryseobacterium* X 




     
Citricoccus       X     X   
Clostridium 
        
X 
     
Comamonas 
        
X 
     
Coprococcus 
    
X 
         
Corynebacterium X 




   
Curtobacterium       X        
DA101             X  
Deinococcus 






     
Delftia         X   X   
Dermabacter        X       
Dermacoccus        X    X   






















Devosia       X        
Dialister   X X  X         
Dietzia X 




    
Dorea  X   X          
Dyadobacter       X        
Enhydrobacter X 
             
Enterobacter X X X    X X    X   
Enterococcus  X             
Erwinia 
        
X 
     
Erythrobacter X 
             
Escherichia  X             
Eubacterium X   X   X X    X   
Exiguobacterium* 
      
X 
       
Facklamia 
     
X 




            
Filifactor 
   
X 
          
Finegoldia    X X X X        
Flavobacterium X 
     
X 
       
Friedmanniella            X   
Fusobacterium 
   
X 
          
Gardenella 
     
X 
        






      
X 






















Geobacillus*       X  X X     
Geodermatophilus       X        
Gillisia X              
Gluconacetobacter       X        
Gluconobacter       X        
Gordonia X X     X  X   X   
Granulicatella    X           
Haemophilus   X            
Haloanella             X  
Helcococcus        X       
Hylemonella X              
Hymenobacter       X        
Hyphomicrobium X      X        
Iamia              X 
Janibacter         X   X   
Janthiobacterium       X        
Jeotgalicoccus          X     
Kaistobacter         X      
Kingella    X           
Klebsiella X X X  X  X  X X  X   
Kocuria        X       
Kribbella       X        
Kytococcus        X       






















Lachnospira              X 
Lactobacillus  X    X         
Lactococcus       X   X     
Lautropia    X           
Legionella X              
Leptochrichia    X           
Leucobacter       X  X X  X   
Leuconostoc          X     
Limnohabitans X              
Luteococcus       X        
Luteolibacter       X        
Lysinibacillus       X   X     
Macrococcus              X 
Megasphaera  X   X         X 
Methylibium X           X   
Methylobacterium X      X  X      
Methylosinus X      X        
Methylotenera         X   X   
Methyloversatilis X        X      
Microbacterium X      X   X     
Microbispora       X        
Micrococcus X      X X       
Microlunatus       X        
Modestobacter*         X      
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Mogibacterium    X           
Moraxella   X            
Moryella  X             
Mycobacterium X X       X X     
Mycoplasma        X       
Myroides         X      
Nannocystis       X        
Negativicoccus        X       
Neisseria           X    
Nocardioides       X        
Nostoc X      X        
Novosphingobium X      X        
Ochrobactrum       X        
Oligella      X         
Oribacterium   X X           
Oscillospira         X      
Paenibacillus X      X  X      
Parabacteroides  X   X          
Paracoccus       X     X   
Parascardovia    X X          
Patulibacter       X        
Pediococcus          X  X   
Pedobacter X              
Peptococcus     X X         






















Peptostreptococcus  X  X  X  X       
Phaeospirillum X              
Phenylobacterium       X        
Photobacterium*               
Phycicoccus       X  X      
Planomicrobium         X      
Polaromonas X              
Pontibacter*         X      
Porphyromonas  X X X           
Prevotella    X  X         
Propionicimonas       X        
Propionibacterium      X  X       
Pseudochrobactrum            X   
Pseudoclavibacter       X        
Pseudomonas X      X X X     X 
Pseudonocardia       X     X   
Pseudoxanthomonas       X     X   
Psychrobacter*          X     
Rathayibacter       X        
Rheinheimera X              
Rhodococcus       X  X   X  X 
Rhodoplanes X           X   






















Roseburia  X   X          
Roseococcus         X      
Roseomonas (X)            X  
Rothia   X X           
Rubrivivax X           X   
Ruminococcus  X   X          
Rummeliibacillus       X        
Salinibacterium X      X        
Sarcina  X     X X      X 
Schlegella* X           X   
Sejongia X      X        
Selenomonas    X          X 
Serratia X      X  X     X 
Shewanella X      X   X    X 
Simplicispira            X   
Snethia      X         
Sphingobacterium         X      
Sphingobium X      X        
Sphingomonas X      X        
Spirosoma X      X  X      
Sporosarcina       X        
Staphylococcus        X   X    
Stenotrophomonas X      X        






















Streptococcus   X X    X       
Sulfurospirillum X              
Sutterella  X   X         X 
Tepidimonas*         X    X  
Teracoccus          X     
Tetragenococcus               
Thermicanus       X        
Thermoactinomyces X      X   X     
Thermus* X              
Treponema  X  X          X 
Trichococcus            X   
Varibaculum               
Veillonella  X  X           
Vibrio X             X 
Virgibacillus       X        
Wautersiella             X  
Weissella          X     
Williamsia         X      
Xanthobacter       X        
Yonghaparkia       X        
Zoogloea X           X   
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17 identified taxa had both human and environmental sources. For 7 taxa, the natural 
source is unknown, including Wauterisiella and Balneimonas. Many taxa identified 
were groups which contain known human pathogens such as Clostridium, 
Burkholderia, Enterobacter and Neisseria.    
All surfaces analysed supported the presence of complex microbial communities. A 
principal component analysis (PCA) was carried out to mathematically test the 
relationship between bacterial communities from bed space, non-bed space, sink and 
floor samples. PCA allows a large number of variables (in this case bacterial taxa) to 
be reduced to smaller numbers, called principal components, whilst maintaining the 
maximum variance from the data set. This reduction allows complex data sets to be 
plotted and enables similarities and differences in samples to be visualised (351). 
Samples that cluster together on a PCA plot show a degree of similarity, in this case 
they show that they contained a similar taxonomic profile. Bed space samples 
showed general clustering, as did floor and sink samples. Sink samples were shown 
to have a clustering pattern that was largely distinct from bed space, non-bed space 




Figure 6.17: Principal Component Analysis, showing clustering of 
samples with overlaps between bed space and floor samples.  
Bed space, non-bed space and floor samples had some overlaps, particularly with 
reference to the most commonly isolated taxa which made up 1 % or more of total 
sequence reads (Figure 6.18). Bed spaces had the greatest number of taxa found at   
> 1 % of sequencing reads than anywhere else on the ward. Bacterial taxa common 
to bed spaces, non-bed space areas and floors were Acinetobacter, Corynebacterium, 
Enhydrobacter, Lactobacillus, Neisseria, Prevotella, Propionibacterium, 
Pseudomonas, Rothia, Staphylococcus and Streptococcus. More taxa were shared 
between floors and bed spaces than between floors and non-bed space areas and bed 




Figure 6.18: Venn diagram showing the taxa forming > 1 % of 
sequencing reads isolated from 3 different areas of Koala ward. 
Overlaps indicate taxa isolated from multiple areas. 
Bed spaces were largely dominated, in terms of number of sequencing reads, by 
Propionibacterium and this was more pronounced in samples K7.A, K8.C and 
K12.C (Figure 6.19). Streptococcus was dominant in 2 samples K2.A and K11.D and 
was present in all other samples. Staphylococcus, Corynebacterium, Prevotella and 




Figure 6.19: Bacterial taxa comprising > 1 % of total sequencing reads 




































































Some taxa were each only present in one bed space sample including Actinomyces, 
Chryseobacterium and Enterobacter in K3.B, Finegoldia and Varibaculum in K5.D, 
Filifactor and Enterococcus in K6.C, Micrococcus in K7.A, Lactococcus in K7.D 
and Mycoplasma, Hymenobacter and Deinococcus in K8.A (Figure 6.19). Most of 
these taxa were only found in bed space samples. The number of taxa representing   
> 1 % of sequence reads was lowest in sample K8.C and highest in sample K6.C. 
Staphylococcus was dominant in 2 non-bed space samples and Acinetobacter 
dominant in one. The remaining sample had no clear dominant genus and 
Acinetobacter, Staphylococcus, Streptococcus and Corynebacterium represented 
similar numbers of reads (Figure 6.20). Propionibacterium was found less frequently 
than in bed space samples but Prevotella was identified in similar proportions. 
Peptostreptococcus was identified from K2.E and K4.E and Rickettsia was found in 




Figure 6.20: Bacterial taxa comprising > 1 % of total sequencing reads 










































Staphylococcus was again dominant in most floor samples, with the exception of 
K12.F, in which Streptococcus was dominant in terms of number of sequencing 
reads (Figure 6.21). Psychrobacter was the only genus to be exclusively found in      
floor samples and was only identified in one sample (K2.F). Acinetobacter and 
Corynebacterium were identified in all floor samples, as was Propionibacterium but 
the latter was again present in lower amounts than in bed space samples. Bacteroides 
was only identified from one floor sample (K12.F) and Granulicatella, 
Haemophilus, Neisseria and Porphyromonas were each only identified once in 
sample K3.F (Figure 6.21). 
With the exception of K2.S, in which Streptococcus made up the majority of 
sequencing reads, Pseudomonas and Methyloversatilis were largely dominant in sink 
samples (Figure 6.22). Some taxa including Schlegelella, Lautropia, Acidovorax, 
Hylemonella and Erythrobacter comprised > 1 % of sequencing reads. These taxa 
were not found in high proportions in samples from other ward areas, which may 






Figure 6.21: Bacterial taxa comprising > 1 % of total sequencing reads 














































Figure 6.22: Bacterial taxa comprising > 1 % of total sequencing reads 



















































6.4.6.3 Identification of bacteria associated with nosocomial 
infection 
Figure 6.23 summarises the relative proportions of bacterial genera known to contain 
species commonly associated with paediatric nosocomial infection that were 
detected on hospital surfaces throughout the sampling period. Escherichia was only 
identified once in a non-bed space sample in March (K2.E) and made up only 0.06 % 
of total sequencing reads. Clostridium and Klebsiella were largely absent from 
samples and when identified, were present in low proportions of between 0.05 and 
0.6 % of total reads. Enterococcus was also not commonly found but was identified 
at bed space C at time point K6 in higher numbers of reads (2 %) than at other time 
points analysed. Staphylococcus was found frequently and in all sample types. 
There was significantly more Staphylococcus identified on sink samples than floor 
samples (p = 0.03) and similar proportions were identified from bed space, non-bed 
space and floor samples. Streptococcus was found in all samples and often in lower 
proportions on sinks, although the sample site did not appear to have a significant 
impact on the proportion of Streptococcus reads identified. Acinetobacter was also 
identified in all samples and was generally at a consistent level. However, K3.B and 




Figure 6.23: Relative proportions of bacterial genera known to contain 
species commonly associated with paediatric nosocomial infection that 
were detected on the hospital surfaces throughout the sampling period.   
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There was no significant difference in sample type and the proportion of 
Acinetobacter identified.  Pseudomonas was found throughout samples at low levels 
but greater proportions occurred in all sink samples analysed, with a notable peak in 
sample K3.S (March), in which 93 % of all sequence reads were identified as 
Pseudomonas. There was a significant difference in the average proportions of 
Pseudomonas observed between the bed space areas and sinks (p = 0.002) and the 
difference between floors and sinks was almost at a significant level statistically      
(p = 0.057) but no difference was observed between non-bed space areas and sinks 
(p = > 0.05). 
6.5 Discussion 
6.5.1 Bacterial total viable counts 
As part of the overall aim to explore the nature and diversity of microorganisms in 
different indoor environments, this study has analysed the bacterial contamination on 
a high-dependency children’s neurology ward over the course of a year. Monitoring 
bacterial bioburden is often carried out routinely in healthcare settings to assess the 
efficacy of cleaning regimes or in response to outbreaks. However, this approach is 
controversial (13), (45), (163), (205) as it does not take into account specific species 
and cleaning is a complex issue to address, with conflicting information available 
regarding its overall contribution to reductions in HCAIs.  
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Official UK government regulations regarding acceptable levels of microorganisms 
on hospital surfaces do not currently exist. Levels have been proposed based on food 
preparation industry standards and in 2003, Malik et al. carried out an audit of 
surface screening in 4 hospitals and used the cut-off criterion of < 2.5 CFU  / cm
2
 as 
a guideline for surface cleanliness (352). They recommended intervention strategies 
such as further cleaning and investigations should a site fail screening and have more 
than 2.5 CFU / cm
2 
present. They presented no hospital evidence-based reasoning for 
these guidelines but the limits have since been adopted for further investigative work 
and even for use on the International Space Station (163), (353). If these criteria 
were applied to the data collected above, intervention strategies would have to be put 
in place when a CFU count of 62.5 per TVC contact plate and above was observed. 
This would mean that over the course of the screening, 26 % of sites would have 
failed inspection, resulting in vastly increased expenditure on cleaning and other 
intervention strategies. Close to or over half of sites would have failed at time points 
K2, K5, K6 and K12, which would likely meet criteria for ward closure if these 
guidelines were in place. The limit proposed by Malik et al. does not take into 
account bacterial species; the consequences of Staphylococcus epidermidis being 
present on a surface might be far less than that of the same number or less of 
pathogenic E. coli, for example. 
In 2004, SJ Dancer proposed the cut off limit of 5 CFU / cm
2
, equating to 125 CFUs 
per contact plate in the current study. This figure was proposed based on the US 
Department of Agriculture’s limits of bacteria on food-processing equipment (354) 
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and again, not on any evidence-based hospital screening examples. The hospital 
environment is dynamic and likely to contain different levels and types of 
microorganisms to those found in food preparation facilities. However, Dancer has 
since published articles with other authors and reverted to using the lower cut-off 
limit, referring to it as a ‘standard’ (163), (164), (176). As the current study has 
shown, surfaces are frequently contaminated and at levels above both criteria 
suggested by Malik and Dancer.   
Overall levels of bacteria recovered from TVC plates on the ward were consistent 
with levels recorded in other areas of the hospital. Lower levels of contamination 
were observed on high touch areas and higher levels observed on floors and 
windowsills. This pattern was also seen in the results from Chapter 4 and a recent 
study conducted at GOSH (un-published data) showed similar patterns of 
contamination in ICUs, wards and other outpatient’s areas. The data from the un-
published study combined the analysis of how many times an object was touched, 
CFU counts and hand washing behaviour and showed that transmission of bacteria to 
other people likely occurs in shared ward areas. Staff tend to wash hands prior to 
entering a bed space but often fail to when exiting, meaning that microorganisms 
from the patient, or objects around them, get transmitted to other areas on the ward. 
This may explain the often higher TVC counts observed on non-bed space items.  In 
fact, the bed space areas on Koala ward generally had lower TVCs than the other 
areas, except for at time point K2. This was the first time point when the ward was 
open to patients and the TVC counts may reflect the fact that staff had only been 
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working on the ward for 2 weeks and may not have been used to their surroundings 
and new equipment. 
Although no official observational surveys were carried out during the current study, 
some incidents were noted. One such case was of a patient having a highly-resistant 
E. coli infection but needing the specialist care of the neurology team, so could 
therefore not be isolated. The patient was nursed on the open ward under strict 
barrier-nursing conditions. However, it was observed on more than one occasion that 
nursing staff would attend to the patient wearing gloves and aprons but would often 
leave the bed space to cross the ward to collect an item, thus potentially spreading 
bacteria to shared areas.  
Bed space TVC counts were shown to be related to the presence of patients with 
infection control microbial alerts. TVC counts were always lower in the bed space 
area of a patient with such an alert in place and this could indicate that staff were 
much more aware of the possibility of contamination of the area and therefore 
cleaned more frequently and rigorously. This was in contrast to another study 
conducted at GOSH by Gaudart et al., in which the presence of patients and the 
presence of patients with an active bacterial infection on Koala ward were shown to 
be predictors of environmental contamination (45). The study by Gaudart et al. was 
conducted on 2 intensive care units (ICU) and CFU counts were on average higher 
than those obtained from the ward in the current study. The ICU environment is 
more tightly regulated in terms of who can enter and the differences in 
322 
 
contamination levels may indicate differences in cleaning frequency. Regular simple 
wipe downs of near bed space equipment, as occurred on the open ward in this study 
appear to reduce levels of bacterial contamination and keep TVCs low. 
This study was intended to be an overall long-term analysis of the bacterial numbers 
and species on Koala ward, with a view to understanding more about the indoor 
microbiota. As such, staff and patient behaviour, air-flow rates, touch frequencies, 
exact cleaning times and other factors were not closely monitored. However, these 
factors may play a role in contributing to environmental bacterial levels and 
community profiles.  
Cleaning cannot be relied on alone to reduce the transmission of microorganisms and 
can be difficult in practice. Figure 6.24 shows a bed space area on Koala ward when 
occupied, demonstrating the presence of objects which may contribute to 
environmental contamination and the potential difficulty in cleaning the area. 
The current study shows that despite regular cleaning, surfaces have persistent 
bacterial contamination. The areas that were regularly cleaned had minimal TVCs, 
such as patient tables and for the most part, bed rails. When a patient with a 




Figure 6.24: A bed space in use on Koala ward, demonstrating 
potential difficulty in cleaning the space.  
This was always apparent (even without discussing with staff) when screening was 
conducted due to the reduced levels of bacteria in that bed space. The baseline count 
on Koala ward prior to patients moving in was conducted after a level 3 deep clean 
had been carried out. The data show low counts in most areas, however the chair 
arms appeared to perhaps have been overlooked, in that one had a count of 46 CFU, 
another had 70 CFU and a third had > 200 CFU recovered. Chairs were brand new 
and a thorough clean was reported to be carried out. A mid-level window ledge and 
floor also showed high levels of bacterial contamination. This was prior to any 
patients or staff using the space and indicates that it is difficult to keep items free 
from bacteria even when an area is not used and has been deep cleaned. K3 
screening occurred after a Norovirus outbreak and a level 3 clean had been carried 
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out. Bed space C was the only occupied area, yet intermediate to high levels of 
bacteria were found throughout the ward. 
Other authors have demonstrated a relationship between relative humidity and 
temperature and CFU counts (10), (35), (72). However, most of this work has been 
conducted with regards to air and less is known about how temperature and RH 
influence surface bacterial counts in indoor environments. Many species of bacteria 
can survive for months on surfaces, including those associated with HCAIs such as 
S. aureus, Klebsiella spp., Acinetobacter spp., E. coli and P. aeruginosa (67). Low 
temperatures of 4 – 6 OC have been associated with increased bacterial survival on 
experimental surfaces relative to higher temperatures of 18 
O
C and above (355), 
(356). However, increased humidity increases survival rate in the case of E. coli 
(355) and Acinetobacter (91) and other bacteria (67). This study did not show any 
correlation between temperature and CFU counts observed or RH and CFU counts 
observed. However, bacterial counts were higher during the summer months (K5 and 
K6). Whilst this does not appear to be related to temperature, it may have been 
related to windows being opened more frequently during this time, or perhaps even 
the tendency of people to spend more time outdoors, lying on grass for example. 
This may have increased the number of bacteria they carried onto the ward. This is 
however purely speculative but the increase in bacterial contamination during the 
summer months might be something to be considered when cleaning is carried out. 
Perhaps a more intensive or frequent cleaning effort could be put into place over 
these months if a correlation with increased HCAIs is noted. The survival of bacteria 
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on surfaces is a complex interplay of factors including nutrient and moisture 
availability, temperature, biofilm formation and others and each surface is likely to 
have different local conditions.  
The mechanisms and relative contributions of different factors to environmental 
contamination are complex. Despite this, the data presented here demonstrate some 
patterns and allow some inferences to be made. Overall bacterial counts on Koala 
ward were low and therefore by inference the presence of pathogens should have 
also been low. However, the presence of viable but not culturable bacteria and the 
inability of some species to grow on the type of agar medium used, might mean an 
underestimation of the true surface contamination present.  The presence of a patient 
did not lead to increased TVCs, in fact when a patient with an infection control alert 
was present, TVC counts recovered were lower than when a patient without an alert 
was present. Temperature and RH did not appear to influence TVCs. TVCs cannot 
provide accurate bacterial identification and are not useful when wanting to assess 
risk but may provide an overall indication of cleanliness. 
6.4.2 Pseudomonas aeruginosa isolation 
Cultures taken from sinks were analysed for the presence of Pseudomonas 
aeruginosa as it is a recognised nosocomial pathogen and known inhabitant of 
hospital sinks (14), (86), (170), (167), (320), (357). Breathnach et al. found the 
presence on sinks of 2 strains of carbapenemase-producing P. aeruginosa associated 
with outbreaks in 2 different UK hospitals (66). Also, the HPA reported 73 hospitals 
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in the UK with cases of this type of multi-drug resistant P. aeruginosa in 2010 – 
2011 (358). The results of the Pseudomonas screening carried out in this study show 
the presence of P. aeruginosa on Koala ward at the time of screening. However, 
none of the isolated strains appeared resistant to any antibiotic tested. With the 
exception of one sink in April (K3), P. aeruginosa only appeared in the summer 
months (K5 - K7) and no culture evidence could be found after August on sinks. 
Patients were admitted to the ward in July and August with active P. aeruginosa 
infections but appear not to have been the source of sink contamination due to the 
isolation of the species in April and June. As the patients already had an active 
infection at the time of admission, it could also be inferred that they did not acquire 
infection from the sinks on Koala ward.  
P. aeruginosa outbreaks are often considered to be a result of poor design or faulty 
or misused sinks and drainage equipment. The building in which Koala ward is 
housed was completed and opened for use in 2012 and sink contamination with 
culturable P. aeruginosa appeared 1 month after opening. No issues were reported 
with sinks during the entire screening process. Pseudomonas is ubiquitous in water 
and appears not to have taken much time to establish a niche in a new sink. The lack 
of antibiotic resistance in all isolated strains may be an indicator that the 
contamination was purely environmental. Antibiotic use is the driver of resistance 




6.4.3 NGS analysis of bacterial communities 
The use of next-generation sequencing has allowed an insight into the microbial 
communities present on surfaces on a hospital ward.  
The majority of sequences identified from the ward belonged to the phyla 
Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. Previous studies using 
NGS have also found these to be the dominant phyla in a variety of indoor 
environments (63), (70), (71).  Numerous taxa within the phyla observed on the ward 
are normally associated with humans and form a part of the commensal flora. Many 
taxa known to contain species responsible for opportunistic infection were also 
observed, including Flavobacterium, Legionella, Stenotrophomonas, and Gemella.   
Skin-associated taxa including Propionibacterium, Staphylococcus and 
Streptococcus were observed in high proportions from all samples. This was not 
unexpected as it has previously been shown that the main source of microbial 
particles in indoor environments is the presence of humans (10), (35,48–52) and 
skin-associated bacteria have been shown to persist on surfaces (13), (359). Other 
human-associated bacteria were also observed in all samples, including those 
associated with the oral cavity, mucous-membranes, gut and urogenital tract. 
Neisseria and Prevotella, for example, were commonly isolated. Many of these 
human-associated taxa are anaerobic and would not therefore have been identified 
using standard culture-based environmental screening methods. Anaerobic bacteria 
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are of particular concern in hospital environments due to the presence of patients 
with indwelling devices and the invasive procedures often carried out which can 
introduce opportunistic pathogens to sites where they may cause infection.  
The most commonly observed colonies on TVC plates from bed space items were 
Staphylococcus. Only a small number of cultured isolates were sequenced, however, 
these did represent the most commonly observed morphotypes and 
Propionibacterium and Streptococcus were not identified despite these taxa making 
up a large proportion of NGS reads obtained. Staphylococcus and Micrococcus were 
common, however, indicating that they perhaps out-compete other bacteria which 
may be present in high numbers on surfaces. Bacillus spp. were frequently observed 
on TVC culture plates, particularly from non-bed space areas such as high 
windowsills and floors. However, relatively few Bacillus sequences were identified 
through NGS. Bacillus spp. were the most frequently isolated bacteria on Tiger 
ward, the outpatient’s area and classroom presented in Chapter 4 and also in similar 
studies conducted in a child-care facility (360), and school (361). Many Bacillus 
species are known to grow well on blood agar or TSA (362), as used throughout this 
study. In Chapter 4 and the cited work in schools and child-care facilities, culture 
was used prior to sequencing and this appears to have led to the overgrowth and 
therefore over-representation of Bacillus spp. in these indoor environments. These 
findings confirm the need for more molecular-based community analysis work and 
highlight the importance of not enriching samples prior to sequencing to avoid 
misrepresentation of community structure.  
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Bokulich et al. observed similar results to the current work, reporting the presence of 
high levels of Streptococcus, Staphylococcus, Neisseria and Enterobacteriaceae on a 
neonatal intensive care unit (NICU) (363). They also noted higher abundances of 
Acinetobacter and Pseudomonas on non-neonate associated items, which bears some 
similarity to this study in that Pseudomonas was more prevalent on sinks and non-
bed space items. Acinetobacter however, was found throughout Koala ward. Dunn et 
al. also found that skin, oral and gut-associated bacteria were dominant in residential 
environments and found a significant spatial difference with regards to diversity 
(63). In a study by Hewitt et al., also in a NICU, Enterobacter, Neisseria, 
Pseudomonas, Streptococcus and Staphylococcus were all identified from surfaces 
(364). They also found evidence of other opportunistic pathogens such as 
Acinetobacter, Clostridium and Legionella and that NICU bacterial diversity is 
similar to that of other environments, with human skin being a primary contributor to 
surface contamination. The same again was found by Oberauner et al. when looking 
at microbial communities in an ICU (365).  
It appears that microbial communities in a variety of indoor spaces share similar 
patterns and these tend to be dominated largely by bacteria normally-associated with 
humans. However, the consequences of the presence of potentially pathogenic 




The presence of gut and urogenital tract-associated bacteria implies a lack of 
compliance with hand washing guidelines or inadequate cleaning after nappy-
changing or bed-pan use. Gut-associated bacterial taxa including Bacteroides, 
Faecalibacterium, Blautia and Enterobacter were found in all samples and are of 
particular concern in healthcare environments. A large proportion of gut-associated 
bacteria are Gram negative and these bacteria have a natural resistance to some 
antibiotics. In an environment where there is added selective pressure due to the 
prescribing of antibiotics, resistance genes can be transferred, leading to a spread of 
resistance between species. Bacteroides spp. can be significant clinical pathogens 
and can cause bloodstream infection (BSI) and wound infections and have been 
shown to be highly resistant to many antibiotic classes (366). Enterobacter spp. are 
also frequently associated with BSI (367).  
A large number of different environmental taxa were identified on the ward in all 
samples. Environmental bacteria may often be considered to be non-pathogenic but 
certain taxa can be of concern, particularly in a hospital environment. Gordonia spp. 
are environmental bacteria which have recently been shown to be increasingly 
related to human infection, causing a wide range of clinical diseases including BSI 
and brain abscesses (368). Ochrobactrum spp. are soil and water-dwelling organisms 
but have been identified as the causal agents of bacteraemia in neonates (369), (370) 
and septic arthritis in an immunocompetent adult (371). Pseudoclavibacter spp. are, 
again, soil bacteria but have been found in clinical samples (372) and implicated in 
wound-infection (373). It may be that bacterial taxa considered to be only 
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environmentally-associated and non-pathogenic may play a greater role in human 
infection than previously thought. The ability to detect these uncommon indoor taxa 
through NGS may allow greater insight into their roles as pathogens. 
In contrast to microbial communities identified by other authors in other indoor 
areas, there appeared to be a relatively even spread of taxa throughout the ward, with 
no significant difference in the number of taxa isolated from bed space, non-bed 
space and floor and samples. Sinks on Koala ward, however had a lower number of 
bacterial taxa than other areas and a distinct profile. In a study investigating the 
bacterial communities within public toilet facilities, it was found that there was a 
significantly more diverse bacterial community associated with the floor than other 
areas of the facility (70). This was not seen on Koala ward and may be due to the 
much more frequent and rigorous cleaning carried out in hospital environments. 
Areas in homes and kitchens which were subject to less cleaning have been shown to 
have higher levels of bacterial diversity (63), (71). Flores et al. reported the presence 
of soil-associated bacteria in higher proportions on floors than other surfaces and this 
was also observed in the Koala ward samples. Whilst all ward floor samples had 
Staphylococcus or Streptococcus identified in the largest proportion, other taxa such 
as Acinetobacter and Psychrobacter were present in higher proportions than in 
samples from other areas of the ward. This change in dominant taxa would perhaps 
indicate that the bottom of shoes bring in bacteria from the outside environment.   
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TVC counts were shown to be lower when patients were present with microbial 
alerts, perhaps indicating more frequent and effective cleaning of these bed spaces. 
Only 2 samples from bed spaces with patients with microbial alerts were 
successfully amplified and sequenced (K6.C and K8.C). This may mean that less 
DNA was present in other cases, leading to non-amplification. The patient in bed 
space C at time point K6 had active bacterial infections with Enterococcus, 
Klebsiella, and Stenotrophomonas maltophilia. Enterococcus sequences were found 
at 2 % of total reads for this sample. This genus was identified in 9 of 12 bed space 
samples that were sequenced but the average proportion of reads observed was only 
0.1 %. This is much lower than observed in the bed space of the patient who had an 
active Enterococcus infection. Stenotrophomonas sequences made up 0.06 % of 
reads for this bed space which was slightly lower than the average of 0.07 % for all 
other bed space samples and the same applied to Klebsiella. The floor and sink 
samples were also sequenced for this time point and neither showed elevated levels 
of any of the 3 genera related to the patient’s infections. This may reflect differences 
in ability to recover or sequence Gram negative species. The patient in bed space C 
at K8 had active infections with P. aeruginosa, Prevotella and Serratia marcescens, 
however higher proportions of sequence reads were not recorded for any of the 
related genera.  Due to the lack of samples from bed spaces of patients with active 
infection, it cannot be accurately determined if they contributed to contamination of 
their near or wider environment.   
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The presence of Pseudomonas on sink samples was confirmed through culture and 
biochemical analysis. Sequence analysis showed no Pseudomonas sequences at time 
point K2 but at time point K3, Pseudomonas made up 93 % of the total sequence 
reads for that sample (Table 6.10).  
Table 6.10: Number of reads observed for Pseudomonas sp. from all 




K2.S  0 0 
K3.S 14049 93 
K4.S 9062 21 
K6.S 187 1.44 
K7.S 1489 12 
This corresponds to the culture data in that the first time point when P. aeruginosa 
was isolated from a sink was also K3. K5, K6 and K7 were also culture positive for 
P. aeruginosa. The sink sample from K5 failed to amplify but Pseudomonas 
sequences were observed at K6 and K7, although in lower proportions than K3 and 
K4. At the 2 former time points, Methyloversatilis was the dominant genus, 
accounting for 55 % and 64 % of sequence reads. Methyloversatilis was first isolated 
from the sediment of Lake Washington in 2004. The type species is M. universalis 
and it has been shown to be resistant to ampicillin, erythromycin, chloramphenicol, 
trimethoprim / sulfamethoxazole (SXT), vancomycin and penicillin (374). There is 
no available literature regarding the presence of Methyloversatilis in indoor 
environments, or its potential for pathogenicity. However, it is a Gram negative 
bacterium with antibiotic resistance characteristics and was found not only on sink 
samples, but also floor and non-bed space items on the hospital ward at many 
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sampling points, so may be of future concern. Other taxa not found commonly 
throughout the ward were observed in sink samples including Schlegelella, 
Hylemonella, Erythrobacter, Lautropia and Acidovorax. The three former taxa are 
associated with water (375), (376), (377). However, Erythrobacter spp. tend to be 
associated with sea water and in this case, the taxonomic identification may have 
failed to correctly identify this isolate. Erythrobacter is however a member of the 
Sphingomonadaceae family which have members known to be associated with 
hospital tap water (378). 
Despite the difficulties encountered with library preparation for NGS analysis, useful 
sequence data were recovered. This work has however confirmed difficulties faced 
by other authors in assessing microbial communities in hospital environments due to 
the very small amount of DNA that can be isolated from these surfaces (379). This 
may explain the lack of studies published from these environments and the lack of 
long-term studies, as missing data points make time series analysis impossible.  
There appears to have been no relationship between TVC counts and ability to 
amplify DNA for NGS. Very low TVC counts were recovered from the ward at the 
K1 baseline-sampling time point and only one of these samples (K1.E) yielded 
enough DNA to sequence. At the K2 time point, average ward CFUs increased and 
more samples were sequenced. However, intermediate TVC counts were recovered 
from bed space A (K2.A) and this sample was able to be sequenced, yet bed space D 
had higher TVC counts and was not able to be amplified. Highest TVC counts were 
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recorded at time points K5 and K6 but only one of 7 samples from K5 could be 
amplified and only 3 from K6. Total CFU levels were low again after these two time 
points until K12 when they increased to a higher level, yet only some samples from 
K7, K8 and one from K11 amplified. Inhibition of each sample was tested for using 
the internal positive control qPCR assay and inhibited samples were excluded, so the 
reason for poor or no amplification of samples remains unknown. The barcoded 
primers along with linkers and adapters for NGS are 62 bp long for the forward 
primer and 68 bp for the reverse, which might account for some of the difficulty in 
amplification of target sequence DNA, especially at low target concentration. 
Despite the knowledge that PCR amplification with greater than 30 cycles can 
significantly increase the numbers of chimeric sequences obtained, leading to 
questionable identification, work has been published using over this number of 
cycles, presumably due to the low amount of DNA present (363), (365). These 
studies, and no doubt others who do not report full PCR conditions, used a nested 
PCR strategy to first amplify the whole 16S rRNA gene, followed by amplification 
of the target region within the gene to add barcodes. The current study however, was 
aimed at obtaining sequence identification that was as accurate as possible and 
therefore only used a maximum of 30 cycles of PCR amplification. As such and by 
using the identification algorithms present in the QIIME software, it can be assumed 
that bacterial identification is as correct as possible. This may have come at the 
detriment of losing a large proportion of samples and not being able to analyse the 
full time series as initially intended, however the results obtained can be relied upon 
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as an accurate as possible representation of bacterial taxa present at time of 
sampling.  
The lack of samples amplifying from the baseline time point meant that sequence 
data obtained at subsequent time points could not be compared and an understanding 
of if and how microbial communities changed from baseline could not be 
established. However, the non-bed space sample from K1 was analysed and showed 
no difference in the number of taxa identified compared to non-bed space samples 
from later time points. Although, at the baseline time point, there was no clearly 
dominant genus present, with Streptococcus, Staphylococcus, Acinetobacter and 
Corynebacterium making up similar proportions of total sequencing reads. This 
changed at subsequent time points with Staphylococcus becoming dominant in terms 
of numbers of sequencing reads. This probably reflects the increase in human 
activity on the ward after K1. No large differences were observed in other sample 
types between time points. Bed space samples sometimes had greater proportions of 
Propionibacterium than at other time points (K7.A, K8.C and K12.C) however; this 
was likely due to the presence of an individual with higher numbers of this genus 
present on their skin. The same applies to floor samples when peaks in taxa such as 
Psychrobacter at K2 and Rothia at K12 likely indicate an outside source. Although 
taxa identified could not be fully analysed as a function of time, time did not appear 
to alter the microbial communities present.  
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The > 97 % similarity level cut-off for identification used in this study was chosen as 
it is currently the standard for studies investigating microbial communities (63), (71), 
(226), (363), (364), (365), (380), (381). The cut-off is chosen to identify taxa which 
contain closely related members and does not identify to species-level. This enables 
the dataset to be more manageable in downstream analysis. The method used also 
has some inherent problems when it comes to species-level identification. For 
example, a number of bacterial genera do not have enough heterogeneity in the 16S 
rRNA gene region to be able to establish a difference and assign a species. 
Streptococcus mitis and S. oralis, for example, show 99 – 100 % similarity in the V5 
– V7 region of the 16S rRNA gene, therefore cluster together as 1 species (214). It is 
also not always possible to assign a taxonomic lineage due to the extensive nature of 
reference databases and the presence of incomplete and un-verified sequences (214). 
The naïve Bayesian classification method used in this study and by others uses 
sequences from the Ribosomal Database Project (RDP) to identify bacterial taxa in 
accordance with the standard Bergey system of bacterial taxonomy. This has been 
shown to identify full and partial-length 16S rDNA sequences of 400 bp or more to 
the genus level with an accuracy of approximately 88.7 % (220). However, the 
accuracy when attempting to identify species is reduced to approximately 25 %. The 
lack of species resolution makes it impossible to predict the pathogenicity of any 
identified bacteria, however, a high proportion of taxa identified do contain species 
that are known human pathogens, including Acinetobacter, Stenotrophomonas, 
Flavobacterium and Escherichia. The presence of these and other bacterial genera in 
a hospital environment could be a concern and previous studies have shown that 
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when comparing bacterial taxa found on surfaces and hospital-acquired infections 
over the same time period in the same area, there was a correlation (365).  
Another issue surrounding correct identification is the hypervariable region of the 
16S rRNA gene chosen for use. The V6 region (as used in this work) has been 
described as the most variable of the 16S rRNA hypervariable regions, and its use 
gives high levels of discriminatory power (214). Currently, however, there is no 
single primer set that can be used for NGS that is capable of identifying all known 
bacteria which may lead to misevaluation of the diversity present (147), (222). 
Further knowledge may have been gained from this study by the use of more than 
one primer set for NGS, however, the cost was prohibitive for this work. The primers 
used in this study were chosen as they had previously been shown to be useful in 
identifying a broad range of bacterial isolates (214).  
Another general limitation of the technique is that PCR cannot detect bacterial 
replication competence. This may lead to an over-estimation of risk as a proportion 
of bacterial sequences identified may have originated from non-viable organisms. 
However, the presence of bacterial nucleic acid means that the organism must have 
been present at some point in time and may very well have been capable of infection 
or colonisation. GOSH infection control policy indicates that presence of microbial 
nucleic acids from nominated pathogenic species after cleaning, indicates a cleaning 
failure and that there may still be potential for infection. Also, non-viable organisms 
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can still transfer genetic material to others and therefore still pose a threat should 
they carry drug-resistance genes. 
The diversity and composition of bacterial communities observed on Koala ward is 
likely driven by several factors, including the frequency of cleaning, the number of 
people in the environment and the sources of bacteria introduced into the 
environment. Time series analysis could not be conducted; however, diversity in 
samples did not appear to alter significantly between samples from different time 
points. This indicates that the bacterial communities within this ward were fairly 
stable. Occasional local differences were observed at bed spaces, perhaps indicating 
the presence of a person carrying higher numbers of certain taxa.  
Bacterial communities showed some clustering when a PCA was carried out 
indicating that bed space samples were similar in diversity as were floor samples. 
Non-bed space items did not cluster together, indicating that they often had different 
community compositions which may reflect differences in microorganisms carried 
onto the ward by different people and outside sources. There was not a large 
distinction between clusters of these three types of sample, indicating an overlap of 
community members but sinks had a distinct clustering pattern, likely due to the 
higher numbers of water-associated bacteria present. The clustering patterns 
observed may have been more pronounced if more samples had been included. It is 
difficult to draw solid conclusions from small data sets such as this but general 
trends could be seen from the data.  Human-associated bacteria were found in high 
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proportions throughout the ward with some taxa such as Propionibacterium being 
more frequently found in the bed space areas. Staphylococcus, Streptococcus, 
Prevotella, Acinetobacter and Corynebacterium were ubiquitous.  
This study highlights that despite frequent cleaning and a relatively regulated 
environment, distinct and diverse microbial communities are present on surfaces on a 
paediatric hospital ward. Overall contamination levels appear low when using 
standard culture methods and do not reflect the diversity of bacteria truly present. 
Levels of contamination peak in the summer months for reasons unknown and not 
related to temperature or RH but tend to be lower around patients with microbial 
alerts as issued by infection control teams. Bacterial communities tend to contain 
fewer members than other indoor environments and appear to be fairly stable with 
respect to composition but do contain taxa which may be related to human 
pathogens. Skin-associated bacteria are the most commonly identified groups in this 
environment, as has been found with other indoor environments but environmental 
bacteria are also common. These groups may be of clinical consequence in a hospital 









7.1 Project background 
Microorganisms are resilient, can utilise diverse energy sources and can survive in 
an astounding range of ecological niches, from the extreme heat and lack of light 
found at hydrothermal vents (382), to the sub-zero temperatures and lack of nutrients 
in Arctic permafrost (383). It is therefore unsurprising that they have been able to 
adapt to the man-made built environment and establish connections to the health and 
disease states of the people who inhabit these places. The contribution of 
microorganisms present in indoor environments to disease in particular, has been 
known for many years. Florence Nightingale was a staunch advocate of window 
ventilation to hospital wards and homes in order to prevent illness and also 
recognised the role of fomites in the transmission of disease. Writing in ‘Notes on 
Nursing: What it is, and what it is not’ in 1859 (384), she commented:  
“For a sick room, a carpet is perhaps the worst expedient which could by any 
possibility have been invented. If you must have a carpet, the only safety is to take it 
up two or three times a year, instead of once. A dirty carpet literally infects the 
room. And if you consider the enormous quantity of organic matter from the feet of 
people coming in, which must saturate it, this is by no means surprising.” 
7. Summary and conclusions 
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As technology has advanced, the scientific community has been better able to 
understand the mechanisms and microorganisms responsible for the contamination 
noted by Nightingale and others. The microbial communities in indoor environments 
have, until relatively recently, only been understood with regards to what could be 
cultured on agar plates. This methodology, whilst having provided useful 
information in the past, cannot always be relied upon to capture the entirety of a 
microbial community due to the presence of viable but not culturable members and 
those which have fastidious growth requirements (15–17). The agar culture method 
also fails to take into consideration the presence of viruses, which require complex, 
time-consuming and expensive identification processes. 
Molecular methods, in particular PCR, have been used to gain a greater 
understanding of  indoor microbial communities but due to previous technical 
limitations, such as the need for cloning and sequencing, have often failed to capture 
the full diversity of microorganisms present. Also, as viruses do not contain a 
universal gene target such as the 16S rRNA gene found in bacteria and Archaea, 
molecular methods for virus identification have tended only to focus on specific 
species. This means that limited knowledge is available regarding the viral 
component of indoor ecosystems. In addition, very little comparative work is 
available directly comparing microbial ecosystems in different environments.  
At the time of commencement of the current study, NGS was beginning to be 
applied as a rapid, relatively cheap and accessible method for microbial community 
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analysis. It had previously been beyond the capacity of small laboratories and many 
research projects. As such, very few investigations had beied out into the microbial 
communities of indoor spaces. 
In view of the above outline, this project aimed to fill three major gaps in the 
available literature; to determine: 
1. If levels of microbial contamination and community composition were 
different in healthcare and educational settings. 
2. If viruses could be isolated from the air and from surfaces in a healthcare 
environment and what factors might influence this.  
3. If microbial numbers and community composition changed over the course of 
a year on a new hospital ward and if the causes and consequences of any 
observed changes could be identified. 
These aims were achieved through the sampling of various indoor environments 
using a combination of standard monitoring techniques such as TVC culture plates 
and molecular methods such as qPCR and NGS.  
7.2 Summary of main findings 
Through using a combination of culture and molecular techniques, various different 
bacteria were found to be present in different environments that are frequented by 
children. Overall bacterial contamination in terms of TVCs was lower in hospital 
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environments than in a classroom and this was likely due to the increased cleaning 
frequency on the ward and outpatient’s waiting area. Items located > 1.5 m from the 
ground tended to be more contaminated than lower items, with the exception of 
floors, which were found to have amongst the highest TVC counts in all 3 locations. 
Items that were frequently touched often had low TVCs and this was probably due to 
the fact that they were obvious targets for cleaning.   
Small numbers of bacterial taxa were found in all 3 environments initially sampled 
and Bacillus was the most commonly isolated genus from the classroom and 
outpatient’s area. Tiger ward also had a high proportion of Bacillus present but 
Staphylococcus was the most frequently observed genus. Pseudomonas also 
appeared to be more prevalent on the ward than the outpatient’s area and classroom. 
The low numbers of taxa observed compared to NGS studies was due to the methods 
used to isolate bacteria from these environments, demonstrating that culture-based 
techniques do not capture full diversity. Due to the small number of bacteria isolated 
however, species resolution was possible in some cases and resulted in the 
identification of potentially pathogenic organisms in all 3 environments. E. cloacae 
was isolated from all 3 environments and A. baumanii was isolated from Tiger ward.  
As a result of the findings presented in Chapter 4, infection control teams at GOSH 
reviewed the use and cleaning frequency of the outpatient’s waiting area in order to 
prevent the potential transmission of infection to susceptible patients.  
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Chapter 5 presents data which show that viruses can be isolated from an indoor 
environment. A number of different viral nucleic acids were identified on surfaces in 
an outpatient’s clinic at GOSH. Adenovirus DNA was ubiquitous and often present 
in very high copy numbers. Despite not being able to determine the consequences of 
this in terms of infection risk, the presence of such high copy numbers of a known 
viral pathogen was a concern. Other viral nucleic acids were isolated but with lower 
frequency and this could be due to the fact that patients with NV and RV, for 
example, may not have attended the clinic if they had acute illness. That being said, 
viral nucleic acids from these species were still identified and the only potential 
source would have been the presence of an infected person as the viruses identified 
do not grow outside of human cells.  
The use of TTV as a viral marker of contamination was also investigated and results 
indicated that it might be a more useful marker than TVCs, which are often used. As 
reported by other authors in studies investigating environmental virus contamination 
(44), door handles were frequently contaminated with virus nucleic acids. This part 
of the study was a proof-of-concept investigation and showed that viral nucleic acids 
are present on surfaces and in the air of clinical environments and may indicate the 
presence of infectious viruses which may be a risk to patient and staff health. 
Investigation of the bacterial contamination of a high-dependency children’s ward 
over the course of a year showed that the ward environment in this case, was 
generally quite clean in terms of TVCs. Peaks in contamination levels were recorded 
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2 weeks after the opening of the ward and in summer months. This may indicate that 
cleaning regimens could be intensified over the course of the summer, should these 
higher counts relate to incidence of infection. TVC counts however do not provide 
extensive information regarding bacterial identification and can therefore not be 
directly related to risk. Indeed, some taxa, such as Bacillus and Micrococcus 
appeared common to TVC plates but were not present as high proportions of 
sequencing reads obtained when NGS was carried out. Numerous taxa were also 
identified by sequencing that would fail to grow on TVC plates and may be a risk to 
patients. 
Bacterial contamination was less when a patient with a microbial alert was present 
but patients did not appear to alter the amount of contamination otherwise. This 
implies that staff members were aware of the potential of transmission from surfaces 
when a patient had a known infection and took steps to reduce it. However, it has 
previously been reported that patients are at greater risk of acquiring an infection if a 
previous room occupant had that infection (162). This may be due to the 
contamination of non-bed space items and these items were found to have higher 
overall TVC counts in the current study. It may also not apply to open wards which 
may be more frequently cleaned, or where surfaces are wiped down frequently by 
staff. 
The number of bacterial taxa isolated using NGS in Chapter 6 was far greater than 
the culture and sequencing method used in Chapter 4. Also, it indicated that the 
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dominant taxa in terms of sequencing reads were usually human-associated when 
considering bed space, non-bed space and floor samples. The findings were similar 
to published studies from hospital and other indoor environments.  
Despite frequent cleaning, viruses and complex bacterial communities persist on 
indoor surfaces. It has been demonstrated by other authors that frequent cleaning 
reduces the abundance of potentially pathogenic bacterial taxa on hospital surfaces 
(363) and also leads to lower diversity present (62), (70). This may be of 
consequence where human pathogens may accumulate and out-compete non-
pathogenic bacteria. However, cleaning is an important part of hospital infection 
control strategies and it may reduce the incidence of some nosocomial infections. 
Less is known about the importance of bacterial communities in other indoor 
environments but this study has shown that TVCs can be high and potentially 
pathogenic species can be isolated from classrooms. These environments do not have 
the same strict cleaning regimes as healthcare environments but the presence of 
bacteria may not be as concerning due to the lack of people with underlying 
conditions.  
One of the greatest difficulties in preventing infections and outbreaks is identifying 
the sources and transmission routes of pathogenic microorganisms. It is known that 
the presence of humans is the main contributing factor to the type and level of 
microbial contamination observed in indoor environments. The results presented in 
this thesis demonstrate that human-associated bacteria dominate most surfaces 
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within a paediatric hospital ward and that patterns, although not as distinct as in 
other indoor areas, can be seen with regards to which taxa occupy which areas. Sinks 
have a different pattern of bacterial dominance, with water-associated taxa being 
more prevalent. Although the sources of nosocomial outbreaks are often difficult to 
ascertain, the presence of microorganisms on surfaces indicates that these may be 
potential reservoirs of infection. These findings may imply that more of an emphasis 
should be placed on interventions that reduce the initial contamination, rather than 
trying to deal with it once it is established. 
Due to the ever-increasing threat from antibiotic-resistant microorganisms, low 
compliance with hand-hygiene methods, persistence of bacteria in indoor 
environments that have been designed to reduce their presence and issues 
surrounding cleaning materials and strategies, more control mechanisms need to be 
discovered. Some authors propose that simple methods such as returning to natural 
ventilation and allowing sunlight into buildings might reduce nosocomial infection 
(385). Whilst it is true that natural ventilation reduces risk of airborne infection, this 
strategy is not enough for the prevention of nosocomial infection from surface 
sources.  Other authors suggest more technological solutions may be imminent. With 
the use of NGS technologies, indoor environments could be rapidly screened and 
rather than sterilize everything, targeted solutions could be produced, leaving 
potentially beneficial bacteria in place (386).  
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The decreasing cost of high-throughput NGS could possibly see its use in routine 
monitoring of healthcare environments. It could be a valuable tool to measure the 
‘normal’ profile of an area, if DNA amplification issues could be circumvented. By 
monitoring any changes away from this normal baseline, an early-warning system 
for preventing the transmission of HCAIs could be put in place. It would also allow 
the effects of interventions to be studied in much greater detail.  However, it is clear 
from the presented research and the lack of published data providing long-term 
information, that the techniques and methodologies are not always straightforward, 
especially when dealing with low concentration DNA samples, as may be obtained 
from a relatively clean hospital environment. The time taken to obtain data from 
NGS is comparable to culturing with a single run on a MiSeq taking approximately 
39 hours. However, the analysis of data is still time consuming and requires 
specialist knowledge to interpret. Therefore, NGS technologies do not currently have 
the capacity to provide rapid, real-time information applicable to high turnover 
clinical environments 
7.3 Limitations of the study 
The amplicon sequencing technique used as part of this study to investigate 
microbial communities is a powerful and rapid tool for high throughput microbial 
identification. Despite this, however, it still has numerous shortcomings. The 
‘Operational Taxonomic Unit’ is described as organisms sharing > 97 % similarity in 
their 16S rRNA gene sequence and translates to genus-level identification in this and 
other studies. This cut-off is an arbitrary value and does not provide species 
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resolution. Relatively short read lengths coupled with the limitations of extraction 
methods, PCR biases, limitations of databases, chimeric sequences and other perhaps 
unknown factors, make results difficult to interpret at species level and this is 
therefore rarely reported, with most researchers only identifying to genus level.  
Although the methods used are not currently sensitive enough to provide species-
level identification for all bacteria present and cannot therefore identify the presence 
of known pathogens, the prevalence of skin and gut-associated bacteria throughout 
the indoor environment is a concern. Pathogens frequently found in the gut and on 
the skin may be transmitted via surfaces and cause colonisation or infection. This 
lack of taxonomic resolution makes it impossible to differentiate pathogens and non-
pathogens from the same genus. Findings could be supplemented with other 
identification techniques such as species-specific qPCR, for example but this negates 
the purpose of NGS high throughput sequencing. As technology advances and more 
sophisticated solutions become available, this limitation will likely become less of an 
issue. The current development of longer read lengths from Illumina of 2 X 300 bp 
and the introduction of 3
rd
-generation sequencing technologies such as those from 
Pacific Biosciences may enable greater resolution from microbial communities. It 
may also be of interest to consider the importance of microbial community profiles 
and how various species might interact with each other in this particular 
environment. Diversity studies taking into account the functional potential of 
bacteria present may indicate pathogenicity or the transfer of virulence elements 
between bacteria (387). They may also be able to differentiate live, VBNC and dead 
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cells. Low diversity taxa (< 1 % of total) have been shown to be the most 
metabolically active in the gut (388), perhaps this may also apply to hospital 
environments, explaining why known pathogens may be present in low abundance 
but remain an issue in terms of clinical disease. Of course, this is speculation and 
could only be determined with large-scale functional studies, or 
‘metatranscriptomics’, which was beyond the scope of this study. Also, these types 
of investigations cannot be carried out until metagenomic studies have been first 
applied.  
Another limitation of this technique is the use of the 16S rRNA gene itself. As 
previously mentioned, despite this gene being used for the majority of published 
community analysis studies, it may lack discriminatory power for certain taxa. In 
addition, there is evidence that horizontal gene transfer and recombination of the 16S 
rRNA gene can occur and may lead to incorrect identification of bacteria (389), 
(390). Horizontal gene transfer is the exchange of DNA between different species 
and has previously been thought not to have occurred with the 16S rRNA gene due 
to its vital and stable function (390). Despite these issues, the 16S rRNA gene is 
currently the most frequently used and is arguably, the best tool available for 
microbial community analysis.  
DNA extraction methods have been shown to influence the number of microbial taxa 
identified from NGS samples (347), (391). PCR bias is also a major limitation of the 
technique in that it can lead to erroneous identification due to amplification of errors 
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throughout the cycling process (346), (392). The DNA extraction technique used in 
this study appeared to provide the best results when comparing different methods but 
may have contributed to the low DNA concentrations obtained. However, the 
method is widely used and performed well with test samples. DNA amplified well 
with standard 16S rRNA gene primers and issues only occurred when carrying out 
barcode PCR, which could not have been foreseen when choosing a DNA extraction 
method. Swabbing surfaces using cotton swabs was shown to recover < 10 % of test 
bacteria in Chapter 3. This indicates that the sampling method is also a limiting 
factor in DNA recovery and alternative methods may provide a better representation 
of bacteria present. The cotton swabs used in this study are however common to 
environmental sampling studies, including those which use NGS (70), (71), (364). 
Perhaps as methods develop and the use of NGS becomes more commonplace, the 
focus of these studies will become the development of sampling techniques and pre-
sequencing processing in order to provide more accurate data.  
The study of bacterial microbiomes through NGS and high-throughput sequencing is 
relatively new and at the time of commencing this project, no work had been 
published regarding its use in indoor environments. The Illumina MiSeq was not 
commercially available and standard protocols have still yet to be published and 
accepted. As is the case with any new technology, the rapid evolution of methods 
and race for discovery often lead to later understanding of flaws in methodology and 
analysis. As understanding grows, better methods are developed and understanding 
is deepened. This project was undertaken when little was known about the microbial 
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communities within indoor environments, with reference to NGS and has therefore 
been able to identify not only some interesting insights but also some limitations to 
the techniques used. It therefore provides a useful basis for further work to explore 
the hospital microbiome, in particular, in greater depth.  
The main limitation of this study was the lack of amplification of a number of 
samples collected from the ward of the course of the year. The reasons for this 
remain unknown but appear to be due to a combination of factors which may include 
the presence of low amounts of DNA coupled with chemicals which may affect the 
sequencing reaction and possibly the length of the barcode primers themselves. In 
contrast to other environmental samples such as soil, the overall numbers of 
microorganisms on hospital surfaces is very low. This may be compounded by the 
regular cleaning occurring in healthcare environments. This appears to lead to low 
amounts of DNA being able to be isolated from surfaces which leads to difficulty in 
community analysis. However, despite not all samples being successfully amplified, 
the project has been able to address a number of the initial aims. One of the main 
aims of this project was to determine the ‘baseline’ composition of microbial 
communities present on the ward and see if and how this changed with time. Due to 
the difficulty in amplification of DNA, this aim was not able to be achieved. 
However, enough samples were sequenced to see that the general community 
structure does not appear to change significantly over time. Microbial communities 
in this environment appear to be fairly stable in terms of taxa present and those 
which are observed in greatest frequency. 
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7.4 Future work 
This study, while significantly contributing to knowledge surrounding the indoor 
microbiota, has raised some questions that may be addressed with future work. Some 
of these questions may be explored through the following research directions: 
1. Further testing of environmental sampling, DNA extraction methods and 
PCR amplification to attempt to overcome difficulties with samples. 
2. The comparison of 16S rRNA gene regions in their ability to identify 
bacterial taxa. 
3. The use of specific qPCR panels to further investigate the species of bacteria 
present and molecular typing to relate them to patient infection. 
4. The use of newer NGS technologies with longer read lengths and alternative 
PCR-free methods for microbial community analysis. 
5. The larger-scale sampling of different areas to detect virus nucleic acids 
6. The direct comparison of different indoor environments using NGS. 
7. The analysis of the function of microorganisms identified. 
7.5 Conclusion 
This study intended to explore different aspects of the indoor microbiome in 
different environments using a variety of techniques, to highlight the differences and 




Microorganisms were present in all locations sampled and were detectable by a 
variety of techniques ranging from laboratory culture to specific qPCR and cutting-
edge NGS. Each of these techniques provides different information that when 
combined, gives a great insight into the microbiome of an indoor space. However, 
the meaning of the findings is still hard to decipher. It is clear that microorganisms 
are present in indoor environments in spite of various solid strategies to remove them 
and prevent their spread, such as cleaning, hand hygiene and engineering design. 
What that means in terms of risk is difficult to assess without full knowledge of 
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A range of Trust policies are designed to reduce the risk of patients acquiring 
potentially pathogenic microorganisms by cross transmission from other patients, 
staff or visitors, or directly from the environment. Standard infection prevention and 
control precautions and environmental cleaning are adequate to reduce risk in 
most situations.  
 
Policies are present as clinical guidelines: 
http://www.gosh.nhs.uk/clinical_information/clinical_guidelines?category=I 
 
However, some situations arise where additional controls are implemented for 
which microbiological monitoring is required to validate the control has been 
successfully applied.  
 
Aims and objectives 
 
The aim of this policy is to help reduce the risk of patients or staff acquiring 
potentially pathogenic microorganisms from the environment. 
When microbiological screening of the environment is required 
Environmental clearance for specific organisms:  
Where a specific microorganism or clinical infections is recognised to lead to greater 
risk through environmental contamination, whether or not a cross transmission has 
occurred assurance is required that adequate cleaning has taken place beyond that 
demonstrated by the satisfactory standard checks (e.g. visual) after appropriate 
cleaning has been completed and before re-occupation of area.  
Organisms and procedure listed below. 
 
Confirmation of protective isolation ventilation:  
Where increased patient susceptibility is present due to a severe immunodeficiency 
(congenital or acquired) and local risk assessment has designated requirement for a 
protective environment including HEPA filtered air. (Procedure below - Appendix 5: 
Environmental air screening protocol for critical ventilation systems supplying 
clinical areas; Schedule of sampling is in Estates Ventilation Policy). 
 
Operating theatre environment – Validation of microbiological air standard is 
required at commissioning and annually as part of the planned preventative 
maintenance described in Estates Ventilation Policy (Testing procedure below) 
 
Water quality – microbiological quality of water is monitored routinely for legionella 
and Pseudomonas aeruginosa (as described in Estates Legionella policy) and as 
required when investigations of specific organisms suggests water may be involved 
in the transmission.  
 
 How sampling is performed and the expected standard results are 
interpreted against 
 
Procedures and standards are shown below in appendices 
This policy does NOT cover 
  
 Monitoring of air volumes and pressures as part of the validation of 
specialist ventilation units (schedule and parameters in Ventilation policy) 
 Schedule for testing for legionella (see Legionella control policy) and 
Pseudomonas aeruginosa in water (to be included in Estates document in 
preparation). 
 Microbiological monitoring of water in dialysis, decontamination 
department, hydrotherapy pool where separate policies exist 
 Environmental monitoring in Pharmacy suites, gene or cell therapy, SSD, 




Duties and responsibilities 
 
Infection prevention and control (IPC) team – to update policy and undertake 
procedure. To teach other to undertake procedures as required by clinical areas 
and keep records. 
 
Staff at ward level – to liaise with IPC, ensure area clean and ready; to undertake 
screening if trained 
 
External contracted companies – to comply with these procedures 
 
Procedure or guideline 
 
Environmental clearance for specific organisms 
Screening will only take place after appropriate adequate cleaning has been 
completed and signed off according to normal standards (Infection Clean Protocol 
GOS-EAF-PRO-10587) 
 
Individual risk assessment is performed by the Infection Prevention and Control 
Team (IPC Team) to grade risk associated with any particular organism. The need 
to perform screening is dependent on the organism, any current 
outbreak/transmission and susceptibility of individuals who may be exposed.  
 
Examples of organisms which may be screened for include: 
 
 Methicillin resistant Staphylococcus aureus (MRSA) 
 Multi-resistant gram negative species  
 Clostridium difficile 
 Vancomycin-resistant enterococci (VRE) 
  Norovirus 
 Adenovirus 
 Carbapenem-resistant Enterobacteriaceae and Acinetobacter species 
 
Other organisms as determined by IPC Team 
 
Preparation of bed spaces and patient areas 
 
Bed spaces may be screened post-level 2 or 3 clean carried out by the cleaning 
contractor.   
 
Bed spaces should be left for at least 2 hours post-clean to allow all surfaces to 
dry adequately.   
 
Bed spaces need to have been checked by a cleaning supervisor and ward 
representative (as per cleaning SLA) before screening takes place and the bed 
space checking form must be signed to say that a check has taken place before 
screening is undertaken.  Bed spaces must be visibly clean; if they are not then 
screening must be suspended until the room has been re-cleaned. 
 
Bed spaces must be free of all disposable equipment, clinical equipment and linen.  
If this is not the case screening cannot be carried out until these are removed.  
Please note that the room is unlikely to be organism free if these items have not 
been removed pre-clean as they impede cleaning.  It may be advisable to request 
the room be cleaned again before screening.   
 
If the room has not been properly prepared or is still visibly dirty this must be 
flagged both to the cleaning contract supervisor and the senior ward staff member, 
as well as the IP&C team and the member of Facilities in charge of the cleaning 
contract.   
 
If this situation is found an incident form must be completed.   
  
Screening should be carried out by a trained member of staff. This may be a 
member of IP&C Team or a ward designated staff member. 
 
After screening the bed space will be sealed until the results are back and a 
decision as to whether or not to open the room made.  
 
Screening samples may be processed by a number of methods with availability of 
results differing between 1 and 5 days.  
 
The decision to open the room must be made in conjunction with ward manager 
(who is expected to liaise with consultant staff) and IP&C and an individual risk 
assessment.  
 
If a bed space is found to have two consecutive cleaning failures due to microbial 
detection after consultation with the IP&C Team then a meeting must be called to 
include the contract manager, the Mitie supervisor and appropriate ward staff and 
an action plan developed.  (Infection Cleaning Policy/document library) 
 
 General Ward / Clinic Areas 
 
General ward areas may be screened in response to cross transmission or 
outbreaks.  Ward areas will be screened by a member of the Infection Control 
Team and may be carried out in relation to a requested level 2/3 cleaning instead 
of the routine ward clean. 
 
When is Screening Necessary? 
 
The risk assessment considers the organisms, underlying condition of host, 
potentially susceptible individuals, current transmissions, prior experience with this 
organism and any clinical consequences of delay in bed opening. Screening may 
be requested for specific very high risk organisms (highly transmissible or highly 




Experience has shown certain strains and patient conditions lead to increased risk 
of cleaning failure (despite visually satisfactory inspection). For some children, the 
IP&C team are able to alert these children on PIMS as carrying highly 
transmissible strains. Screening will be carried out post discharge of patients with 
a highly transmissible strain of MRSA after a level 3 clean. Screening may also be 
necessary with other strains in an outbreak situation. 
 
Screening results will take 72 hours (longer if processed over a weekend) 
 
Criteria for bed space reopening - all sites free from MRSA 
 
Multi-resistant Gram negative species 
 
A large number of children are present in the trust colonised with multi-resistant 
bacteria and routine trust screening, isolation and cleaning protocols are adequate 
to control most of these.  
 
However, certain highly resistant bacteria may be present for which screening 
should be carried out post discharge. The alert that this is a highly resistant strain 
of gram negative microorganism should be included on the alert in PIMS. A level 3 
clean is usually required pre-screen. 
 
Screening results will take 72 hours (longer if processed over a weekend) 
 
Examples include Enterobacteriaceae (Klebsiella, Enterobacter and Escherichia) 
or Pseudomonas aeruginosa carrying genes for transmissible carbapenemases, or 
multi-resistant Acinetobacter baumanii (MRAB), which have caused major 
outbreaks in other London hospitals. 
 
Criteria for bed space reopening - all sites free from Multi-resistant Gram negative 
organisms 
 Clostridium difficile 
 
Screening may be requested in response to outbreaks or in relation to specific 
patient factors. 
 
C. difficile cases are usually sporadic in this trust, but the organism produces very 
resistant spores and outbreaks frequently occur in many health care settings. 
Screening will not be carried our routinely following detection of a case, but may 
be carried out in response to a request from the Infection Control Team/Consultant 
Microbiologist. Screening results will take up to 7 days 
 
Criteria for bed space reopening - all sites free from C. difficile 
 
Vancomycin-resistant Enterococcus faecium or Enterococcus faecalis 
(VRE) 
 
Screening may be requested in response to outbreaks or in relation to specific 
patient factors. 
 
Detection of VRE is uncommon in GOSH, but the faecally carried organism has 
been responsible for outbreaks in the past, usually felt to be propagated through 
environmental contamination despite cleaning. Screening will be considered post 
discharge of any patient colonised or infected with VRE, this should be included on 
the alert in PIMS and would require a level 3 clean pre-screen.  
 
Screening results will take 72 hours (longer if processed over a weekend) 
 
Criteria for bed space reopening - all sites free from VRE 
Norovirus 
 
Screening will be carried out in response to a request from the Infection Control 
Team / Consultant Microbiologist.  Screening may also be requested in response to 
outbreaks and in rooms where the next admitted patient is likely to be 
immunosuppressed (e.g. Lion, Giraffe, Elephant and wards) 
 
Screening results will take up to 72 hours (longer if processed over a weekend) 
 




All cubicles occupied by Adenovirus excreting children which will next have severely 
immuncompromised children in (Fox, Robin and Butterfly BMT cubicles) must be 
screened after the level 3 clean post-discharge.   
 
Screening may also be requested in response to outbreaks and in rooms where 
the next admitted patient is likely to be immunosuppressed (e.g. Lion, Giraffe, 
Elephant and wards) 
  
Screening results will take up to 72 hours (longer if processed over a weekend) 
 
Criteria for re-opening:  Decision to open room before results will be assessed with 
respect to the risk in next room occupant. 
 
Criteria for bed space re-opening: 
 
The cubicle is opened with no further cleaning required if no site has an 
Adenovirus positive CT result of lower than 39. 
 
If the cubicle has 2 sites positive with Adenovirus at CT’s of no lower than 34, then 
those sites are re-cleaned twice using chlorine and the cubicle can be re-opened, 
as long as the sites positive to do include the floor inside the room.  If the floor 
inside the cubicle is positive than the cubicle undergoes a repeat ‘deep clean’ and 
is re-screened. 
 
If the cubicle has more than 2 sites with an Adenovirus positive CT of 34 – 38 or if 
any one site has a CT of lower than 34, then the entire room must have a repeat 
‘deep clean’ and be re-screened in full before opening.   
 
If the same objects fails to become negative after 3 cleans and screens, that 
object if possible is replaced within the cubicle and disposed of appropriately. 
 
Step by step guide and flowchart  
How to Carry Out Environmental clearance for Specific organisms 
 
 
A set of predefined areas should be screened according to the attached protocols.  
 
See appendix 1 – bacterial screening protocol 
See appendix 2 – bacterial screening form 
See appendix 3 – viral screening protocol 
See appendix 4 – viral screening form 




General ward areas may be screened in response to cross transmission or 
outbreaks.  Ward areas will be screened by a member of the Infection Control 
Team and may be carried out in relation to a requested level 2/3 cleaning instead 
of the routine ward clean.  Screening results will take up to 7 days depending on 









1 Corridor floor outside of cubicle/ante room 
entrance of a known positive 
10cm2 
2 Corridor floor outside of cubicle/ante room 
entrance of a known negative 
10cm2 
3 Storage trolley surface outside of the room 
of known positive 
10cm2 
4 Storage trolley surface outside of the room 
of known negative 
10cm2 
5 Sluice work surface 10cm2 
6 Sluice room door handle (exit to corridor) Entire handle 
7 Macerator lid Round the entire seal 
8 Nappy weighing scales Entire top surface 10cm2 
9 PC keyboards Every key and surface on the 
right(~10cm2) 
10 Nurses station 10cm2 
11 Nurses station phone Entire Keypad and handle 
12 Notes trolley 10cm2 
Monitoring of areas with critical mechanical ventilation systems  
 
Screening will be carried out by the IPC team, or a company that fulfils the 
screening criteria under direction of estates, under the following conditions: 
 
 During commissioning 
 As part of the annual maintenance schedule annual verification 
 In areas where work has been undertaken on mechanical ventilation units     
providing protective HEPA filtered environment or operating theatre standard air 
quality where air quality may be altered (work on filter or down stream of filter) 
 In areas supplied by mechanical ventilation where the fabric of the room has 
been breached. 
 
All maintenance work or renovation in the clinical areas must be discussed with 
the Infection Control Team prior to implementation.  Screening will be undertaken 
using the protocol set out in appendix 5 and form appendix 6. 
 
Screening will involve the use of settle plates (blood agar alone is adequate) and 
air sampling (carried out prior to the placement of settle plates) onto blood agar.  
Sampling will be undertaken post level 3 clean and the room will be closed to entry 
throughout the sampling time.  Screening time will depend on the area to be 
screened, but will take a minimum of three hours. 
Screening results will take 72 hours (longer if processed over a weekend) 
 
Plates are incubated according to laboratory protocol BSOP0058 
Specifications for microbiological air sampling (BSOP0058) 
 
Test types:  1 cubic metre air tests (also called active air test or air test): 
collected using a calibrated air sampling device, 1 cubic metre of air 
 will be sampled on to a suitable agar plate. In house we use blood 
agar, although other non-selective agar is suitable. 
 
Incubation:  18-24 hours at 35 -37OC with initial 1 day cfu report.  
 
Reading:     Plates are read for colony count (fungi are identified to genus level) 
 
Report:   Bacterial count in cfu/m3  
Fungal count in cfu/m3 (ensure report no Fungi grown and any 
growth is identified to genus level) 
 
   Settle plates: 9 cm blood agar plates left for 2 hours. 
 
Incubation:  18-24 hours at 35 -37 OC with initial 1 day cfu report. Then 2 
additional days at room temperature to give final report. 
 
Reading:     Plates are read for colony count (fungi are identified to genus level) 
 
Report:   Bacterial count in cfu/ plate  
Fungal count in cfu/plate (ensure report no Fungi grown and any 
growth is identified to genus level) 
 
Criteria for satisfactory validation – depends on the standard the area 
has been built and designed to e.g. HTM2025 or HTM 03-01   
 
Theatres: 
HTM 03-01 modified standards: 
Non-HEPA filtrated area   -10 or less cfu/m3 total count 
HEPA filtrated area   -10 or less cfu/m3 with no fungal colonies 
 
HTM 2025 modified standards: 
Non-HEPA filtrated area   -35 or less cfu/m3 total count 
HEPA filtrated area   -35 or less cfu/m3 with no fungal colonies 
 
Requirement for each area should be described in the Estates produced schedule 
but in summary: 
 
Theatres: 
Theatres are currently operating to 2025 (to which they were designed) but we aim 
to achieve 03-01 where possible, so theatre results that do not meet 03-01 total 
count need to be reviewed. 
 
Protective isolation rooms and ward areas: 
Newer PPVL rooms should meet HTM 03-01, with no Fungi detected 
 
Older rooms and wards were built with HTM2025 standards. 
If 03-01 standard is not meet the area needs review and individual decision made 
considering commissioning and annual verification records of what was achieved. 
  
 Areas requiring specialised ventilation screening: 
 
 Operating theatres 
 Clinical areas with HEPA filtration – Robin and Fox wards; Butterfly  
 PICU, NICU, CICU, Angio Suite, HSDU 
 All individual rooms providing protective isolation  
 
Other critical ventilation systems, shown below, are NOT covered by this policy 
 Pharmacy: Cytotoxic Suite, TPN Suite, Sterile Unit 
 SSD 
 Gene and cell therapy suites 
Areas should comply with good manufacturing clean room standards, 
administered by Pharmacy or research sponsors. 
 Pathology laboratories. Covered by Pathology documents. 
 Mortuary 
 
Requirements for microbiological sampling 
 
 Investigations will be undertaken by the Infection Control Team / Microbiology 
Department 
 Any problems requiring urgent attention must be discussed with the Infection 
Control Team. 
 Notification of the cleaning programme must be sent in advance, in writing, by 
the project leader concerned to the Infection Control Department 
 Confirmation that the programme is on time, must be made by phone, by the 
project leader to the Infection Control Team (CNS or Infection Control Clinical 
Scientist) or Infection Control Doctor 
 Appropriate arrangements for removal and storage of furniture, sterile and non-
sterile stores must be made prior to commencement of any work. 
 
Procedures to be undertaken prior to microbiological sampling 
 
 Air flow and pressure parameters must be confirmed as meeting standards by 
Estates prior to any microbiological testing - Ventilation validation reports MUST 
be sent to Infection Control Team / Microbiology Department in time for these to 
be checked prior to sampling 
 Level 3 clean (Infection Clean Protocol GOS-EAF-PRO-10587) 
 Check  that all appropriate windows and doors are closed 
 Check that air conditioning is switched on.  It must be ensured that both main 
and backup systems are fully functional. 
 The area must be locked and left empty for a minimum of 2 hours prior to air 
sampling. 
 It is the responsibility of the project leader concerned to inform the Infection 
Control Team that the area is ready for sampling. 
 
Communication of results 
 
  If testing is performed by an external company employed by Estates, result 
must be sent to Infection Control Team. Results will be made available by the 
Medical Microbiologist, or member of the Infection Control Team, who will phone 
and email the appropriate manager / project leader 
 Where a microbiological failure is documented, individual advice on re-
cleaning and sampling will be given by the Infection Control Team or Medical 
Microbiologist 
 
Local arrangements for implementation 
 
Who to Contact 
 
Infection Control Team bleep 0640 ext 5284 and either the Virology or 
Microbiology lab as appropriate. 
 
Who Should Carry Out Screening 
 
This should be performed by a member of the Infection Control Team or a member 
of staff trained by the Infection Control Team; or company appointed by Estates 
 
Distribution of Screening Results 
 
The member of staff in charge of the ward will be contacted with the environmental 
screening results.  If the cubicle/ward area is passed as clean the area is then 
available for use. 
 
If the cubicle/ward area fails the first environmental screen the Infection Control 
team will discuss with the member of staff in charge what subsequent tasks need 
to be undertaken.  The cleaning contract liaison and the cleaning supervisor will 
also be informed of any screening failure (as per the Infection Clean Protocol 
GOS-EAF-PRO-10587).   
 
If repeat cleaning and screening is undertaken as a result of a failure the reporting 
process is the same.  However if a cubicle/ward area fails its environmental 
screening more than twice a meeting will be called as detailed in the cleaning 
policy to evaluate why failures are occurring and how the situation can be 
resolved.   
 
Archiving of screening results 
 
Samples will be booked in to the laboratory computer system.  Paper copies of 
results are not sent to clinical areas but will be archived in IP&CT office in a folder 




 Staff carrying out environmental screening should be trained and signed off as 
competent by a member of the Infection Control Team.  A training update should 
be carried out annually and a training record maintained.  Members of staff being 
trained to carry out environmental screening need to be trained to carry out both 
bacterial and viral sampling; as these procedures are different. 
 
The training will be carried out by the IP&C team and record maintained locally by 
the ward or theatres. 
 
Auditing and monitoring 
 
 Annual audit against Estates maintenance records to confirm microbiological air 
tested when appropriate 
 Annual audit against level 3 clean list to check screening was requested when     
appropriate 
 Annual audit training records for update 




Appendix 1: Screening Protocol 
 
Bacterial Environmental Screening Method (MRSA and Multi-Resistant 




Bacteria can be a source of contamination when a patient who is infected / 
colonised is present in a cubicle.  These bacteria can also survive for long periods 
in the environment and so when a patient, with an alert requiring a level three 
clean, is discharged or moves room, we need to know that the cubicle is free from 
bacteria before placing another patient inside.  The Infection Control team may ask 
that you sample (swab) a room after cleaning to make sure that all the bacteria 
have been removed. 
 
What you need 
 
Supplies needed on ward  
 
 Permanent marker pen (to write on tubes) 
 Charcoal swabs (kept in a clean dry location) 
 Gloves 
 Disposable aprons (white) 
 Polythene specimen bag to put your samples in once taken 
 Sterile water (from the clean utility) 
 
Supplies provided upon request by bacteriology (phone bacteriology each 
time): 
  
 Bacteria Environmental Screening Form (1 per cubicle - to be completed 
during screening by the person swabbing) 
 
What you do 
 
When you have been asked to screen a cubicle by the Infection Control Team: 
 
Call bacteriology and ask for the number Bacterial Environmental Screening 
Forms (1/ cubicle).  Tell them where you are screening and for which organism / 
alert. 
Find out from the person in charge the information you need to fill out the Bacterial 
Environmental Screening Form and complete it.  
When you have everything from the what you need section including gloves and 
aprons (taken from the clean utility room) put everything in a clean suitable place 
outside of the cubicle i.e. a fold table, or use a clean plastic tray which you can take 
into the room. 
Wash your hands thoroughly with soap and water. 
Put on a disposable plastic apron and gloves. 
Enter the cubicle 
 Write on the Bacterial Environmental Screening Form in the Swab No. column 
the number of the swab you are taking (i.e. 1 – 12) and write in the Site Swabbed 
column which area you are going to sample (use the sites to be included table on 
the back of the form).  Label the swab you are going to use with the swab number, 
site, cubicle number, ward and date.  Only label one swab at a time!  
 Once your swab is labelled and the form written take a clean swab from its pack, 
being careful not to touch the cotton end.   
Lightly moisten the swab in the sterile water.   
Swab the area (use the Area to be Swabbed description in the table on the back of 
the form to help you) 
Put the cotton end of the swab back into the tube containing the charcoal transport 
media. 
Put the tube in the clean sample bag. 
Collect the plastic caps to be thrown away in a clinical waste bin when you have 
finished taking all the swabs. 
Repeat steps 7 and 8 with each swab to be taken. 
 If at any point you think you may have got something on your gloves you must 
change them for a clean pair. 
If the room does not appear clean or the appropriate items (curtains etc) have not 
been removed report this to the nurse in charge or contact the Infection Control 
Team. 
 The swab remains and all gloves and aprons must go in a clinical waste bin.  If you 
have used a tray make sure it is thoroughly washed with soap and water. 
Make sure that you wash your hands thoroughly with soap and water. 
Fill in the form on the cubicle door to say that sampling has been carried out. 
Send the completed form and samples to bacteriology using the chute system. 








Site Area to be Swabbed 
 
1 Floor under sink 4 inch2/10cm2 
2 Bathroom door handle Entire handle 
3 Chair with arms Both arms 4 inch2/10cm2  
4 Oxygen outlet (above bed) Entire surface 
5 Telephone keypads Entire keypad 
6 Taps in Patient Bathroom Entirety of both taps 
7 Mattress top 4 inch2/10cm2 
8 Bed/Cot frame under bed 4 inch2/10cm2 
9 Trolley surface (in ante room if present) 4 inch2/10cm2 
10 Side window sill (right hand side) 4 inch2/10cm2 
11 Cubicle room exit door handle (cubicle side) Entire handle 
12 Corridor floor outside of cubicle/ante room 
entrance 
4 inch2/10cm2 
Additional sites should be swabbed (samples 13+) if there are any areas that look 
dusty or unclean.  This should be reported back to the Infection Control Team. 
 
Contact Numbers 
Infection Control: 5284  
Bacteriology lab 5280/8661  
Consultant Microbiologist: 7930/5237/8594 
 
 
Appendix 2: Screening Form 
 
Bacterial Environmental Screening Form  
 
Cubicle Tested:  _________ Ward:                            
Patients ID:  _________ Patient discharge date:                     
Date of Cleaning: _________ Level of Cleaning: ________ 
Bacteria:  _________ 
 
 





Site Swabbed Culture Results 
 1 Floor under sink  
 2 Bathroom door handle  
 3 Chair with arms  
 4 Oxygen outlet (above bed)  
 5 Telephone keypads  
 6 Taps in Patient Bathroom  
 7 Mattress top  
 8 Bed/Cot frame under bed  
 9 Trolley surface   
 10 Side window sill (right hand  
 side) 
 11 Cubicle room exit door handle 
(cubicle side) 
 
 12 Corridor floor outside of 
cubicle/ante room entrance 
 
Please inspect the room prior to screening.  If the room is visibly dirty do not 
screen and inform the infection control team on ext. 5284/bleep 0640. Out of hours 
inform the PEC on duty.  If any of the sites are not present select another site and 
list it on the form.  Always screen 12 sites. 
 
 
Name: ______________ Signature:________________ 
 
 




Site Area to be Swabbed 
 
1 Floor under sink 10cm2 
2 Bathroom door handle Entire handle 
3 Chair with arms Both arms ~5cm2 on each 
4 Oxygen outlet (above bed) Entire surface 
5 Telephone keypads Entire keypad 
6 Taps in Patient Bathroom Entirety of both taps 
7 Mattress top 4 inch2/10cm2 
8 Bed/Cot frame under bed 4 inch2/10cm2 
9 Trolley surface (in ante room if present) 10cm2 
10 Side window sill (right hand side) 4 inch2/10cm2 
11 Cubicle room exit door handle (cubicle 
side) 
Entire handle 
12 Corridor floor outside of cubicle/ante room 
entrance 
10cm2 
If any of the items on the above list are not there (i.e. mattress) or an anteroom is 
not present, please take at least 12 swabs.  Choose which extra places/items to 
swab from the suggested list below.  Please swab any areas which are visibly dirty 
and report them to the Infection Control Team.  Make a note of where each extra 
sample was taken from on the Bacterial Environmental Screening Form in the 
space provided. 
 
Suggested Additional Areas 
 









 Contact Numbers 
Infection Control: 5284 
Bacteriology lab 5280/8661  
Consultant Microbiologist: 7930/5237/8594 
 
 
Appendix 3: Screening Protocol 
 





Enteric viruses can be a source of contamination when a patient who is infected is 
present in a cubicle. These viruses can also survive for long periods in the 
environment and so when a patient with adenovirus or norovirus is discharged or 
moves room, we need to know that the cubicle is free from virus before placing 
another patient inside.  The Infection Control team may ask that you sample 
(swab) a room after cleaning to make sure that all the virus particles have been 
removed. 
 
What you need 
 
Supplies needed on ward (call virology when running low on swabs or pens): 
 Permanent marker pen (to write on tubes) 
 Sterile cotton wool swabs (kept in a clean dry location) 
 Gloves 
 Disposable aprons (white) 
 Polythene specimen bag to put your samples in once taken  
 
Supplies provided upon request by virology (phone virology each time): 
 Batches of  tubes of sterile water (12 per cubicle to be swabbed) 
 Enteric Virus Environmental Screening Form (1 / cubicle - to be 
completed during screening by the person swabbing) 
 
What you do 
 
When you have been asked to screen a cubicle by the Infection Control team: 
 
Call virology and ask for the number Enteric Virus Environmental Screening 
Forms (1 per cubicle) and tubes of sterile water (12 per cubicle) you need. 
If out of hours call bacteriology for tubes - see contact numbers at the bottom of the 
sheet 
Find out from the person in charge the information you need to fill out the Enteric 
Virus Environmental Screening Form and complete it.  
When you have everything from the what you need section including gloves and 
aprons (taken from the clean utility room) put everything in a clean suitable place 
outside of the cubicle i.e. a fold table, or use a clean plastic tray which you can take 
into the room. 
Wash your hands thoroughly with soap and water. 
 Put on a disposable plastic apron and gloves. 
Write on the Enteric Virus Environmental Screening Form in the Swab No. 
column the 
number of the swab you are taking (i.e. 1 – 12) and write in the Site Swabbed 
column which area you are going to sample (use the sites to be included table on 
the back of the form).  Label the tube you are going to use with the swab number, 
label both the lid of the tube and the side of the tube.  Only label one tube at a time!  
Once your tube is labelled and the form written take a clean swab from the pack, 
being careful not to touch the cotton end.   
Enter the cubicle to be screened, open the tube and lightly moisten the swab in the 
water.   
Swab the area (use the Area to be Swabbed description in the table on the back of 
the form to help you) 
Put the cotton end of the swab back into the water in the tube and break off the 
wooden end so that you can do up the lid. 
Put the tube in the clean sample bag. 
Collect the broken wooden ends to be thrown in a sharps bin when you have 
finished taking all your swabs. 
Repeat steps 6 and 7 with each swab to be taken. 
If at any point you think you may have got something on your gloves (i.e. water) you 
must change them for a clean pair. 
Throw away the swab remains in the sharps bin and all gloves and aprons must go 
in a clinical waste bin.  If you have used a tray make sure it is thoroughly washed 
with soap and water. 
Make sure that you wash your hands thoroughly with soap and water. 
Fill in the form on the cubicle door to say that sampling has been carried out. 
Send the completed form and samples to virology using the chute system. 





Site Area to be Swabbed 
 
1 Floor under sink 4 inch2/10cm2 
2 Bedside Lamp controls 10cm2 
3 Chair with arms Both arms 4 inch2/10cm2  
4 Door handle into patient bathroom  Entire handle 
5 Telephone keypads Entire keypad 
6 Taps in Patient Bathroom Entirety of both taps 
7 Mattress top 4 inch2/10cm2 
8 Bed/Cot frame under bed 4 inch2/10cm2 
9 Trolley surface (in ante room if present) 4 inch2/10cm2 
10 Side window sill (right hand side) 4 inch2/10cm2 
11 Cubicle room exit door handle (cubicle side) Entire handle 




Infection Control: 5284 
Virology Lab: 8507 
Bacteriology lab (out of hours only): 5280/8661  
Consultant Microbiologist: 7930/5237/8594 
 
 Appendix 4: Screening form 
 
Enteric Viruses Environmental Screening Form (Noro/Adeno) 
 
Cubicle Tested:  ______    Ward: ________ 
Patients ID:  ______    Patient discharge date: ___   
Date of Cleaning: ______          Level of Cleaning: ____     
Virus: ____________ 
 





Site Swabbed Culture 
Results 
 1 Floor under sink  
 2 Bedside Lamp controls  
 3 Chair with arms  
 4 Door handle into patient bathroom 
(cubicle side) 
 
 5 Telephone keypads  
 6 Taps in Patient Bathroom  
 7 Mattress top  
 8 Bed/Cot frame under bed  
 9 Trolley surface (in ante room if 
present) 
 
 10 Side window sill (right hand side)  
 11 Cubicle room exit door handle 
(cubicle side) 
 
 12 Corridor floor outside of cubicle/ante 
room entrance 
 
Please inspect the room prior to screening.  If the room is visibly dirty do not screen 
and inform the infection control team on ext 5284/bleep 0640.  Out of hours inform 
the PEC on duty.  If any of the sites are not present select another site and list it on 
the form.  Always screen 12 sites. 
 
If the room is being screened for Adenovirus (BMT patients): 
 Any pillows should have been thrown away prior to the room being cleaned.  
Please indicate if this was the case _____________ 
 The clinical waste bin should have been sent to MEDU prior to the room 
being cleaned.  Please indicate if this was the case ________________ 
Name: _________________________  Signature: _________________________ 
 
 




Site Area to be Swabbed 
 
1 Floor under sink 10cm2 
2 Bedside Lamp controls 10cm2 
3 Chair with arms Both arms ~5cm2 
4 Door handle into patient bathroom Entire handle 
 5 Telephone keypads  
6 Taps in Patient Bathroom Entirety of both taps 
7 Mattress top  
8 Bed/Cot frame under bed  
9 Trolley surface (in ante room if present) 10cm2 
10 Side window sill (right hand side) 4 inch2/10cm2 
11 Cubicle room exit door handle (cubicle side) Entire handle 
12 Corridor floor outside of cubicle/ante room  10cm2 
If any of the items on the above list are not there (i.e. mattress) or an anteroom is 
not present, please still take 12 swabs.  Choose which extra places/items to swab 
from either the suggested list below, or areas which are visibly dirty.  Make a note of 
where each extra sample was taken from on the Enteric Viruses Environmental 
Screening Form in the space provided. 
 
Suggested Additional Areas 
 







Infection Control: 5284 
Virology Lab: 8507 
Bacteriology lab (out of hours only): 5280/8661  
Consultant Microbiologist: 7930/5237/8594 
Appendix 5: Environmental air screening protocol for critical ventilation 
systems supplying clinical areas  
 





Microbiological air sampling of mechanically ventilated clinical areas designated 
‘critical’ is required at commissioning and regular validation verification, as 
stipulated in the Ventilation policy.  
Each critically ventilated area will have a ‘schedule’ (currently under protection by 
Estates) describing the design and validation standards. 
Non-HEPA filter supplied areas will usually be designed to ‘Theatre standard’ (</= 
10 or less cfu/m3 if commissioned against HTM 03, </= 35 cfus if HTM 20:25), while 
those areas with HEPA filtration (protective isolation rooms, ward common areas, or 
HEPA filtered theatres) will be expected to provided standard theatre air plus 
additionally be free of detectable fungus.  
 
Test selection and number of samples: 
 
Routine theatre standard air testing - Routine air testing will be carried out with a 
validated air sampling device. Currently the Sampl’air sampler is available to 
 Infection Control but other validated devices are suitable as long as they test a 
minimum of 1m3 of air. 
 
One 1m3 air test will be performed per room e.g. operating theatre, preparation 
room, patient bedroom, room antechamber; multiple tests in large areas e.g. one 
per bed space in open HEPA filtered unit. The device will be located in centre of 
area where patient usually sited. 
 
Additional fungal testing in HEPA filtered areas - Additional tests for bacterial 
and fungal growth will be performed by use of settle plates. 
 
4 plates per operating theatre or room; two per smaller areas e.g. prep or 
antechamber. 
 
Before testing ensure ventilation is to standard and area is clean 
Do not test a commissioned or validated area unless Estates (or designated 
company) have confirmed the mechanical ventilation if performing to standard 
volume, flow and pressure regimen. 
 
What you need: 
 
Supplies required:  
 Permanent marker pen (to write on agar plates) 
 Gloves x 2 
 Disposable overshoes x 2 
 Disposable theatre cap x2 
 Scrubs 
 Surgical mask x 2 
 Sterile/disposable gown x2 
 Polythene specimen bag to put your samples in once taken 
 Rubber bands (to band your plates together for safe transportation) 
 Agar plates  
 One blood agar plate for each air sample 
 Four blood plates for each bedspace or theatre area sampled 
 Two blood plates for each antechamber sampled 
 Sterile filter heads for the air sampler 
 Sampl’air Lite air sampler  
 Tape (to tape up the room whilst settle plates are down) 
 Notice (to say keep out sampling underway) 
 Environmental Screening of Mechanically Ventilated Rooms Form (1 
per area - to be completed during screening by the person carrying out the 
screening) 
 Smoke testing equipment pack 
 Tray/autoclave bag to hold equipment 
 
 
What you do: 
 
Charge Sampl’air lite overnight and ensure that filter heads have been autoclaved 
Before agreeing to sample ventilation performance should be confirmed as working 
to specification with the measurement details sent to estates and to the IP&CT and 
 a level 3 clean has been carried out (wait at least 60 minutes after cleaning before 
sampling to let the chlorine dry thoroughly) 
Before sampling inform the microbiology lab that there will be environmental 
samples collected for processing 
Collect equipment into a tray or autoclave bag and change into scrubs 
When you arrive at the room ensure there is a cleaning sign off sheet on the door 
indicating that a level 3 clean has been carried out 
Wash hands with soap and water (where available), alcohol if not 
Don overshoes, cap, gown, mask and gloves in that order 
Visually inspect the room for cleanliness and for breaches in the building fabric.  
Ensure all clinical equipment and fabric items such as curtains and pillows have 
been removed.  If room has not been cleaned or there is anything that would affect 
sampling DO NOT SAMPLE! Check with estates and IP&CT team 
Undertake smoke testing of the room to ensure the direction of air flow is as 
expected.  If not as expected DO NOT SAMPLE! Check with estates and IP&CT 
team 
Break the smoke tube so that smoke is released being careful not to inhale 
Attach the bulb and press to produce smoke along the door frames, plug sockets 
and other sources of ingress/egress of air 
Label blood agar plates using a permanent pen as written on the Environmental 
Screening of Mechanically Ventilated Rooms Form 
Include date and time of sampling, room sampled, air sample, initials of person 
sampling 
Take a labelled blood agar plate and fit it to the Sampl’air lite 
Remove the protective cover from the top of the air sampler 
Remove the lid of the agar plate 
Clip the base of the agar plate into place on the top of the air sampler 
Place the lid of the agar plate onto the opened sterile filter pack (see step 12)  
Attach the sterile filter head to the Sampl’air Lite: 
Open the sterile pack without touching the inside of the pack 
Lift the filter from the pack by its sides without touching the top filter section 
Attach the filter head onto the top of the Sampl’air Lite, covering the attached agar 
plate without touching it 
Press the on button on the Sampl’air Lite this will bring up a screen saying SAMPLE 
Press the green arrow button; this brings up a message saying 10Min 
Press the right arrow button which changes the 10Min message to 1000L 
Press the green arrow button again, this bring up a message saying START 01:00 
(indicating the sampler will start with a 1 minute delay) 
Enter the first room to sample (always start in the room with the cleanest air and 
work your way backwards e.g. theatre prep, main theatre, anaesthetic room.  Place 
the sampler in the centre of the room, if possible at waist height and press the green 
arrow button to start the sampler. You will then have 1 minute to vacate the space 
before the sampling starts. (You can also start the sampler with a remote from the 
doorway if you can get a good angle to the sampler) 
You must remove yourself from the space that you are sampling completely and 
make sure that all doors are closed. When approaching the doorway to the 
sampling space you should be able to hear the sampler beeping if it has finished.  If 
there is an observation window the sampler has a bar that fills and a counter that 
clocks up as sampling is completed 
When the sampler has finished collect the sampler being sure not to touch the filter 
section on the top. 
 Remove the filter section by holding the sides, ensuring you do not touch the top 
section.  
Place the filter clean side down on the sterile wrapping (e.g. with the top filter 
section raised above the paper) and place the lid of the agar plate onto the agar 
plate before removing it and placing in a specimen bag 
Repeat this process for each room to be sampled.  Change filter heads if you ever 
suspect a contamination event might have occurred or after every 10 air samples 
taken 
When all rooms have had an air sample taken label up settle plates for each room.  
Settle plates should be labelled as per the Environmental Screening of Mechanically 
Ventilated Rooms Form 
Labelling should include date and time of sampling, room sampled, position within 
the room and initials of person sampling. 
Plates should be positioned with the lid of the plate balanced against the edge of the 




In a room with antechamber, settle plates should be placed in the room farthest 
from exit first, being careful not to contaminate them via touch or aerosolized 
droplets.  Plates should then be placed in the antechamber before exit. In a theatre 
plats should be placed in prep room, then theatre. 
When settle plates have been placed leave the sampling area and tape up the 
entrance to prevent others accessing the sampling area, put up notice saying 
Infection Control Sampling Underway.  Use an elastic band to collect together air 
sampling plates and remove PPE  
Give air sampling plates and form to bacteriology for processing (plates will be 
incubated at 37oC for 48 hours and will be read for total viable counts at 24 and 48 
hours) 
Settle plates must be left for a minimum of two hours before collection.  When 
collecting settle plates appropriate PPE must again be worn, remove tape and 
signage.  Sign and date the Mitie form to say sampling has been undertaken. 
Give settle plates to bacteriology for processing (plates will be incubated at 37oC for 
24 and room temperature for a further 48 hours. Plates will be read for total viable 
counts and fungal growth at 24, 48 and 72 hours. 
Email the appropriate project team to say that sampling has been undertaken and 
with a date that the expected results are due. 
When microbiology results are available phone the projects team to let them know 
whether the room has passed or failed and confirm by email (sent to the IP&CT, 
projects team and estates and facilities) 
 
 
 Appendix 6: Screening Form 
 
Environmental Screening of critical ventilated clinical areas:  Form 
 
Area Tested: _______________ Date of Cleaning: ___________ 
 
Level of Cleaning: ___________ Smoke testing as expected (circle):     






(air or settle plate) 
Site Culture Results 
    
    
    
    
    
    
    
    
    
    
    
    
    
    




Please inspect the room prior to screening.  If the room is visibly dirty do not screen 
and inform the infection control team on ext. 5284/bleep 0640.  Out of hours inform 
the floor manager. 
 
 
Name: _____________________________
 Signature:________________________ 
 
